data_6hq1_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6hq1 _Structure_validation_residue.Date_analyzed 2019-10-04 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 CA--C 1.498 -1.058 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -66.8 -38.48 86.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.8 m -63.2 -39.54 94.92 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.34 -40.6 97.75 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.2 mtm -66.85 -40.12 87.8 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.23 -44.2 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.28 -43.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -41.57 97.39 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.27 -43.41 98.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 122.0 -0.438 . . . . 0.0 110.108 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.99 -39.65 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.16 -38.12 89.93 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.51 92.29 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -113.04 68.84 0.68 Allowed 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -84.0 57.13 4.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.88 158.52 34.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.44 -36.99 85.55 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 -7.72 53.84 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.57 -178.58 35.37 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.0 t -101.83 132.8 47.38 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -69.57 154.99 41.19 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -61.78 -42.57 99.17 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.16 -38.24 90.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.1 m -62.29 -38.2 88.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.141 -0.349 . . . . 0.0 110.279 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.75 -49.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.749 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.88 -33.26 65.94 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.101 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.91 -46.55 87.25 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.921 -0.487 . . . . 0.0 109.764 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -61.41 -48.28 81.93 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.1 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.96 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.93 -42.68 97.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.703 -0.623 . . . . 0.0 110.389 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -67.42 -42.05 83.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.983 -0.448 . . . . 0.0 111.826 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -93.99 -21.17 19.35 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.006 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.05 145.66 51.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.38 130.27 37.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.92 160.41 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.08 -178.47 18.73 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.209 -2.356 . . . . 0.0 107.209 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -65.15 -40.13 93.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.68 -38.98 92.86 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.0 93.35 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.9 -40.02 91.48 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.1 t -64.43 -41.57 96.51 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -64.79 -39.1 93.05 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.09 -45.46 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.52 -40.64 97.4 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.83 -43.36 88.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.8 m -63.99 -41.2 97.57 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.979 -0.45 . . . . 0.0 110.094 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.7 mt -62.51 -44.2 99.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.02 -43.18 99.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.61 98.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.923 -0.486 . . . . 0.0 109.962 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.13 -39.12 91.5 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.79 -40.02 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 m -61.13 -43.94 98.1 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -72.29 -16.82 61.9 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.818 -0.551 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.45 2.21 70.66 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -44.08 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.82 136.62 33.01 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 51.3 mttm -85.13 150.97 24.47 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -91.25 138.94 31.2 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -127.11 164.26 21.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -61.77 173.31 1.04 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.132 0.967 . . . . 0.0 110.614 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.55 33.82 57.86 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.38 120.21 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.25 -38.29 3.15 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.86 -62.34 1.7 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.3 m -108.38 -33.72 7.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.48 47.68 33.79 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.8 m -70.68 141.52 51.61 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -131.27 149.04 52.73 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 73.0 mtp85 -117.46 153.48 33.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp . . . . . 0 CA--C 1.496 -1.114 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 CA--C 1.502 -0.881 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 -37.88 89.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -62.45 -39.39 93.19 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.82 -38.69 92.05 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.76 -41.62 95.74 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.43 -43.3 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.16 -43.02 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.06 98.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.32 92.05 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.913 -0.492 . . . . 0.0 110.291 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -63.48 -36.7 84.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.21 85.46 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.09 75.72 1.17 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -83.49 59.6 5.18 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -69.39 167.1 17.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 -38.0 89.11 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 6.46 33.25 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.9 -159.78 34.69 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.0 t -115.31 138.33 51.08 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 78.0 p -72.9 162.01 30.02 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -62.6 -41.82 99.2 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.49 -39.19 93.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.3 m -63.65 -39.25 93.86 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 122.05 -0.406 . . . . 0.0 110.009 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.55 -49.46 84.32 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.029 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.36 -32.64 66.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.925 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.59 -45.39 90.61 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.11 -48.36 82.0 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.62 -45.59 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.178 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.82 -41.15 97.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -69.73 -39.74 76.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.038 -0.414 . . . . 0.0 112.095 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -96.73 -17.99 19.94 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.487 -0.758 . . . . 0.0 112.085 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -129.21 147.6 51.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -82.03 121.57 26.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.89 158.39 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.29 179.29 26.98 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.15 -39.85 90.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -64.22 -38.66 91.83 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.52 91.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -39.94 91.21 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 m -65.14 -39.57 93.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -67.4 -37.72 83.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.81 -48.08 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 121.935 -0.478 . . . . 0.0 110.356 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -66.92 -31.15 71.55 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.188 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.92 -42.67 85.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.6 m -64.9 -40.64 95.41 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.7 mt -62.06 -44.61 99.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -43.05 99.63 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -63.21 -41.48 99.14 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.5 -39.71 95.17 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.705 -0.622 . . . . 0.0 109.375 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.0 -40.69 89.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -61.98 -40.86 97.07 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.9 m -69.98 -27.77 64.98 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 7.26 56.33 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.52 -43.12 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.0 mt -98.26 145.92 26.16 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.7 mttt -84.48 150.91 24.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.93 137.72 32.13 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.4 m -127.3 164.0 22.73 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -60.7 174.2 0.63 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.175 0.988 . . . . 0.0 110.813 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.77 33.02 58.45 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 120.16 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.45 -38.34 3.13 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -62.39 1.69 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 m -108.46 -33.13 7.15 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.09 47.84 28.95 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 72.7 m -70.73 141.01 51.53 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -132.39 147.32 52.38 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 90.8 mtt180 -114.01 154.49 27.56 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -179.265 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.5 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.6 -37.26 86.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m -61.99 -38.97 90.58 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.19 -40.33 97.2 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.3 mtm -65.7 -40.66 92.53 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 14' ' ' ILE . 60.1 mt -63.24 -43.75 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.59 -41.87 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.32 94.31 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.51 -38.7 91.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 10' ' ' ILE . 47.4 mm -66.0 -41.51 89.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -68.34 -24.68 64.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.96 90.97 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -122.36 81.22 1.81 Allowed 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -86.72 47.58 1.51 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.63 156.48 26.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -67.22 -19.17 65.5 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.68 -6.68 59.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.53 -175.63 39.21 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -106.01 132.97 51.46 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.8 150.8 46.48 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -62.45 -41.77 98.99 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -63.81 -39.43 94.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.31 -38.05 89.63 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.67 -48.42 88.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.021 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.85 -35.25 69.8 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.046 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -65.11 -40.69 94.9 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.613 -0.679 . . . . 0.0 109.664 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.52 -49.56 76.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -43.07 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.15 -40.43 97.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.916 -0.49 . . . . 0.0 111.11 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.8 p -83.47 -16.54 45.32 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.369 -0.832 . . . . 0.0 112.032 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.41 -24.94 12.09 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 119.327 0.967 . . . . 0.0 110.27 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.34 149.62 51.05 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.0 120.47 25.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.05 157.19 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.63 -177.75 25.95 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.7 -41.78 91.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.12 -39.58 94.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.18 93.59 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.5 -42.32 96.12 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.4 m -65.52 -39.48 91.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.84 -36.27 82.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.84 -43.9 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -62.51 -40.21 96.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.72 -40.26 95.03 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -65.23 -41.69 94.13 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -63.05 -45.16 99.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.74 -39.35 94.08 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.91 -41.13 97.75 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.85 -39.51 94.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.77 -40.48 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.1 m -61.45 -41.45 97.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.3 m -70.23 -27.66 64.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.45 1.37 59.15 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.16 -42.77 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.94 139.7 30.97 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.2 mttt -84.84 151.08 24.57 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -101.31 138.14 38.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.7 m -123.14 164.21 19.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -60.43 174.8 0.51 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 122.181 0.991 . . . . 0.0 110.868 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.02 58.66 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 108.334 -1.907 . . . . 0.0 108.334 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.95 121.09 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.14 -38.99 2.88 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -62.22 1.75 Allowed 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -108.08 -34.54 6.85 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.67 48.06 37.43 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.0 m -70.27 138.91 51.99 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.7 151.79 51.37 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 87.7 mtm180 -122.41 153.74 38.67 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 tp . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.49 -38.0 86.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.3 t -62.34 -39.92 94.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.27 -41.27 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -67.27 -39.88 86.13 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 14' ' ' ILE . 54.4 mt -62.8 -43.39 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.49 -42.58 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.98 92.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.67 94.64 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.9 mm -65.33 -42.6 94.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.02 -37.7 88.49 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.52 93.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.96 67.56 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -89.44 59.33 4.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.51 161.57 18.51 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.78 -21.63 64.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.82 -7.46 57.89 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.4 177.76 38.64 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -97.63 132.37 43.35 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -71.35 148.59 46.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.63 -42.38 98.81 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.51 -38.55 91.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -66.63 -30.38 70.64 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.741 -0.599 . . . . 0.0 110.24 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.4 mt -63.29 -49.8 81.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.562 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -72.89 -33.44 66.03 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.624 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.0 -45.41 89.12 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -61.47 -48.48 80.94 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.33 -46.07 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.208 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.71 -41.4 96.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.75 -0.594 . . . . 0.0 110.294 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -70.06 -39.85 75.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.948 -0.47 . . . . 0.0 112.192 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -97.19 -15.24 20.97 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.981 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.44 146.76 52.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.43 119.6 25.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.5 161.52 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.83 167.01 52.47 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.57 -22.63 61.71 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -89.87 -1.96 58.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.24 59.31 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.44 -40.2 90.28 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 m -66.03 -40.3 90.9 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.73 -36.96 81.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.79 -43.63 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.49 -39.85 94.81 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.83 -40.86 95.87 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -64.41 -43.67 93.65 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.71 -43.97 99.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.55 -42.31 98.65 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.95 -43.36 99.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.91 -39.75 95.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.419 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.78 -40.37 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -62.04 -41.82 98.52 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -69.86 -27.79 65.12 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.5 8.31 52.68 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.5 -44.65 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.83 143.16 26.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 33.5 tptt -91.78 151.0 20.81 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.04 137.35 35.08 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -128.41 164.0 23.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.24 172.25 1.54 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.065 0.936 . . . . 0.0 110.578 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.15 34.97 57.71 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.51 119.22 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.24 -37.88 3.29 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.52 -62.08 1.78 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.06 -33.16 7.26 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.22 47.75 28.46 Favored Glycine 0 C--N 1.355 1.611 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -70.47 143.12 51.85 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.396 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -129.49 146.87 51.28 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 80.9 mtm180 -124.44 178.26 5.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 CA--C 1.496 -1.132 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.361 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 CA--C 1.501 -0.92 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -66.68 -36.49 82.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -62.24 -36.11 80.98 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.85 -40.23 94.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.02 -40.01 87.15 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.12 -44.09 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.46 -43.16 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.42 98.77 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.94 91.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 122.187 -0.321 . . . . 0.0 110.513 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -69.12 -42.81 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.588 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.86 -19.9 61.89 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.526 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.5 97.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -113.52 77.41 1.05 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -83.64 59.93 5.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.61 163.04 25.82 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.75 -29.57 70.1 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.77 2.11 49.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.53 -165.36 35.29 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -107.86 137.13 46.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -72.57 157.16 38.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.66 -43.74 98.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.883 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.13 -26.9 65.12 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.718 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -65.88 -38.18 88.09 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.04 -48.6 88.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.82 -36.92 67.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.793 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.53 -41.42 96.38 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.547 -0.721 . . . . 0.0 110.167 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -62.02 -48.72 79.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.61 -45.53 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.04 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -64.07 -41.91 97.17 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.549 -0.72 . . . . 0.0 110.318 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 t -69.0 -41.91 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.929 -0.482 . . . . 0.0 111.833 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.17 -20.38 20.53 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.091 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -128.75 147.87 50.81 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.99 119.51 26.37 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.62 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.15 171.39 48.26 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.25 -37.77 84.06 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -73.29 -12.15 60.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.2 62.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.07 -40.8 95.05 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -70.53 -35.6 73.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -66.6 -39.42 88.38 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.86 -44.08 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -41.63 98.46 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.49 -40.08 92.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -64.16 -43.17 95.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.15 -44.94 99.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.98 -39.79 95.77 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -64.32 -41.92 96.56 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -39.44 93.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.59 -40.01 87.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.6 m -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -72.28 -17.21 61.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.882 -0.512 . . . . 0.0 109.689 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.63 5.72 66.51 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.37 -43.89 94.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.6 143.24 30.07 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.04 149.9 23.02 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -87.08 139.7 30.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -128.21 164.19 23.07 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -61.22 174.39 0.7 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.056 0.931 . . . . 0.0 110.632 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.4 58.52 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.98 119.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.81 -38.12 3.22 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.01 -62.98 1.5 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.9 p -109.01 -29.35 8.61 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.25 47.72 56.8 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -70.53 143.75 51.54 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -129.82 145.92 51.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -109.87 150.67 28.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.497 -1.089 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.76 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -66.92 -36.25 81.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -62.89 -37.29 86.35 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.18 -39.46 92.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.4 mtp -65.89 -41.23 91.77 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.19 -43.89 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -62.09 -43.38 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.24 98.2 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -43.17 96.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 122.035 -0.416 . . . . 0.0 110.331 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.2 mt -68.58 -39.62 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.9 -38.42 91.0 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.76 94.87 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 19' ' ' ASN . 78.3 mm-40 -104.01 65.38 0.8 Allowed 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.22 45.34 0.74 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 17' ' ' GLU . 64.2 t30 -68.01 149.65 49.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.99 -37.09 85.78 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -21.5 64.89 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.54 175.76 19.2 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -101.8 126.73 48.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -69.94 154.32 42.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.9 -41.42 97.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.23 -38.61 91.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -61.93 -37.51 84.95 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.43 -48.74 87.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.93 -34.41 66.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.492 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.89 -41.48 97.71 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.444 -0.785 . . . . 0.0 110.038 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -61.87 -48.02 82.4 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.72 -45.04 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.002 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.07 -40.07 95.46 Favored 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 121.67 -0.644 . . . . 0.0 110.367 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 t -70.41 -42.05 72.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 122.028 -0.42 . . . . 0.0 111.795 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -96.73 -14.35 22.07 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.568 -0.708 . . . . 0.0 112.135 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.67 151.03 50.73 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.6 121.6 31.95 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.36 158.41 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.02 175.73 36.87 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.43 -39.86 85.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -66.75 -28.39 68.37 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.14 68.8 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.3 -40.56 94.62 Favored 'General case' 0 C--N 1.353 0.717 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.0 m -66.37 -40.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -65.15 -39.89 93.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.29 -45.84 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.01 -41.47 99.58 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -66.43 -39.49 88.95 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.95 -41.84 95.15 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.04 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.69 -42.32 99.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -42.46 99.57 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.1 -40.24 95.8 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 121.775 -0.578 . . . . 0.0 109.547 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.62 -40.8 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.4 m -62.08 -40.91 97.42 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 -27.64 65.1 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.09 7.77 54.58 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.16 -43.92 91.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.66 147.38 23.36 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -90.43 148.8 22.56 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.65 151.03 26.47 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -141.85 164.14 30.99 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -63.27 172.53 1.88 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 122.036 0.922 . . . . 0.0 110.762 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.27 34.32 58.02 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.41 119.44 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.13 3.2 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.2 1.74 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.3 m -107.74 -32.18 7.74 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.68 47.64 32.61 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -70.53 140.92 51.92 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -131.55 149.07 52.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 81.5 mtm180 -124.87 177.39 6.05 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.565 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.498 -1.042 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -66.64 -35.93 81.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.7 p -62.53 -36.62 83.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.22 -39.24 92.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.2 mtp -66.07 -40.86 91.23 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.32 -42.94 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.86 -42.54 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.103 -0.373 . . . . 0.0 110.123 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.05 94.08 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.061 -0.399 . . . . 0.0 110.172 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.42 -38.08 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -61.57 -36.9 81.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.84 89.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -114.56 69.32 0.71 Allowed 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -82.96 57.95 4.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -80.8 165.73 21.62 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.32 -36.6 84.64 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -8.82 57.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.9 -163.82 33.66 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.1 m -115.97 141.06 48.61 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.6 m -72.87 155.52 39.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.59 -42.38 98.78 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -62.9 -38.64 91.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -62.35 -39.65 93.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.2 mt -60.56 -49.52 84.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.954 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.65 -33.18 66.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.938 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -64.09 -45.41 88.82 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.959 -0.463 . . . . 0.0 109.768 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -61.17 -48.34 82.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.14 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.094 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.72 -41.95 95.61 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 121.68 -0.637 . . . . 0.0 110.407 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -69.05 -42.07 76.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.916 -0.49 . . . . 0.0 111.942 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -94.69 -16.64 22.94 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.526 -0.734 . . . . 0.0 112.138 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.46 147.65 52.18 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.61 120.82 25.56 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.88 157.79 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.58 -179.1 24.78 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.64 -41.3 92.77 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.61 -38.92 92.96 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.86 92.65 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.03 -39.94 91.7 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.1 m -64.72 -39.97 94.54 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.19 -36.6 82.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.36 -45.88 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.34 -40.65 97.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.5 tp -63.63 -44.3 94.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -63.4 -43.07 98.62 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.84 -40.14 95.88 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -63.71 -42.29 97.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.27 -40.51 96.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.48 -40.92 89.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.0 m -61.97 -41.12 97.64 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.7 m -70.08 -27.61 64.75 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.93 8.53 55.43 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.12 -43.5 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.92 143.84 28.77 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -85.4 151.17 24.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -94.87 135.11 36.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.406 ' HG1' ' HG3' ' A' ' 72' ' ' ARG . 4.2 m -119.56 164.46 15.79 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -59.24 175.17 0.33 Allowed 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.095 0.95 . . . . 0.0 110.982 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.26 35.08 53.66 Favored Glycine 0 C--N 1.357 1.741 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.79 119.89 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.1 -38.12 3.2 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -62.37 1.69 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.1 m -108.48 -35.1 6.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.5 47.86 32.67 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 64.4 m -70.58 143.46 51.54 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -130.81 151.42 51.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG3' ' HG1' ' A' ' 62' ' ' THR . 80.4 mtm180 -122.0 164.92 16.83 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.439 -0.998 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -67.83 -34.74 77.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -61.43 -38.13 86.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.08 -43.64 98.4 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -39.9 89.96 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.7 -44.79 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.17 -42.26 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.23 -42.77 99.19 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.25 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.51 -39.86 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -64.73 -37.62 88.22 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.493 -0.755 . . . . 0.0 109.017 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.63 91.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -106.96 68.84 0.74 Allowed 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -79.98 51.79 1.4 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -70.02 147.95 49.44 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -61.97 -37.65 85.59 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.44 -9.41 58.5 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.87 169.89 28.61 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 t -95.34 128.91 42.57 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -71.29 157.16 38.6 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -60.8 -42.57 97.87 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -63.15 -39.27 94.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.2 m -63.46 -39.03 93.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.04 -49.4 84.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.71 -32.89 66.06 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.131 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.66 -45.65 93.13 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.833 -0.542 . . . . 0.0 109.687 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.29 -48.2 82.48 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.99 -45.02 99.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.17 -39.59 94.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.486 -0.759 . . . . 0.0 110.211 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.36 -39.93 74.33 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.001 -0.437 . . . . 0.0 112.075 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -98.25 -16.94 19.21 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.841 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.09 147.4 52.61 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -84.52 121.52 27.71 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.0 159.49 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.54 179.44 26.7 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.09 -40.85 91.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.36 -38.57 91.66 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.76 91.42 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.89 -39.68 90.17 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.11 -40.38 94.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.69 -37.01 81.71 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -45.36 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.98 -40.18 96.95 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.29 -44.19 92.44 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.1 t -63.27 -42.81 99.16 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.21 -42.65 99.49 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.56 -42.12 99.34 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.7 -40.71 97.46 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.808 -0.557 . . . . 0.0 109.574 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -66.0 -40.71 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.4 m -62.04 -40.97 97.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.1 m -69.86 -27.64 65.0 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.76 8.33 54.46 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.17 -43.49 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -98.29 144.82 27.3 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -84.73 151.1 24.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -87.87 137.58 32.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -127.59 164.49 21.89 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.51 173.5 0.7 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.09 0.948 . . . . 0.0 110.509 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.15 32.97 57.75 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.7 119.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -37.81 3.32 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.92 -63.07 1.47 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.9 p -109.32 -30.49 7.96 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 48.0 37.95 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -70.46 143.05 51.89 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -132.18 149.57 52.36 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -118.9 165.4 14.11 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 CA--C 1.499 -1.007 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -67.0 -36.4 82.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -63.08 -36.33 83.22 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.08 -40.35 94.52 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -66.66 -40.4 88.62 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.441 ' O ' HG12 ' A' ' 14' ' ' ILE . 53.7 mt -63.66 -43.5 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.5 -42.4 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.24 93.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.36 93.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.0 mm -65.8 -44.0 93.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.21 -35.75 81.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.45 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -116.11 71.56 0.79 Allowed 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -86.82 58.99 5.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -80.51 162.12 24.5 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.9 -27.68 66.86 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -1.73 47.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -177.59 37.62 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 t -98.93 129.44 45.26 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -70.44 150.72 45.93 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -61.75 -43.53 98.68 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.318 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.09 -38.97 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.26 -38.12 89.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.6 mt -61.37 -49.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 121.975 -0.453 . . . . 0.0 110.331 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.9 -33.86 68.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.076 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.28 -40.85 86.17 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.92 -49.07 77.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.63 -44.99 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.849 -0.532 . . . . 0.0 110.408 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -69.08 -39.66 78.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.808 -0.558 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.08 -20.19 18.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.966 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.8 146.27 51.54 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -75.27 135.1 40.96 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.48 160.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.48 -178.63 17.54 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.03 -40.27 94.59 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -65.1 -39.43 93.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.76 91.98 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.01 -40.65 94.36 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 95.1 p -69.55 -34.84 74.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -68.39 -36.12 78.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.87 -39.89 95.81 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.92 -42.34 85.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -62.7 -44.92 94.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.202 -0.311 . . . . 0.0 110.59 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 pt -67.48 -34.24 67.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.925 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.95 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.5 -39.43 93.49 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.76 -40.69 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.2 m -61.42 -44.34 97.3 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.099 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.2 p -73.0 -15.92 61.52 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.898 -0.501 . . . . 0.0 109.835 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.67 6.18 66.01 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.09 -43.83 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.67 138.08 35.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -87.82 151.97 22.46 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -83.98 135.46 34.44 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.445 ' HG1' ' HG3' ' A' ' 72' ' ' ARG . 3.6 m -127.14 164.15 22.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -60.15 172.5 0.8 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.109 0.957 . . . . 0.0 110.671 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.22 33.09 57.42 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.56 119.11 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.93 -37.87 3.31 Favored Glycine 0 C--N 1.351 1.395 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.9 -62.97 1.5 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.7 p -108.96 -30.3 8.16 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.36 47.75 49.5 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.8 m -70.19 144.58 51.89 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.583 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -130.07 148.92 51.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.445 ' HG3' ' HG1' ' A' ' 62' ' ' THR . 80.7 mtm180 -120.07 169.75 9.92 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 CA--C 1.495 -1.145 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -66.63 -38.3 86.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.0 m -63.29 -40.57 97.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.91 -39.92 95.3 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mtp -66.37 -40.49 89.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.03 -43.73 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.6 t -62.49 -41.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.33 98.33 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.14 97.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.72 -40.49 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.95 -36.54 84.72 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.97 90.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -121.67 73.67 1.08 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -84.68 57.69 4.5 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -66.11 148.41 51.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -62.16 -38.52 89.34 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.87 65.61 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.14 170.58 14.36 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.5 m -97.77 130.48 44.71 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -69.24 146.45 52.31 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -61.46 -40.57 94.99 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.74 -38.47 91.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -61.78 -39.88 93.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.09 -48.89 86.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.082 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.42 -34.87 68.14 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.409 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -66.56 -40.65 89.11 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.551 -0.718 . . . . 0.0 110.171 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.71 -48.68 79.66 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.28 -45.75 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.42 -41.77 96.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.744 -0.597 . . . . 0.0 110.448 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.0 m -70.22 -39.88 74.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.962 -0.461 . . . . 0.0 112.128 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -96.33 -16.75 21.13 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.873 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.35 147.64 52.59 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -84.23 121.43 27.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.83 156.41 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.89 179.62 34.14 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.1 -41.67 90.29 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.79 -39.02 93.25 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.63 91.88 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -60.91 -42.63 98.43 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -65.14 -39.19 92.68 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.38 -38.39 90.87 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.45 -45.02 99.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.27 -41.85 98.82 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.9 tp -66.57 -41.96 87.76 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -62.5 -42.76 99.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.58 -45.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -63.89 -40.51 96.7 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -62.94 -41.74 99.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.87 -39.27 93.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 m -61.5 -41.09 96.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -70.05 -27.94 65.06 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 7.58 56.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.38 -43.24 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.17 146.19 26.41 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -84.66 150.75 24.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -91.43 138.41 31.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 m -128.02 163.65 24.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -61.27 171.53 1.34 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.063 0.935 . . . . 0.0 110.574 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.22 23.89 64.86 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.88 120.61 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.595 0.712 . . . . 0.0 109.146 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.24 -38.92 2.91 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.41 -62.4 1.7 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -108.6 -33.47 7.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.22 20.4 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.9 m -70.25 140.87 52.48 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -131.22 149.67 52.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -117.68 158.04 25.39 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 CA--C 1.497 -1.089 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.506 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -68.22 -37.31 80.71 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.7 p -63.59 -34.69 78.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.7 -42.79 95.05 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.46 -41.03 93.84 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.452 ' O ' HG12 ' A' ' 14' ' ' ILE . 64.4 mt -63.14 -44.41 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.37 -43.08 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.36 95.05 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.05 93.03 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.8 mm -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.26 -27.37 64.38 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.111 -0.368 . . . . 0.0 110.079 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.16 95.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.84 75.08 0.97 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -85.68 59.45 5.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -79.6 152.89 29.8 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.36 -37.27 86.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.06 64.66 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 173.92 16.49 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.5 p -96.16 137.56 35.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.5 p -77.34 159.69 29.35 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -65.32 -39.96 93.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -63.3 -39.67 95.23 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -61.95 -39.87 93.58 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.8 mt -60.82 -49.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.201 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.52 -33.74 67.11 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.001 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.61 -46.11 89.77 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.85 -48.81 78.85 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.57 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.172 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.77 -18.15 62.77 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.0 m -89.17 -35.75 16.06 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.501 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -100.88 -12.2 19.18 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.74 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 152.06 51.61 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 124.66 31.62 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.01 160.41 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.72 -178.07 19.29 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.93 -41.65 95.34 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -63.85 -38.84 92.57 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -38.81 92.38 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.73 -39.95 90.53 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.2 t -64.72 -41.64 95.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -64.72 -38.49 91.18 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.67 -45.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -62.33 -41.8 98.85 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.54 -39.42 88.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.9 -40.96 95.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.57 -44.82 99.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.44 -39.34 94.23 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.1 -40.95 97.33 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.75 -39.65 94.78 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.21 -40.72 89.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 m -61.42 -41.63 97.47 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -70.33 -27.74 64.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.67 56.28 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.21 -43.33 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.71 146.14 31.16 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -84.72 150.61 24.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.09 137.29 34.35 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 m -122.96 164.01 19.31 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -61.0 174.09 0.69 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.1 0.952 . . . . 0.0 110.627 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.8 33.1 58.29 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.38 120.12 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.78 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.96 -62.53 1.64 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -108.44 -34.14 6.86 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.41 48.42 24.18 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -70.86 141.84 51.23 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -130.98 148.74 52.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -118.09 158.14 25.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.7 tp . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.496 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -68.19 -37.33 80.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -62.42 -38.92 91.59 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.14 -41.36 99.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.4 mmt -66.47 -40.38 89.31 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 14' ' ' ILE . 57.1 mt -63.29 -43.48 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.71 -42.22 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.78 94.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 10' ' ' ILE . 48.1 mm -67.51 -41.66 86.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -62.95 -36.94 85.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.979 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.57 84.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.76 82.06 1.98 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.024 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.03 58.28 4.33 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.33 148.47 51.61 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.23 -36.4 83.53 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -5.65 44.85 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.51 167.18 27.56 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -86.72 133.34 33.68 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.3 t -69.09 147.61 51.22 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -61.09 -41.45 96.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.56 -38.31 90.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.9 m -63.05 -38.39 90.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 122.057 -0.402 . . . . 0.0 110.199 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -60.96 -49.73 83.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.937 -0.477 . . . . 0.0 110.017 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.73 -34.06 66.81 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.769 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.25 -45.37 91.87 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.09 -49.13 78.57 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.74 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.169 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -65.43 -41.43 93.54 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.689 -0.632 . . . . 0.0 110.593 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.5 m -69.36 -39.98 77.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 112.026 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -97.18 -15.79 20.72 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.447 -0.783 . . . . 0.0 111.657 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -133.47 147.19 51.66 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.96 126.61 32.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.97 157.32 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.27 176.5 34.24 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.49 -41.56 88.75 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.95 -38.97 93.03 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.36 94.52 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -60.82 -42.12 97.07 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -65.59 -39.54 91.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.85 -34.0 76.84 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.6 mt -60.49 -43.53 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.29 -39.78 89.58 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.4 m -64.5 -41.73 96.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.1 mt -63.16 -44.2 99.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -62.35 -42.95 99.8 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -62.45 -42.52 99.52 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.57 -39.55 94.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.72 -40.55 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.8 m -61.76 -43.57 98.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.068 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -72.44 -15.93 61.82 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.782 -0.574 . . . . 0.0 109.72 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.55 2.94 69.49 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.28 -44.3 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mp -97.12 143.53 27.84 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.2 mttt -84.85 150.65 24.85 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -96.27 138.37 33.98 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 70' ' ' SER . 2.4 m -123.7 164.39 19.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -63.09 174.92 0.99 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.115 0.959 . . . . 0.0 110.568 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.22 33.55 59.0 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.2 t -70.55 120.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.02 -62.32 1.71 Allowed 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -108.46 -34.62 6.71 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.53 47.88 25.8 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 60.8 m -70.61 141.5 51.75 Favored 'General case' 0 C--N 1.358 0.963 0 CA-C-N 118.109 0.954 . . . . 0.0 108.464 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -131.85 150.02 52.28 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.413 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 88.6 mtm180 -122.25 155.57 35.61 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -67.36 -37.45 83.23 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -62.52 -39.11 92.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.62 -43.17 97.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.425 ' HB3' HG12 ' A' ' 32' ' ' ILE . 77.8 mtm -65.58 -39.96 92.19 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' HG12 ' A' ' 14' ' ' ILE . 61.4 mt -62.36 -44.16 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.82 -42.5 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.56 91.83 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.95 95.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 10' ' ' ILE . 39.7 mm -69.39 -41.56 80.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.01 -39.23 93.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -40.92 93.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.74 71.24 0.88 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.78 58.52 5.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.14 164.2 25.88 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.01 -38.76 92.47 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.25 -4.49 42.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.4 -171.75 35.44 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 t -105.47 132.06 52.11 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -69.5 155.15 40.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.02 -43.07 99.44 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.98 -39.14 93.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.6 m -62.98 -38.53 91.49 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.66 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 121.987 -0.445 . . . . 0.0 110.187 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.91 -33.01 65.73 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.084 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.28 -44.64 94.52 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.24 -48.73 80.14 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 9' ' ' MET . 95.6 mt -63.08 -45.11 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.199 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.29 -40.39 95.86 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.861 -0.525 . . . . 0.0 111.398 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -83.73 -14.79 50.76 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.568 -0.707 . . . . 0.0 112.358 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.39 -20.71 12.15 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 119.538 1.063 . . . . 0.0 110.651 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -129.75 149.02 51.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.92 121.11 25.6 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.17 161.44 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.57 170.08 51.6 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.31 -37.75 83.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -80.58 0.31 34.51 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.22 63.27 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -40.07 89.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -66.61 -39.96 88.59 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -66.14 -39.74 90.08 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.38 -45.35 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.71 -40.46 97.21 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.39 -42.88 92.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.5 t -63.13 -43.71 97.65 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.28 -43.78 98.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -61.1 -43.01 99.54 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.55 -41.16 98.45 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.38 -39.16 92.29 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.7 t -66.69 -39.73 84.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 m -60.98 -44.34 97.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.006 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 p -72.58 -16.94 61.74 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 109.55 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.99 70.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -65.5 -44.75 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.25 149.3 24.67 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 84.8 tttt -97.16 142.27 29.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -81.61 139.53 34.97 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -131.15 163.87 26.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.9 175.47 1.17 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.982 0.896 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.23 31.47 59.37 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -70.25 119.45 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.06 3.25 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.11 -63.45 1.39 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 p -109.28 -29.54 8.43 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.88 38.62 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -70.6 143.14 51.61 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -132.45 149.74 52.28 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 72.3 mtp180 -127.27 177.52 6.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.496 -1.115 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 -35.34 79.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -62.5 -37.19 85.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.4 mtp -66.81 -40.21 87.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.63 -43.02 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.3 98.8 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.68 91.89 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 122.085 -0.384 . . . . 0.0 110.401 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.23 -39.74 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -63.26 -38.62 91.88 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.62 93.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.12 67.48 0.65 Allowed 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -83.98 58.35 4.66 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.12 155.13 39.99 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -67.27 -19.99 65.58 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.01 -2.74 58.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 177.7 41.43 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -105.4 130.93 53.39 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 m -68.94 153.56 43.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -62.21 -41.4 98.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.98 -38.49 91.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.7 m -61.97 -37.81 86.18 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.66 -48.6 87.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -73.13 -37.13 66.75 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.487 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.1 -40.43 96.2 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.273 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.65 -48.52 80.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.0 mt -62.86 -44.95 99.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.165 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.49 -38.56 91.46 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.747 -0.596 . . . . 0.0 111.55 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.0 p -86.38 -15.34 40.7 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.485 -0.76 . . . . 0.0 112.256 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -110.48 -20.03 12.72 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 119.373 0.988 . . . . 0.0 110.465 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.42 150.15 52.26 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -86.24 118.38 25.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.85 161.69 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.22 167.41 50.83 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.87 -19.14 61.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -90.94 -1.61 57.81 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.47 -25.6 62.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.42 -39.01 85.88 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.6 t -63.79 -43.57 95.93 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -68.34 -37.84 80.92 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.34 -46.36 96.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.27 -39.91 95.92 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.94 -44.87 94.88 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -64.94 -41.74 95.25 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.61 -44.46 99.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.66 -43.44 98.85 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.58 -41.97 98.32 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.31 -39.43 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.09 -39.84 86.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.2 m -60.91 -42.83 98.82 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -70.22 -27.88 64.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.94 54.16 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.68 -43.35 93.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.01 142.96 29.08 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.18 151.55 22.61 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.85 138.39 32.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -128.68 164.09 23.69 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -61.01 174.1 0.69 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.062 0.934 . . . . 0.0 110.572 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.98 32.9 58.19 Favored Glycine 0 C--N 1.357 1.712 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.69 119.15 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -37.92 3.29 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.73 -63.03 1.48 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 p -108.92 -29.88 8.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.06 47.85 43.44 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.1 m -70.33 142.51 52.19 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -130.98 149.44 52.6 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -119.27 164.95 14.89 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.737 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttp . . . . . 0 N--CA 1.437 -1.11 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -67.53 -35.54 79.29 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -61.82 -38.7 89.13 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.45 -40.99 98.39 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.4 mtt -67.02 -40.23 87.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.67 -43.35 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.43 -43.57 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.0 98.71 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.74 -44.58 93.08 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 122.043 -0.411 . . . . 0.0 110.161 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.14 -39.89 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -63.6 -39.4 94.27 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.82 96.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -105.88 63.8 0.68 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -86.28 59.78 5.84 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -80.99 168.36 18.79 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -64.63 -36.89 85.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.64 -5.29 49.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.47 -167.83 32.88 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.7 t -107.21 131.63 53.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -71.6 158.24 36.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -60.61 -44.84 95.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -64.82 -37.7 88.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.9 m -62.87 -38.43 90.82 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 122.275 -0.266 . . . . 0.0 110.646 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -61.17 -49.95 82.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.232 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -73.11 -33.13 65.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.004 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.28 -45.84 89.58 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -61.36 -48.41 81.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.16 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.894 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.49 -41.45 96.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.655 -0.653 . . . . 0.0 110.313 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.89 -39.87 76.0 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.934 -0.479 . . . . 0.0 112.066 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -97.09 -16.42 20.52 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.959 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.59 147.08 52.23 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -81.1 121.92 26.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.13 157.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.82 -179.93 25.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -65.97 -39.77 90.66 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -64.4 -39.31 93.6 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.64 91.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.77 -40.21 91.67 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.9 p -68.04 -35.88 78.98 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -68.83 -35.72 77.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.88 -44.24 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.79 -40.54 97.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.08 -40.85 91.15 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -64.4 -43.42 94.48 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.73 -44.77 99.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.87 -43.82 98.08 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.82 -41.95 97.76 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 121.895 -0.503 . . . . 0.0 110.089 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.99 -39.97 94.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.655 -0.653 . . . . 0.0 109.428 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.2 t -65.26 -40.02 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 m -61.16 -43.55 98.71 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.827 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.0 p -72.29 -17.19 61.89 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.845 -0.535 . . . . 0.0 109.742 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.02 7.41 65.93 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.4 -42.96 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.1 mt -97.64 143.68 28.06 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 151.86 21.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -90.39 134.5 34.3 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.7 m -121.82 164.16 17.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -58.83 174.79 0.32 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.109 0.956 . . . . 0.0 111.042 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.63 53.38 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.9 119.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.48 -38.14 3.2 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.02 1.8 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.34 -34.43 6.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.08 47.23 38.87 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.1 m -71.04 142.85 50.89 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -131.3 151.37 51.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -120.57 168.89 10.88 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 CA--C 1.497 -1.081 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.745 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.15 -39.22 89.64 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.0 p -64.71 -36.57 84.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.48 -42.74 91.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.428 ' HB3' HG12 ' A' ' 32' ' ' ILE . 78.1 mtm -65.93 -39.5 90.56 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.83 -43.53 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.91 -43.92 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.6 98.88 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.68 93.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.146 -0.346 . . . . 0.0 110.142 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.69 -40.09 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.96 -39.87 95.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.38 97.51 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -107.64 66.72 0.67 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.84 59.7 4.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -75.01 150.65 38.88 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -68.34 -27.01 65.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -6.57 56.58 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.51 166.73 31.01 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -94.96 129.38 42.03 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -66.56 147.32 53.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -61.53 -40.52 94.94 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.17 -38.91 92.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -63.03 -36.54 83.9 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.25 -50.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.922 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.33 -32.92 64.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.24 -45.49 93.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.33 -47.83 84.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.428 HG12 ' HB3' ' A' ' 9' ' ' MET . 95.2 mt -61.64 -46.56 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.19 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.14 -41.15 95.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.22 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.8 -39.83 76.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.914 -0.491 . . . . 0.0 112.237 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -97.8 -15.36 20.3 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.504 -0.747 . . . . 0.0 112.019 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -130.28 147.48 52.01 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.88 119.64 24.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.43 161.23 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.08 171.96 52.46 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.33 -39.83 85.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -77.82 -5.35 50.56 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.23 80.51 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.5 -38.95 82.25 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 t -63.66 -42.93 98.01 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -36.64 81.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.45 -43.06 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.81 -41.08 97.32 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.17 -40.9 90.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.5 m -65.65 -42.05 91.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.11 -44.37 99.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -61.85 -43.72 98.27 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.51 -41.71 98.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 121.967 -0.458 . . . . 0.0 110.049 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.03 -39.7 95.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.601 -0.687 . . . . 0.0 109.215 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.52 -40.12 87.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -61.19 -41.34 96.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.1 m -70.31 -27.62 64.53 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.99 8.05 55.79 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.26 -44.02 91.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.95 147.68 22.87 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -92.72 149.45 21.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -81.95 151.66 27.1 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 m -142.98 163.67 32.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -60.39 172.0 0.95 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.192 0.996 . . . . 0.0 110.865 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.99 33.04 57.98 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.6 t -70.57 119.88 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -38.12 3.21 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.47 1.65 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.5 m -108.52 -33.41 7.05 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.91 48.39 16.46 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 107.379 -2.288 . . . . 0.0 107.379 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.3 m -70.26 142.34 52.33 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -130.94 149.22 52.67 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 14.8 mmm180 -123.32 177.52 5.56 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.578 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 CA--C 1.498 -1.049 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -67.14 -36.24 81.44 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.6 m -61.83 -38.85 89.73 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.42 -41.44 98.7 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.7 -39.22 84.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.04 -43.29 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.22 -43.2 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.96 98.55 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.26 93.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.997 -0.439 . . . . 0.0 110.283 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.95 -39.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -63.55 -39.15 93.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.79 95.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -107.72 65.13 0.64 Allowed 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -86.15 59.25 5.53 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.85 168.86 18.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -37.13 86.54 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.05 -2.46 40.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.16 38.48 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 t -111.38 132.12 54.67 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.4 p -73.08 162.26 29.67 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -63.36 -40.71 98.03 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.47 -39.01 93.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.5 m -63.32 -38.78 92.47 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.04 -0.412 . . . . 0.0 109.904 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.3 -49.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.109 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.57 -33.44 66.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.972 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.11 -45.35 88.98 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.857 -0.527 . . . . 0.0 109.657 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.33 -48.64 80.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.41 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.085 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.01 -41.83 95.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.791 -0.568 . . . . 0.0 110.411 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.9 m -69.33 -40.06 77.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.85 -0.531 . . . . 0.0 112.08 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -98.18 -14.23 20.48 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.957 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -133.66 148.19 51.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -81.27 127.23 32.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.54 157.16 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.49 177.63 30.93 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.9 -42.07 90.68 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.54 -39.61 94.08 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.6 95.11 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.67 -41.87 95.92 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.3 m -65.51 -39.84 92.31 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.7 -34.88 78.83 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.37 -44.64 96.45 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.02 -40.34 97.46 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.95 -40.73 91.59 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -64.11 -42.89 96.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.83 -44.56 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -62.07 -43.28 99.18 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.45 98.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.995 -0.441 . . . . 0.0 109.996 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -39.43 92.54 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -66.13 -40.19 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 m -60.85 -44.55 96.83 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -73.04 -15.94 61.5 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.812 -0.555 . . . . 0.0 109.877 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.68 64.72 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.25 -43.22 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.29 145.67 26.42 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -88.73 151.9 22.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -81.77 151.94 27.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 m -143.52 164.06 31.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -59.24 167.17 1.88 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.181 0.991 . . . . 0.0 110.794 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.59 61.75 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.79 118.42 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.28 -38.33 3.14 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.67 1.92 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.7 m -107.54 -32.09 7.84 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 47.59 28.67 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 m -70.87 141.42 51.23 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -133.11 150.15 52.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -118.39 166.3 12.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.496 -1.11 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.668 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 CA--C 1.501 -0.915 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -65.03 -37.95 89.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.5 m -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.5 -40.1 96.18 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.4 mtm -66.46 -40.22 89.26 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.05 -43.93 99.3 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.9 t -62.45 -43.02 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.62 99.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.58 91.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.029 -0.419 . . . . 0.0 110.282 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.2 mt -69.35 -39.63 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.49 -39.22 93.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.88 96.12 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -107.5 65.79 0.65 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -82.92 59.34 4.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -77.34 151.65 34.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.64 -37.34 86.96 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.0 64.71 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.35 175.45 15.5 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -100.07 131.69 45.87 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 t -70.46 145.99 50.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.26 -40.65 96.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.85 -38.87 92.71 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.1 m -62.56 -37.33 85.75 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.74 -48.65 87.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.792 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -72.17 -37.32 69.35 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.354 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.99 -41.2 97.58 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.49 -0.756 . . . . 0.0 109.944 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -61.7 -48.49 80.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.85 -45.4 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.083 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.27 -39.81 94.7 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.645 -0.659 . . . . 0.0 110.383 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 t -70.57 -41.98 71.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.887 -0.508 . . . . 0.0 111.72 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -92.87 -21.17 20.02 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.031 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -128.82 146.82 50.82 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -87.5 120.91 29.28 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.04 160.2 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.64 173.99 51.45 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.84 -40.12 83.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.91 -14.93 61.57 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.93 -35.62 81.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.62 -41.25 90.01 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -64.85 -39.9 94.29 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -67.07 -37.07 83.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.88 -41.71 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.63 -40.29 94.34 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.55 -39.84 88.76 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -64.81 -41.58 95.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.078 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 pt -70.11 -34.84 60.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.169 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.26 -39.79 89.7 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -64.57 -41.98 95.94 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.17 -39.36 94.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.46 -40.36 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 m -61.09 -44.41 97.4 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.1 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.4 p -73.17 -16.35 61.43 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.749 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.71 65.51 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.13 -43.46 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.53 142.86 31.43 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 27.8 mtpp -84.68 150.83 24.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -87.49 139.08 30.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 m -129.98 163.95 25.32 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -62.53 170.47 2.45 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.09 0.948 . . . . 0.0 110.602 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 29.51 62.97 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.67 119.16 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.16 -38.66 3.01 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.81 1.87 Allowed 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 m -107.46 -32.32 7.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.4 47.19 36.8 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.5 m -70.95 140.71 51.01 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -130.31 147.32 52.01 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 69.9 mtp180 -115.15 149.05 38.22 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 CA--C 1.498 -1.044 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -68.53 -29.2 67.73 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 84.4 p -63.23 -26.82 68.97 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.81 -42.2 97.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.18 -40.16 82.33 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.59 -43.22 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.18 -42.72 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.63 -42.02 98.3 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.4 93.17 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.97 -0.456 . . . . 0.0 110.244 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.51 -39.33 76.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.421 ' HG3' ' HE3' ' A' ' 18' ' ' LYS . 46.3 tt0 -62.17 -37.76 86.49 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.1 85.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.04 79.19 1.82 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.265 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HE3' ' HG3' ' A' ' 15' ' ' GLN . 97.3 mttt -83.25 58.73 4.62 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -66.05 151.54 46.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.66 -35.89 81.11 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.77 -5.57 46.46 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.84 170.1 35.41 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -95.46 130.67 42.19 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -67.99 151.02 47.74 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -61.69 -41.44 97.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.49 -38.73 92.25 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.7 t -62.37 -39.93 94.77 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.54 -48.83 86.86 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 O-C-N 122.005 -0.435 . . . . 0.0 110.09 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -72.67 -33.98 66.91 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.318 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -66.21 -40.68 90.52 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.42 -48.57 80.57 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.34 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.17 -41.94 96.91 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.77 -0.582 . . . . 0.0 110.457 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -69.46 -39.96 77.42 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.863 -0.523 . . . . 0.0 111.987 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -94.75 -21.21 18.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.569 -0.707 . . . . 0.0 111.826 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -128.62 143.38 50.94 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -77.44 128.1 33.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.81 158.23 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.64 -179.92 28.02 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.52 -31.87 69.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.14 -38.25 81.97 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.36 90.82 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.67 -40.44 92.11 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.31 -39.85 93.01 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -65.3 -39.06 92.02 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.17 -45.0 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.36 -42.1 99.14 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.34 -39.49 85.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -63.58 -43.69 96.25 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.21 -45.39 98.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.9 -39.98 95.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.917 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.76 -41.21 96.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.855 -0.528 . . . . 0.0 109.809 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.99 -39.72 95.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.4 -40.58 88.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -61.18 -41.7 97.26 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -70.22 -27.79 64.75 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.34 8.03 55.35 Favored Glycine 0 C--N 1.349 1.288 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.27 -43.36 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.87 143.8 28.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 87.0 mttt -84.68 150.95 24.79 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -86.76 151.65 23.2 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 m -142.35 164.36 30.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.59 167.9 2.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 122.01 0.91 . . . . 0.0 110.663 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.19 26.63 67.94 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.16 120.76 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.91 0.862 . . . . 0.0 108.832 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -38.82 2.95 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -61.9 1.84 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -107.79 -31.48 8.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.84 48.05 29.54 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -70.51 141.02 51.98 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -132.13 149.46 52.39 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 75.4 mtp180 -116.06 152.62 33.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.5 -0.958 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 CA--C 1.497 -1.067 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.36 -39.17 88.99 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.0 p -65.13 -38.68 91.43 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.836 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.51 -40.08 92.59 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.5 mtp -66.82 -40.49 88.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -64.39 -43.23 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.05 -43.43 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.85 98.35 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.34 93.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 122.003 -0.436 . . . . 0.0 110.246 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.5 mt -68.93 -38.81 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.72 -40.39 97.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.81 96.86 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -106.63 65.37 0.67 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -81.63 57.62 3.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.34 148.12 43.76 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -63.59 -36.64 84.47 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.91 64.98 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.01 169.51 14.74 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 t -99.61 126.05 45.53 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -70.19 153.4 43.16 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -62.14 -41.39 98.22 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.6 -38.2 90.23 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.3 m -63.72 -38.28 90.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.6 mt -60.93 -49.78 83.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.66 -32.84 66.14 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.944 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -62.9 -45.31 93.1 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.815 -0.553 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -61.11 -47.89 84.17 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.46 -46.08 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.197 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.98 -39.56 93.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.518 -0.738 . . . . 0.0 110.29 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.39 -39.87 74.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.999 -0.438 . . . . 0.0 112.18 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -99.61 -13.59 19.33 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.13 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.36 148.84 52.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -87.14 118.56 26.62 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.91 157.96 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.01 177.27 35.21 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -39.29 87.61 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -63.79 -38.31 90.64 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.11 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.77 -40.37 92.32 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -65.28 -39.96 93.27 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.79 -38.2 88.34 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.54 -45.32 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.57 -41.24 98.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.98 -39.59 87.2 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.8 m -64.72 -40.75 95.88 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.2 mt -62.13 -45.33 98.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -64.02 -39.95 95.25 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.2 -40.97 99.0 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.21 -38.45 89.21 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.46 -40.64 88.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -60.78 -44.18 97.13 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.082 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.9 p -72.89 -16.72 61.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.773 -0.58 . . . . 0.0 109.725 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.86 7.6 64.32 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.5 -43.23 94.42 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.7 mt -99.43 146.78 25.95 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -86.1 151.9 23.31 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.16 136.26 33.12 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -127.8 163.7 23.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -58.81 172.04 0.58 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.146 0.974 . . . . 0.0 110.845 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 32.18 57.33 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.73 119.47 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -37.94 3.29 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -63.3 1.42 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.1 p -108.75 -29.08 8.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.49 47.93 39.59 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.4 m -70.27 139.76 52.22 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -132.93 150.29 52.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -114.94 154.28 29.02 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -84.88 -10.77 56.79 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -136.94 83.28 28.9 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.41 -76.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.746 1.631 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -131.72 146.83 52.38 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -66.8 -38.48 86.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.8 m -63.2 -39.54 94.92 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.34 -40.6 97.75 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.2 mtm -66.85 -40.12 87.8 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.23 -44.2 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.28 -43.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -41.57 97.39 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.27 -43.41 98.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 122.0 -0.438 . . . . 0.0 110.108 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.99 -39.65 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.16 -38.12 89.93 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.51 92.29 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -113.04 68.84 0.68 Allowed 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -84.0 57.13 4.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.88 158.52 34.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.44 -36.99 85.55 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 -7.72 53.84 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.57 -178.58 35.37 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.0 t -101.83 132.8 47.38 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -69.57 154.99 41.19 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -61.78 -42.57 99.17 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.16 -38.24 90.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.1 m -62.29 -38.2 88.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.141 -0.349 . . . . 0.0 110.279 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.75 -49.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.749 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.88 -33.26 65.94 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.101 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.91 -46.55 87.25 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.921 -0.487 . . . . 0.0 109.764 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -61.41 -48.28 81.93 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.1 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.96 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.93 -42.68 97.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.703 -0.623 . . . . 0.0 110.389 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -67.42 -42.05 83.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.983 -0.448 . . . . 0.0 111.826 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -93.99 -21.17 19.35 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.006 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.05 145.66 51.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.38 130.27 37.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.92 160.41 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.08 -178.47 18.73 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.209 -2.356 . . . . 0.0 107.209 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -65.15 -40.13 93.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.68 -38.98 92.86 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.0 93.35 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.9 -40.02 91.48 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.1 t -64.43 -41.57 96.51 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -64.79 -39.1 93.05 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.09 -45.46 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.52 -40.64 97.4 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.83 -43.36 88.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.8 m -63.99 -41.2 97.57 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.979 -0.45 . . . . 0.0 110.094 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.7 mt -62.51 -44.2 99.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.02 -43.18 99.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.61 98.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.923 -0.486 . . . . 0.0 109.962 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.13 -39.12 91.5 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.79 -40.02 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 m -61.13 -43.94 98.1 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -72.29 -16.82 61.9 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.818 -0.551 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.45 2.21 70.66 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -44.08 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.82 136.62 33.01 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 51.3 mttm -85.13 150.97 24.47 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -91.25 138.94 31.2 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -127.11 164.26 21.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -61.77 173.31 1.04 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.132 0.967 . . . . 0.0 110.614 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.55 33.82 57.86 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.38 120.21 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.25 -38.29 3.15 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.86 -62.34 1.7 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.3 m -108.38 -33.72 7.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.48 47.68 33.79 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.8 m -70.68 141.52 51.61 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -131.27 149.04 52.73 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 73.0 mtp85 -117.46 153.48 33.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp -100.54 126.91 47.03 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.27 107.4 17.29 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.263 1.781 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.579 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -99.81 125.88 45.81 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.3 156.34 30.1 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -86.05 -66.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.921 1.748 . . . . 0.0 113.103 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.57 152.03 51.12 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 -37.88 89.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -62.45 -39.39 93.19 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.82 -38.69 92.05 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.76 -41.62 95.74 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.43 -43.3 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.16 -43.02 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.06 98.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.32 92.05 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.913 -0.492 . . . . 0.0 110.291 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -63.48 -36.7 84.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.21 85.46 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.09 75.72 1.17 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -83.49 59.6 5.18 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -69.39 167.1 17.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 -38.0 89.11 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 6.46 33.25 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.9 -159.78 34.69 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.0 t -115.31 138.33 51.08 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 78.0 p -72.9 162.01 30.02 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -62.6 -41.82 99.2 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.49 -39.19 93.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.3 m -63.65 -39.25 93.86 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 122.05 -0.406 . . . . 0.0 110.009 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.55 -49.46 84.32 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.029 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.36 -32.64 66.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.925 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.59 -45.39 90.61 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.11 -48.36 82.0 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.62 -45.59 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.178 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.82 -41.15 97.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -69.73 -39.74 76.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.038 -0.414 . . . . 0.0 112.095 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -96.73 -17.99 19.94 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.487 -0.758 . . . . 0.0 112.085 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -129.21 147.6 51.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' H ' ' N ' ' A' ' 1' ' ' GLY . 62.8 mtpt -82.03 121.57 26.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.89 158.39 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.29 179.29 26.98 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.15 -39.85 90.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -64.22 -38.66 91.83 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.52 91.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -39.94 91.21 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 m -65.14 -39.57 93.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -67.4 -37.72 83.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.81 -48.08 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 121.935 -0.478 . . . . 0.0 110.356 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -66.92 -31.15 71.55 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.188 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.92 -42.67 85.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.6 m -64.9 -40.64 95.41 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.7 mt -62.06 -44.61 99.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -43.05 99.63 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -63.21 -41.48 99.14 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.5 -39.71 95.17 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.705 -0.622 . . . . 0.0 109.375 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.0 -40.69 89.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -61.98 -40.86 97.07 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.9 m -69.98 -27.77 64.98 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 7.26 56.33 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.52 -43.12 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.0 mt -98.26 145.92 26.16 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.418 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 88.7 mttt -84.48 150.91 24.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.93 137.72 32.13 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.4 m -127.3 164.0 22.73 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -60.7 174.2 0.63 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.175 0.988 . . . . 0.0 110.813 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.77 33.02 58.45 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 120.16 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.45 -38.34 3.13 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -62.39 1.69 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 m -108.46 -33.13 7.15 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.09 47.84 28.95 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 72.7 m -70.73 141.01 51.53 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -132.39 147.32 52.38 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 90.8 mtt180 -114.01 154.49 27.56 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 tp -97.19 126.55 42.46 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -84.12 107.06 16.23 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.26 1.643 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 -179.946 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.632 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -99.14 122.56 42.52 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -154.92 156.13 31.0 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.28 -63.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.797 1.665 . . . . 0.0 113.192 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.02 151.99 51.42 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.6 -37.26 86.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m -61.99 -38.97 90.58 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.19 -40.33 97.2 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.3 mtm -65.7 -40.66 92.53 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 14' ' ' ILE . 60.1 mt -63.24 -43.75 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.59 -41.87 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.32 94.31 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.51 -38.7 91.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 10' ' ' ILE . 47.4 mm -66.0 -41.51 89.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -68.34 -24.68 64.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.96 90.97 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -122.36 81.22 1.81 Allowed 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -86.72 47.58 1.51 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.63 156.48 26.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -67.22 -19.17 65.5 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.68 -6.68 59.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.53 -175.63 39.21 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -106.01 132.97 51.46 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.8 150.8 46.48 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -62.45 -41.77 98.99 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -63.81 -39.43 94.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.31 -38.05 89.63 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.67 -48.42 88.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.021 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.85 -35.25 69.8 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.046 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -65.11 -40.69 94.9 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.613 -0.679 . . . . 0.0 109.664 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.52 -49.56 76.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -43.07 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.15 -40.43 97.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.916 -0.49 . . . . 0.0 111.11 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.8 p -83.47 -16.54 45.32 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.369 -0.832 . . . . 0.0 112.032 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.41 -24.94 12.09 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 119.327 0.967 . . . . 0.0 110.27 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.34 149.62 51.05 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.632 ' H ' ' N ' ' A' ' 1' ' ' GLY . 88.1 tttt -83.0 120.47 25.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.05 157.19 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.63 -177.75 25.95 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.7 -41.78 91.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.12 -39.58 94.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.18 93.59 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.5 -42.32 96.12 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.4 m -65.52 -39.48 91.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.84 -36.27 82.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.84 -43.9 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -62.51 -40.21 96.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.72 -40.26 95.03 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -65.23 -41.69 94.13 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -63.05 -45.16 99.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.74 -39.35 94.08 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.91 -41.13 97.75 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.85 -39.51 94.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.77 -40.48 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.1 m -61.45 -41.45 97.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.3 m -70.23 -27.66 64.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.45 1.37 59.15 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.16 -42.77 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.94 139.7 30.97 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HG3' ' HB1' ' A' ' 74' ' ' ALA . 88.2 mttt -84.84 151.08 24.57 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -101.31 138.14 38.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.7 m -123.14 164.21 19.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -60.43 174.8 0.51 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 122.181 0.991 . . . . 0.0 110.868 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.02 58.66 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 108.334 -1.907 . . . . 0.0 108.334 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.95 121.09 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.14 -38.99 2.88 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -62.22 1.75 Allowed 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -108.08 -34.54 6.85 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.67 48.06 37.43 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.0 m -70.27 138.91 51.99 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.7 151.79 51.37 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 87.7 mtm180 -122.41 153.74 38.67 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 tp -101.85 126.68 48.79 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' HB1' ' HG3' ' A' ' 60' ' ' LYS . . . -84.89 107.54 17.09 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.261 1.69 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.034 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -84.69 -10.93 56.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -136.9 83.19 29.36 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.62 -75.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.816 1.677 . . . . 0.0 112.915 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.2 148.71 52.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.49 -38.0 86.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.3 t -62.34 -39.92 94.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.27 -41.27 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -67.27 -39.88 86.13 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 14' ' ' ILE . 54.4 mt -62.8 -43.39 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.49 -42.58 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.98 92.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.67 94.64 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.9 mm -65.33 -42.6 94.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.02 -37.7 88.49 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.52 93.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.96 67.56 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -89.44 59.33 4.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.51 161.57 18.51 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.78 -21.63 64.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.82 -7.46 57.89 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.4 177.76 38.64 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -97.63 132.37 43.35 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -71.35 148.59 46.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.63 -42.38 98.81 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.51 -38.55 91.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -66.63 -30.38 70.64 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.741 -0.599 . . . . 0.0 110.24 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.4 mt -63.29 -49.8 81.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.562 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -72.89 -33.44 66.03 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.624 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.0 -45.41 89.12 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -61.47 -48.48 80.94 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.33 -46.07 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.208 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.71 -41.4 96.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.75 -0.594 . . . . 0.0 110.294 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -70.06 -39.85 75.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.948 -0.47 . . . . 0.0 112.192 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -97.19 -15.24 20.97 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.981 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.44 146.76 52.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.43 119.6 25.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.5 161.52 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.83 167.01 52.47 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.57 -22.63 61.71 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -89.87 -1.96 58.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.24 59.31 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.44 -40.2 90.28 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 m -66.03 -40.3 90.9 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.73 -36.96 81.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.79 -43.63 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.49 -39.85 94.81 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.83 -40.86 95.87 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -64.41 -43.67 93.65 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.71 -43.97 99.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.55 -42.31 98.65 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.95 -43.36 99.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.91 -39.75 95.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.419 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.78 -40.37 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -62.04 -41.82 98.52 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -69.86 -27.79 65.12 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.5 8.31 52.68 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.5 -44.65 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.83 143.16 26.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 33.5 tptt -91.78 151.0 20.81 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.04 137.35 35.08 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -128.41 164.0 23.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.24 172.25 1.54 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.065 0.936 . . . . 0.0 110.578 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.15 34.97 57.71 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.51 119.22 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.24 -37.88 3.29 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.52 -62.08 1.78 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.06 -33.16 7.26 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.22 47.75 28.46 Favored Glycine 0 C--N 1.355 1.611 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -70.47 143.12 51.85 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.396 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -129.49 146.87 51.28 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 80.9 mtm180 -124.44 178.26 5.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.4 mt -104.71 134.09 48.44 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.56 109.68 18.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.262 1.72 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.608 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -138.0 107.02 6.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -145.89 152.68 48.65 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.4 -55.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 113.478 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -132.49 149.8 52.27 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -66.68 -36.49 82.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -62.24 -36.11 80.98 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.85 -40.23 94.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.02 -40.01 87.15 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.12 -44.09 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.46 -43.16 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.42 98.77 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.94 91.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 122.187 -0.321 . . . . 0.0 110.513 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -69.12 -42.81 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.588 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.86 -19.9 61.89 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.526 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.5 97.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -113.52 77.41 1.05 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -83.64 59.93 5.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.61 163.04 25.82 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.75 -29.57 70.1 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.77 2.11 49.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.53 -165.36 35.29 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -107.86 137.13 46.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -72.57 157.16 38.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.66 -43.74 98.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.883 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.13 -26.9 65.12 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.718 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -65.88 -38.18 88.09 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.04 -48.6 88.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.82 -36.92 67.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.793 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.53 -41.42 96.38 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.547 -0.721 . . . . 0.0 110.167 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -62.02 -48.72 79.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.61 -45.53 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.04 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -64.07 -41.91 97.17 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.549 -0.72 . . . . 0.0 110.318 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 t -69.0 -41.91 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.929 -0.482 . . . . 0.0 111.833 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.17 -20.38 20.53 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.091 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -128.75 147.87 50.81 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.608 ' H ' ' N ' ' A' ' 1' ' ' GLY . 88.1 tttt -85.99 119.51 26.37 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.62 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.15 171.39 48.26 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.25 -37.77 84.06 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -73.29 -12.15 60.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.2 62.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.07 -40.8 95.05 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -70.53 -35.6 73.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -66.6 -39.42 88.38 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.86 -44.08 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -41.63 98.46 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.49 -40.08 92.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -64.16 -43.17 95.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.15 -44.94 99.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.98 -39.79 95.77 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -64.32 -41.92 96.56 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -39.44 93.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.59 -40.01 87.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.6 m -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -72.28 -17.21 61.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.882 -0.512 . . . . 0.0 109.689 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.63 5.72 66.51 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.37 -43.89 94.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.6 143.24 30.07 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.04 149.9 23.02 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -87.08 139.7 30.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -128.21 164.19 23.07 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -61.22 174.39 0.7 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.056 0.931 . . . . 0.0 110.632 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.4 58.52 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.98 119.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.81 -38.12 3.22 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.01 -62.98 1.5 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.9 p -109.01 -29.35 8.61 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.25 47.72 56.8 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -70.53 143.75 51.54 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -129.82 145.92 51.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -109.87 150.67 28.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.41 126.08 45.24 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.28 107.91 18.16 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.264 1.824 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.994 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.31 170.78 21.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -155.2 157.87 31.88 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -84.99 -70.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.794 1.663 . . . . 0.0 112.941 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.98 147.51 52.46 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -66.92 -36.25 81.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -62.89 -37.29 86.35 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.18 -39.46 92.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.4 mtp -65.89 -41.23 91.77 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.19 -43.89 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -62.09 -43.38 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.24 98.2 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -43.17 96.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 122.035 -0.416 . . . . 0.0 110.331 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.2 mt -68.58 -39.62 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.9 -38.42 91.0 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.76 94.87 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 19' ' ' ASN . 78.3 mm-40 -104.01 65.38 0.8 Allowed 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.22 45.34 0.74 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 17' ' ' GLU . 64.2 t30 -68.01 149.65 49.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.99 -37.09 85.78 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -21.5 64.89 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.54 175.76 19.2 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -101.8 126.73 48.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -69.94 154.32 42.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.9 -41.42 97.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.23 -38.61 91.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -61.93 -37.51 84.95 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.43 -48.74 87.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.93 -34.41 66.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.492 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.89 -41.48 97.71 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.444 -0.785 . . . . 0.0 110.038 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -61.87 -48.02 82.4 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.72 -45.04 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.002 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.07 -40.07 95.46 Favored 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 121.67 -0.644 . . . . 0.0 110.367 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 t -70.41 -42.05 72.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 122.028 -0.42 . . . . 0.0 111.795 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -96.73 -14.35 22.07 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.568 -0.708 . . . . 0.0 112.135 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.67 151.03 50.73 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.6 121.6 31.95 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.36 158.41 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.02 175.73 36.87 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.43 -39.86 85.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -66.75 -28.39 68.37 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.14 68.8 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.3 -40.56 94.62 Favored 'General case' 0 C--N 1.353 0.717 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.0 m -66.37 -40.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -65.15 -39.89 93.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.29 -45.84 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.01 -41.47 99.58 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -66.43 -39.49 88.95 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.95 -41.84 95.15 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.04 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.69 -42.32 99.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -42.46 99.57 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.1 -40.24 95.8 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 121.775 -0.578 . . . . 0.0 109.547 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.62 -40.8 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.4 m -62.08 -40.91 97.42 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 -27.64 65.1 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.09 7.77 54.58 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.16 -43.92 91.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.66 147.38 23.36 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -90.43 148.8 22.56 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.65 151.03 26.47 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -141.85 164.14 30.99 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -63.27 172.53 1.88 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 122.036 0.922 . . . . 0.0 110.762 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.27 34.32 58.02 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.41 119.44 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.13 3.2 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.2 1.74 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.3 m -107.74 -32.18 7.74 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.68 47.64 32.61 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -70.53 140.92 51.92 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -131.55 149.07 52.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 81.5 mtm180 -124.87 177.39 6.05 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.67 133.52 52.65 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.09 108.54 17.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp . . . . . 0 C--O 1.262 1.742 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.52 -41.34 93.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -149.16 155.92 40.02 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.02 -64.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.719 1.613 . . . . 0.0 113.319 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.96 149.84 52.32 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -66.64 -35.93 81.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.7 p -62.53 -36.62 83.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.22 -39.24 92.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.2 mtp -66.07 -40.86 91.23 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.32 -42.94 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.86 -42.54 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.103 -0.373 . . . . 0.0 110.123 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.05 94.08 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.061 -0.399 . . . . 0.0 110.172 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.42 -38.08 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -61.57 -36.9 81.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.84 89.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -114.56 69.32 0.71 Allowed 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -82.96 57.95 4.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -80.8 165.73 21.62 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.32 -36.6 84.64 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -8.82 57.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.9 -163.82 33.66 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.1 m -115.97 141.06 48.61 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.6 m -72.87 155.52 39.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.59 -42.38 98.78 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -62.9 -38.64 91.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -62.35 -39.65 93.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.2 mt -60.56 -49.52 84.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.954 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.65 -33.18 66.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.938 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -64.09 -45.41 88.82 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.959 -0.463 . . . . 0.0 109.768 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -61.17 -48.34 82.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.14 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.094 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.72 -41.95 95.61 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 121.68 -0.637 . . . . 0.0 110.407 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -69.05 -42.07 76.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.916 -0.49 . . . . 0.0 111.942 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -94.69 -16.64 22.94 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.526 -0.734 . . . . 0.0 112.138 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.46 147.65 52.18 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.61 120.82 25.56 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.88 157.79 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.58 -179.1 24.78 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.64 -41.3 92.77 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.61 -38.92 92.96 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.86 92.65 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.03 -39.94 91.7 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.1 m -64.72 -39.97 94.54 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.19 -36.6 82.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.36 -45.88 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.34 -40.65 97.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.5 tp -63.63 -44.3 94.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -63.4 -43.07 98.62 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.84 -40.14 95.88 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -63.71 -42.29 97.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.27 -40.51 96.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.48 -40.92 89.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.0 m -61.97 -41.12 97.64 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.7 m -70.08 -27.61 64.75 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.93 8.53 55.43 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.12 -43.5 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.92 143.84 28.77 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -85.4 151.17 24.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -94.87 135.11 36.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.406 ' HG1' ' HG3' ' A' ' 72' ' ' ARG . 4.2 m -119.56 164.46 15.79 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -59.24 175.17 0.33 Allowed 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.095 0.95 . . . . 0.0 110.982 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.26 35.08 53.66 Favored Glycine 0 C--N 1.357 1.741 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.79 119.89 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.1 -38.12 3.2 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -62.37 1.69 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.1 m -108.48 -35.1 6.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.5 47.86 32.67 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 64.4 m -70.58 143.46 51.54 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -130.81 151.42 51.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG3' ' HG1' ' A' ' 62' ' ' THR . 80.4 mtm180 -122.0 164.92 16.83 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.03 132.32 44.42 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.8 108.74 19.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.262 1.723 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.095 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.71 106.56 18.55 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -118.64 92.58 44.37 Favored Pre-proline 0 CA--C 1.503 -0.848 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.89 -33.31 20.5 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 121.187 1.258 . . . . 0.0 112.875 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.81 100.37 4.9 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -67.83 -34.74 77.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -61.43 -38.13 86.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.08 -43.64 98.4 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -39.9 89.96 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.7 -44.79 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.17 -42.26 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.23 -42.77 99.19 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.25 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.51 -39.86 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -64.73 -37.62 88.22 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.493 -0.755 . . . . 0.0 109.017 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.63 91.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -106.96 68.84 0.74 Allowed 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -79.98 51.79 1.4 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -70.02 147.95 49.44 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -61.97 -37.65 85.59 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.44 -9.41 58.5 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.87 169.89 28.61 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 t -95.34 128.91 42.57 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -71.29 157.16 38.6 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -60.8 -42.57 97.87 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -63.15 -39.27 94.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.2 m -63.46 -39.03 93.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.04 -49.4 84.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.71 -32.89 66.06 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.131 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.66 -45.65 93.13 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.833 -0.542 . . . . 0.0 109.687 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.29 -48.2 82.48 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.99 -45.02 99.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.17 -39.59 94.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.486 -0.759 . . . . 0.0 110.211 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.36 -39.93 74.33 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.001 -0.437 . . . . 0.0 112.075 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -98.25 -16.94 19.21 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.841 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.09 147.4 52.61 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -84.52 121.52 27.71 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.0 159.49 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.54 179.44 26.7 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.09 -40.85 91.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.36 -38.57 91.66 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.76 91.42 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.89 -39.68 90.17 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.11 -40.38 94.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.69 -37.01 81.71 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -45.36 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.98 -40.18 96.95 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.29 -44.19 92.44 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.1 t -63.27 -42.81 99.16 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.21 -42.65 99.49 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.56 -42.12 99.34 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.7 -40.71 97.46 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.808 -0.557 . . . . 0.0 109.574 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -66.0 -40.71 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.4 m -62.04 -40.97 97.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.1 m -69.86 -27.64 65.0 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.76 8.33 54.46 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.17 -43.49 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -98.29 144.82 27.3 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -84.73 151.1 24.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -87.87 137.58 32.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -127.59 164.49 21.89 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.51 173.5 0.7 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.09 0.948 . . . . 0.0 110.509 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.15 32.97 57.75 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.7 119.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -37.81 3.32 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.92 -63.07 1.47 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.9 p -109.32 -30.49 7.96 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 48.0 37.95 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -70.46 143.05 51.89 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -132.18 149.57 52.36 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -118.9 165.4 14.11 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -99.66 133.37 44.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.86 109.24 20.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.262 1.742 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -93.68 -2.04 54.44 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -134.0 84.38 43.26 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -85.55 -79.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.674 1.582 . . . . 0.0 112.86 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -132.24 147.85 52.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -67.0 -36.4 82.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -63.08 -36.33 83.22 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.08 -40.35 94.52 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -66.66 -40.4 88.62 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.441 ' O ' HG12 ' A' ' 14' ' ' ILE . 53.7 mt -63.66 -43.5 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.5 -42.4 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.24 93.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.36 93.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.0 mm -65.8 -44.0 93.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.21 -35.75 81.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.45 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -116.11 71.56 0.79 Allowed 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -86.82 58.99 5.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -80.51 162.12 24.5 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.9 -27.68 66.86 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -1.73 47.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -177.59 37.62 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 t -98.93 129.44 45.26 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -70.44 150.72 45.93 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -61.75 -43.53 98.68 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.318 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.09 -38.97 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.26 -38.12 89.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.6 mt -61.37 -49.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 121.975 -0.453 . . . . 0.0 110.331 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.9 -33.86 68.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.076 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.28 -40.85 86.17 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.92 -49.07 77.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.63 -44.99 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.849 -0.532 . . . . 0.0 110.408 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -69.08 -39.66 78.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.808 -0.558 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.08 -20.19 18.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.966 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.8 146.27 51.54 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -75.27 135.1 40.96 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.48 160.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.48 -178.63 17.54 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.03 -40.27 94.59 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -65.1 -39.43 93.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.76 91.98 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.01 -40.65 94.36 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 95.1 p -69.55 -34.84 74.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -68.39 -36.12 78.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.87 -39.89 95.81 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.92 -42.34 85.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -62.7 -44.92 94.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.202 -0.311 . . . . 0.0 110.59 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 pt -67.48 -34.24 67.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.925 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.95 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.5 -39.43 93.49 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.76 -40.69 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.2 m -61.42 -44.34 97.3 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.099 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.2 p -73.0 -15.92 61.52 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.898 -0.501 . . . . 0.0 109.835 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.67 6.18 66.01 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.09 -43.83 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.67 138.08 35.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -87.82 151.97 22.46 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -83.98 135.46 34.44 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.445 ' HG1' ' HG3' ' A' ' 72' ' ' ARG . 3.6 m -127.14 164.15 22.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -60.15 172.5 0.8 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.109 0.957 . . . . 0.0 110.671 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.22 33.09 57.42 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.56 119.11 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.93 -37.87 3.31 Favored Glycine 0 C--N 1.351 1.395 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.9 -62.97 1.5 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.7 p -108.96 -30.3 8.16 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.36 47.75 49.5 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.8 m -70.19 144.58 51.89 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.583 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -130.07 148.92 51.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.445 ' HG3' ' HG1' ' A' ' 62' ' ' THR . 80.7 mtm180 -120.07 169.75 9.92 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.4 mt -100.06 134.8 42.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.89 109.41 21.41 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 tptm . . . . . 0 C--O 1.26 1.648 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.88 -39.12 93.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -136.05 84.08 31.95 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.43 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 121.866 1.711 . . . . 0.0 112.915 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.05 146.03 52.23 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -66.63 -38.3 86.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.0 m -63.29 -40.57 97.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.91 -39.92 95.3 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mtp -66.37 -40.49 89.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.03 -43.73 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.6 t -62.49 -41.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.33 98.33 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.14 97.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.72 -40.49 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.95 -36.54 84.72 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.97 90.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -121.67 73.67 1.08 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -84.68 57.69 4.5 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -66.11 148.41 51.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -62.16 -38.52 89.34 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.87 65.61 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.14 170.58 14.36 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.5 m -97.77 130.48 44.71 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -69.24 146.45 52.31 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -61.46 -40.57 94.99 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.74 -38.47 91.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -61.78 -39.88 93.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.09 -48.89 86.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.082 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.42 -34.87 68.14 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.409 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -66.56 -40.65 89.11 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.551 -0.718 . . . . 0.0 110.171 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.71 -48.68 79.66 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.28 -45.75 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.42 -41.77 96.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.744 -0.597 . . . . 0.0 110.448 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.0 m -70.22 -39.88 74.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.962 -0.461 . . . . 0.0 112.128 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -96.33 -16.75 21.13 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.873 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.35 147.64 52.59 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -84.23 121.43 27.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.83 156.41 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.89 179.62 34.14 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.1 -41.67 90.29 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.79 -39.02 93.25 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.63 91.88 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -60.91 -42.63 98.43 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -65.14 -39.19 92.68 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.38 -38.39 90.87 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.45 -45.02 99.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.27 -41.85 98.82 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.9 tp -66.57 -41.96 87.76 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -62.5 -42.76 99.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.58 -45.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -63.89 -40.51 96.7 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -62.94 -41.74 99.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.87 -39.27 93.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 m -61.5 -41.09 96.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -70.05 -27.94 65.06 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 7.58 56.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.38 -43.24 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.17 146.19 26.41 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 74' ' ' ALA . 87.0 mttt -84.66 150.75 24.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -91.43 138.41 31.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 m -128.02 163.65 24.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -61.27 171.53 1.34 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.063 0.935 . . . . 0.0 110.574 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.22 23.89 64.86 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.88 120.61 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.595 0.712 . . . . 0.0 109.146 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.24 -38.92 2.91 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.41 -62.4 1.7 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -108.6 -33.47 7.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.22 20.4 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.9 m -70.25 140.87 52.48 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -131.22 149.67 52.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -117.68 158.04 25.39 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp -99.0 126.7 44.75 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HB3' ' HG3' ' A' ' 60' ' ' LYS . . . -84.71 107.5 16.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.26 1.636 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.15 -39.21 82.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -131.8 82.44 60.3 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.69 -33.59 12.83 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.5 1.466 . . . . 0.0 113.397 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.41 123.66 27.14 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -68.22 -37.31 80.71 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.7 p -63.59 -34.69 78.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.7 -42.79 95.05 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.46 -41.03 93.84 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.452 ' O ' HG12 ' A' ' 14' ' ' ILE . 64.4 mt -63.14 -44.41 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.37 -43.08 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.36 95.05 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.05 93.03 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.8 mm -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.26 -27.37 64.38 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.111 -0.368 . . . . 0.0 110.079 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.16 95.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.84 75.08 0.97 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -85.68 59.45 5.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -79.6 152.89 29.8 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.36 -37.27 86.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.06 64.66 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 173.92 16.49 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.5 p -96.16 137.56 35.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.5 p -77.34 159.69 29.35 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -65.32 -39.96 93.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -63.3 -39.67 95.23 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -61.95 -39.87 93.58 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.8 mt -60.82 -49.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.201 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.52 -33.74 67.11 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.001 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.61 -46.11 89.77 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.85 -48.81 78.85 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.57 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.172 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.77 -18.15 62.77 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.0 m -89.17 -35.75 16.06 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.501 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -100.88 -12.2 19.18 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.74 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 152.06 51.61 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 124.66 31.62 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.01 160.41 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.72 -178.07 19.29 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.93 -41.65 95.34 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -63.85 -38.84 92.57 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -38.81 92.38 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.73 -39.95 90.53 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.2 t -64.72 -41.64 95.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -64.72 -38.49 91.18 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.67 -45.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -62.33 -41.8 98.85 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.54 -39.42 88.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.9 -40.96 95.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.57 -44.82 99.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.44 -39.34 94.23 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.1 -40.95 97.33 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.75 -39.65 94.78 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.21 -40.72 89.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 m -61.42 -41.63 97.47 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -70.33 -27.74 64.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.67 56.28 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.21 -43.33 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.71 146.14 31.16 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -84.72 150.61 24.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.09 137.29 34.35 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 m -122.96 164.01 19.31 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -61.0 174.09 0.69 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.1 0.952 . . . . 0.0 110.627 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.8 33.1 58.29 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.38 120.12 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.78 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.96 -62.53 1.64 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -108.44 -34.14 6.86 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.41 48.42 24.18 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -70.86 141.84 51.23 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -130.98 148.74 52.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -118.09 158.14 25.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.7 tp -97.79 126.78 43.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.04 107.9 17.37 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.261 1.663 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.17 -40.16 95.52 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -160.25 152.51 17.2 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.5 -45.24 0.43 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.614 1.542 . . . . 0.0 114.462 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.01 136.17 45.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -68.19 -37.33 80.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -62.42 -38.92 91.59 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.14 -41.36 99.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.4 mmt -66.47 -40.38 89.31 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 14' ' ' ILE . 57.1 mt -63.29 -43.48 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.71 -42.22 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.78 94.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 10' ' ' ILE . 48.1 mm -67.51 -41.66 86.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -62.95 -36.94 85.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.979 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.57 84.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.76 82.06 1.98 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.024 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.03 58.28 4.33 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.33 148.47 51.61 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.23 -36.4 83.53 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -5.65 44.85 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.51 167.18 27.56 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -86.72 133.34 33.68 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.3 t -69.09 147.61 51.22 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -61.09 -41.45 96.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.56 -38.31 90.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.9 m -63.05 -38.39 90.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 122.057 -0.402 . . . . 0.0 110.199 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -60.96 -49.73 83.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.937 -0.477 . . . . 0.0 110.017 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.73 -34.06 66.81 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.769 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.25 -45.37 91.87 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.09 -49.13 78.57 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.74 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.169 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -65.43 -41.43 93.54 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.689 -0.632 . . . . 0.0 110.593 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.5 m -69.36 -39.98 77.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 112.026 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -97.18 -15.79 20.72 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.447 -0.783 . . . . 0.0 111.657 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -133.47 147.19 51.66 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.96 126.61 32.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.97 157.32 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.27 176.5 34.24 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.49 -41.56 88.75 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.95 -38.97 93.03 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.36 94.52 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -60.82 -42.12 97.07 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -65.59 -39.54 91.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.85 -34.0 76.84 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.6 mt -60.49 -43.53 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.29 -39.78 89.58 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.4 m -64.5 -41.73 96.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.1 mt -63.16 -44.2 99.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -62.35 -42.95 99.8 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -62.45 -42.52 99.52 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.57 -39.55 94.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.72 -40.55 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.8 m -61.76 -43.57 98.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.068 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -72.44 -15.93 61.82 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.782 -0.574 . . . . 0.0 109.72 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.55 2.94 69.49 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.28 -44.3 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mp -97.12 143.53 27.84 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 74' ' ' ALA . 88.2 mttt -84.85 150.65 24.85 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -96.27 138.37 33.98 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 70' ' ' SER . 2.4 m -123.7 164.39 19.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -63.09 174.92 0.99 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.115 0.959 . . . . 0.0 110.568 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.22 33.55 59.0 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.2 t -70.55 120.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.02 -62.32 1.71 Allowed 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -108.46 -34.62 6.71 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.53 47.88 25.8 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 60.8 m -70.61 141.5 51.75 Favored 'General case' 0 C--N 1.358 0.963 0 CA-C-N 118.109 0.954 . . . . 0.0 108.464 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -131.85 150.02 52.28 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.413 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 88.6 mtm180 -122.25 155.57 35.61 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 tp -103.25 127.07 50.68 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' HG3' ' A' ' 60' ' ' LYS . . . -82.69 107.69 15.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 pttt . . . . . 0 C--O 1.261 1.694 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.22 -39.47 94.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -156.61 156.75 30.4 Favored Pre-proline 0 N--CA 1.438 -1.052 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.13 -70.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 121.741 1.627 . . . . 0.0 113.103 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.82 144.79 51.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -67.36 -37.45 83.23 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -62.52 -39.11 92.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.62 -43.17 97.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.425 ' HB3' HG12 ' A' ' 32' ' ' ILE . 77.8 mtm -65.58 -39.96 92.19 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' HG12 ' A' ' 14' ' ' ILE . 61.4 mt -62.36 -44.16 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.82 -42.5 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.56 91.83 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.95 95.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 10' ' ' ILE . 39.7 mm -69.39 -41.56 80.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.01 -39.23 93.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -40.92 93.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.74 71.24 0.88 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.78 58.52 5.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.14 164.2 25.88 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.01 -38.76 92.47 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.25 -4.49 42.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.4 -171.75 35.44 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 t -105.47 132.06 52.11 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -69.5 155.15 40.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.02 -43.07 99.44 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.98 -39.14 93.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.6 m -62.98 -38.53 91.49 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.66 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 121.987 -0.445 . . . . 0.0 110.187 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.91 -33.01 65.73 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.084 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.28 -44.64 94.52 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.24 -48.73 80.14 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 9' ' ' MET . 95.6 mt -63.08 -45.11 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.199 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.29 -40.39 95.86 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.861 -0.525 . . . . 0.0 111.398 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -83.73 -14.79 50.76 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.568 -0.707 . . . . 0.0 112.358 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.39 -20.71 12.15 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 119.538 1.063 . . . . 0.0 110.651 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -129.75 149.02 51.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.92 121.11 25.6 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.17 161.44 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.57 170.08 51.6 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.31 -37.75 83.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -80.58 0.31 34.51 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.22 63.27 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -40.07 89.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -66.61 -39.96 88.59 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -66.14 -39.74 90.08 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.38 -45.35 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.71 -40.46 97.21 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.39 -42.88 92.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.5 t -63.13 -43.71 97.65 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.28 -43.78 98.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -61.1 -43.01 99.54 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.55 -41.16 98.45 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.38 -39.16 92.29 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.7 t -66.69 -39.73 84.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 m -60.98 -44.34 97.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.006 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 p -72.58 -16.94 61.74 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 109.55 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.99 70.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -65.5 -44.75 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.25 149.3 24.67 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 84.8 tttt -97.16 142.27 29.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -81.61 139.53 34.97 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -131.15 163.87 26.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.9 175.47 1.17 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.982 0.896 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.23 31.47 59.37 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -70.25 119.45 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.06 3.25 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.11 -63.45 1.39 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 p -109.28 -29.54 8.43 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.88 38.62 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -70.6 143.14 51.61 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -132.45 149.74 52.28 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 72.3 mtp180 -127.27 177.52 6.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.87 127.45 55.44 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 109.27 19.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.262 1.712 0 CA-C-O 117.956 -1.021 . . . . 0.0 108.586 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -84.91 -10.37 57.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -153.06 156.85 32.97 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.0 -69.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.649 1.566 . . . . 0.0 113.279 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -132.14 148.65 52.49 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 -35.34 79.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -62.5 -37.19 85.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.4 mtp -66.81 -40.21 87.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.63 -43.02 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.3 98.8 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.68 91.89 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 122.085 -0.384 . . . . 0.0 110.401 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.23 -39.74 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -63.26 -38.62 91.88 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.62 93.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.12 67.48 0.65 Allowed 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -83.98 58.35 4.66 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.12 155.13 39.99 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -67.27 -19.99 65.58 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.01 -2.74 58.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 177.7 41.43 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -105.4 130.93 53.39 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 m -68.94 153.56 43.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -62.21 -41.4 98.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.98 -38.49 91.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.7 m -61.97 -37.81 86.18 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.66 -48.6 87.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -73.13 -37.13 66.75 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.487 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.1 -40.43 96.2 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.273 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.65 -48.52 80.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.0 mt -62.86 -44.95 99.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.165 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.49 -38.56 91.46 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.747 -0.596 . . . . 0.0 111.55 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.0 p -86.38 -15.34 40.7 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.485 -0.76 . . . . 0.0 112.256 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -110.48 -20.03 12.72 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 119.373 0.988 . . . . 0.0 110.465 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.42 150.15 52.26 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -86.24 118.38 25.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.85 161.69 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.22 167.41 50.83 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.87 -19.14 61.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -90.94 -1.61 57.81 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.47 -25.6 62.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.42 -39.01 85.88 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.6 t -63.79 -43.57 95.93 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -68.34 -37.84 80.92 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.34 -46.36 96.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.27 -39.91 95.92 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.94 -44.87 94.88 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -64.94 -41.74 95.25 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.61 -44.46 99.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.66 -43.44 98.85 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.58 -41.97 98.32 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.31 -39.43 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.09 -39.84 86.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.2 m -60.91 -42.83 98.82 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -70.22 -27.88 64.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.94 54.16 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.68 -43.35 93.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.01 142.96 29.08 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.18 151.55 22.61 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.85 138.39 32.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -128.68 164.09 23.69 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -61.01 174.1 0.69 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.062 0.934 . . . . 0.0 110.572 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.98 32.9 58.19 Favored Glycine 0 C--N 1.357 1.712 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.69 119.15 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -37.92 3.29 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.73 -63.03 1.48 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 p -108.92 -29.88 8.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.06 47.85 43.44 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.1 m -70.33 142.51 52.19 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -130.98 149.44 52.6 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -119.27 164.95 14.89 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.64 132.54 44.91 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.31 110.27 21.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm . . . . . 0 C--O 1.261 1.686 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.847 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.2 t0 61.66 44.19 9.15 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -150.76 155.66 35.77 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -85.45 -79.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.688 1.592 . . . . 0.0 112.64 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -132.34 143.77 50.09 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -67.53 -35.54 79.29 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -61.82 -38.7 89.13 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.45 -40.99 98.39 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.4 mtt -67.02 -40.23 87.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.67 -43.35 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.43 -43.57 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.0 98.71 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.74 -44.58 93.08 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 122.043 -0.411 . . . . 0.0 110.161 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.14 -39.89 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -63.6 -39.4 94.27 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.82 96.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -105.88 63.8 0.68 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -86.28 59.78 5.84 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -80.99 168.36 18.79 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -64.63 -36.89 85.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.64 -5.29 49.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.47 -167.83 32.88 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.7 t -107.21 131.63 53.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -71.6 158.24 36.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -60.61 -44.84 95.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -64.82 -37.7 88.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.9 m -62.87 -38.43 90.82 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 122.275 -0.266 . . . . 0.0 110.646 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -61.17 -49.95 82.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.232 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -73.11 -33.13 65.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.004 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.28 -45.84 89.58 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -61.36 -48.41 81.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.16 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.894 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.49 -41.45 96.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.655 -0.653 . . . . 0.0 110.313 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.89 -39.87 76.0 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.934 -0.479 . . . . 0.0 112.066 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -97.09 -16.42 20.52 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.959 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.59 147.08 52.23 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -81.1 121.92 26.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.13 157.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.82 -179.93 25.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -65.97 -39.77 90.66 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -64.4 -39.31 93.6 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.64 91.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.77 -40.21 91.67 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.9 p -68.04 -35.88 78.98 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -68.83 -35.72 77.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.88 -44.24 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.79 -40.54 97.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.08 -40.85 91.15 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -64.4 -43.42 94.48 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.73 -44.77 99.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.87 -43.82 98.08 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.82 -41.95 97.76 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 121.895 -0.503 . . . . 0.0 110.089 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.99 -39.97 94.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.655 -0.653 . . . . 0.0 109.428 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.2 t -65.26 -40.02 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 m -61.16 -43.55 98.71 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.827 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.0 p -72.29 -17.19 61.89 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.845 -0.535 . . . . 0.0 109.742 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.02 7.41 65.93 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.4 -42.96 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.1 mt -97.64 143.68 28.06 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 151.86 21.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -90.39 134.5 34.3 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.7 m -121.82 164.16 17.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -58.83 174.79 0.32 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.109 0.956 . . . . 0.0 111.042 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.63 53.38 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.9 119.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.48 -38.14 3.2 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.02 1.8 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.34 -34.43 6.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.08 47.23 38.87 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.1 m -71.04 142.85 50.89 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -131.3 151.37 51.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -120.57 168.89 10.88 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.7 139.23 35.66 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.87 19.82 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.263 1.792 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 60.01 39.97 19.3 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -132.03 85.86 49.02 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.63 -79.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.746 1.63 . . . . 0.0 113.064 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.09 147.71 52.45 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.15 -39.22 89.64 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.0 p -64.71 -36.57 84.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.48 -42.74 91.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.428 ' HB3' HG12 ' A' ' 32' ' ' ILE . 78.1 mtm -65.93 -39.5 90.56 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.83 -43.53 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.91 -43.92 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.6 98.88 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.68 93.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.146 -0.346 . . . . 0.0 110.142 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.69 -40.09 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.96 -39.87 95.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.38 97.51 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -107.64 66.72 0.67 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.84 59.7 4.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -75.01 150.65 38.88 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -68.34 -27.01 65.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -6.57 56.58 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.51 166.73 31.01 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -94.96 129.38 42.03 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -66.56 147.32 53.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -61.53 -40.52 94.94 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.17 -38.91 92.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -63.03 -36.54 83.9 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.25 -50.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.922 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.33 -32.92 64.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.24 -45.49 93.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.33 -47.83 84.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.428 HG12 ' HB3' ' A' ' 9' ' ' MET . 95.2 mt -61.64 -46.56 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.19 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.14 -41.15 95.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.22 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.8 -39.83 76.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.914 -0.491 . . . . 0.0 112.237 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -97.8 -15.36 20.3 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.504 -0.747 . . . . 0.0 112.019 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -130.28 147.48 52.01 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.88 119.64 24.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.43 161.23 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.08 171.96 52.46 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.33 -39.83 85.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -77.82 -5.35 50.56 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.23 80.51 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.5 -38.95 82.25 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 t -63.66 -42.93 98.01 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -36.64 81.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.45 -43.06 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.81 -41.08 97.32 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.17 -40.9 90.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.5 m -65.65 -42.05 91.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.11 -44.37 99.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -61.85 -43.72 98.27 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.51 -41.71 98.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 121.967 -0.458 . . . . 0.0 110.049 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.03 -39.7 95.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.601 -0.687 . . . . 0.0 109.215 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.52 -40.12 87.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -61.19 -41.34 96.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.1 m -70.31 -27.62 64.53 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.99 8.05 55.79 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.26 -44.02 91.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.95 147.68 22.87 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -92.72 149.45 21.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -81.95 151.66 27.1 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 m -142.98 163.67 32.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -60.39 172.0 0.95 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.192 0.996 . . . . 0.0 110.865 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.99 33.04 57.98 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.6 t -70.57 119.88 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -38.12 3.21 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.47 1.65 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.5 m -108.52 -33.41 7.05 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.91 48.39 16.46 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 107.379 -2.288 . . . . 0.0 107.379 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.3 m -70.26 142.34 52.33 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -130.94 149.22 52.67 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 14.8 mmm180 -123.32 177.52 5.56 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -108.85 132.93 53.54 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.35 109.12 17.59 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.262 1.738 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -159.29 155.4 26.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -156.32 156.42 30.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -85.04 -64.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.726 1.617 . . . . 0.0 112.426 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.88 144.83 51.15 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -67.14 -36.24 81.44 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.6 m -61.83 -38.85 89.73 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.42 -41.44 98.7 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.7 -39.22 84.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.04 -43.29 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.22 -43.2 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.96 98.55 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.26 93.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.997 -0.439 . . . . 0.0 110.283 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.95 -39.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -63.55 -39.15 93.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.79 95.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -107.72 65.13 0.64 Allowed 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -86.15 59.25 5.53 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.85 168.86 18.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -37.13 86.54 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.05 -2.46 40.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.16 38.48 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 t -111.38 132.12 54.67 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.4 p -73.08 162.26 29.67 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -63.36 -40.71 98.03 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.47 -39.01 93.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.5 m -63.32 -38.78 92.47 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.04 -0.412 . . . . 0.0 109.904 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.3 -49.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.109 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.57 -33.44 66.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.972 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.11 -45.35 88.98 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.857 -0.527 . . . . 0.0 109.657 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.33 -48.64 80.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.41 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.085 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.01 -41.83 95.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.791 -0.568 . . . . 0.0 110.411 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.9 m -69.33 -40.06 77.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.85 -0.531 . . . . 0.0 112.08 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -98.18 -14.23 20.48 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.957 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -133.66 148.19 51.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -81.27 127.23 32.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.54 157.16 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.49 177.63 30.93 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.9 -42.07 90.68 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.54 -39.61 94.08 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.6 95.11 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.67 -41.87 95.92 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.3 m -65.51 -39.84 92.31 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.7 -34.88 78.83 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.37 -44.64 96.45 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.02 -40.34 97.46 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.95 -40.73 91.59 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -64.11 -42.89 96.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.83 -44.56 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -62.07 -43.28 99.18 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.45 98.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.995 -0.441 . . . . 0.0 109.996 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -39.43 92.54 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -66.13 -40.19 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 m -60.85 -44.55 96.83 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -73.04 -15.94 61.5 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.812 -0.555 . . . . 0.0 109.877 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.68 64.72 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.25 -43.22 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.29 145.67 26.42 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -88.73 151.9 22.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -81.77 151.94 27.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 m -143.52 164.06 31.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -59.24 167.17 1.88 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.181 0.991 . . . . 0.0 110.794 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.59 61.75 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.79 118.42 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.28 -38.33 3.14 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.67 1.92 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.7 m -107.54 -32.09 7.84 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 47.59 28.67 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 m -70.87 141.42 51.23 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -133.11 150.15 52.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -118.39 166.3 12.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.29 140.9 30.29 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 107.77 19.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.5 tptt . . . . . 0 C--O 1.261 1.665 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.772 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.619 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -103.67 124.09 48.2 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -154.44 155.93 31.19 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -85.72 -66.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.827 1.685 . . . . 0.0 113.315 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.55 153.29 50.0 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -65.03 -37.95 89.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.5 m -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.5 -40.1 96.18 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.4 mtm -66.46 -40.22 89.26 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.05 -43.93 99.3 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.9 t -62.45 -43.02 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.62 99.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.58 91.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.029 -0.419 . . . . 0.0 110.282 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.2 mt -69.35 -39.63 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.49 -39.22 93.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.88 96.12 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -107.5 65.79 0.65 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -82.92 59.34 4.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -77.34 151.65 34.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.64 -37.34 86.96 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.0 64.71 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.35 175.45 15.5 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -100.07 131.69 45.87 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 t -70.46 145.99 50.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.26 -40.65 96.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.85 -38.87 92.71 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.1 m -62.56 -37.33 85.75 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.74 -48.65 87.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.792 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -72.17 -37.32 69.35 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.354 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.99 -41.2 97.58 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.49 -0.756 . . . . 0.0 109.944 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -61.7 -48.49 80.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.85 -45.4 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.083 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.27 -39.81 94.7 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.645 -0.659 . . . . 0.0 110.383 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 t -70.57 -41.98 71.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.887 -0.508 . . . . 0.0 111.72 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -92.87 -21.17 20.02 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.031 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -128.82 146.82 50.82 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' H ' ' N ' ' A' ' 1' ' ' GLY . 88.1 tttt -87.5 120.91 29.28 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.04 160.2 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.64 173.99 51.45 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.84 -40.12 83.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.91 -14.93 61.57 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.93 -35.62 81.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.62 -41.25 90.01 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -64.85 -39.9 94.29 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -67.07 -37.07 83.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.88 -41.71 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.63 -40.29 94.34 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.55 -39.84 88.76 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -64.81 -41.58 95.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.078 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 pt -70.11 -34.84 60.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.169 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.26 -39.79 89.7 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -64.57 -41.98 95.94 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.17 -39.36 94.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.46 -40.36 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 m -61.09 -44.41 97.4 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.1 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.4 p -73.17 -16.35 61.43 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.749 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.71 65.51 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.13 -43.46 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.53 142.86 31.43 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 27.8 mtpp -84.68 150.83 24.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -87.49 139.08 30.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 m -129.98 163.95 25.32 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -62.53 170.47 2.45 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.09 0.948 . . . . 0.0 110.602 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 29.51 62.97 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.67 119.16 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.16 -38.66 3.01 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.81 1.87 Allowed 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 m -107.46 -32.32 7.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.4 47.19 36.8 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.5 m -70.95 140.71 51.01 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -130.31 147.32 52.01 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 69.9 mtp180 -115.15 149.05 38.22 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.89 127.05 35.35 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.89 110.45 20.54 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 C--O 1.26 1.644 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.45 -39.02 91.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.33 83.35 44.26 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.11 -26.11 36.95 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 121.553 1.502 . . . . 0.0 113.193 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -131.34 135.1 46.96 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -68.53 -29.2 67.73 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 84.4 p -63.23 -26.82 68.97 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.81 -42.2 97.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.18 -40.16 82.33 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.59 -43.22 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.18 -42.72 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.63 -42.02 98.3 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.4 93.17 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.97 -0.456 . . . . 0.0 110.244 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.51 -39.33 76.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.421 ' HG3' ' HE3' ' A' ' 18' ' ' LYS . 46.3 tt0 -62.17 -37.76 86.49 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.1 85.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.04 79.19 1.82 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.265 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HE3' ' HG3' ' A' ' 15' ' ' GLN . 97.3 mttt -83.25 58.73 4.62 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -66.05 151.54 46.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.66 -35.89 81.11 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.77 -5.57 46.46 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.84 170.1 35.41 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -95.46 130.67 42.19 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -67.99 151.02 47.74 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -61.69 -41.44 97.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.49 -38.73 92.25 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.7 t -62.37 -39.93 94.77 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.54 -48.83 86.86 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 O-C-N 122.005 -0.435 . . . . 0.0 110.09 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -72.67 -33.98 66.91 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.318 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -66.21 -40.68 90.52 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.42 -48.57 80.57 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.34 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.17 -41.94 96.91 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.77 -0.582 . . . . 0.0 110.457 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -69.46 -39.96 77.42 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.863 -0.523 . . . . 0.0 111.987 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -94.75 -21.21 18.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.569 -0.707 . . . . 0.0 111.826 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -128.62 143.38 50.94 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -77.44 128.1 33.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.81 158.23 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.64 -179.92 28.02 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.52 -31.87 69.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.14 -38.25 81.97 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.36 90.82 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.67 -40.44 92.11 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.31 -39.85 93.01 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -65.3 -39.06 92.02 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.17 -45.0 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.36 -42.1 99.14 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.34 -39.49 85.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -63.58 -43.69 96.25 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.21 -45.39 98.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.9 -39.98 95.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.917 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.76 -41.21 96.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.855 -0.528 . . . . 0.0 109.809 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.99 -39.72 95.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.4 -40.58 88.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -61.18 -41.7 97.26 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -70.22 -27.79 64.75 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.34 8.03 55.35 Favored Glycine 0 C--N 1.349 1.288 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.27 -43.36 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.87 143.8 28.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 87.0 mttt -84.68 150.95 24.79 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -86.76 151.65 23.2 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 m -142.35 164.36 30.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.59 167.9 2.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 122.01 0.91 . . . . 0.0 110.663 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.19 26.63 67.94 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.16 120.76 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.91 0.862 . . . . 0.0 108.832 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -38.82 2.95 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -61.9 1.84 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -107.79 -31.48 8.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.84 48.05 29.54 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -70.51 141.02 51.98 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -132.13 149.46 52.39 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 75.4 mtp180 -116.06 152.62 33.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.76 126.87 35.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.99 109.98 18.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 tptt . . . . . 0 C--O 1.263 1.795 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.663 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -100.05 127.8 46.22 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -135.04 83.17 40.55 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.93 -76.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 121.769 1.646 . . . . 0.0 112.476 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -131.71 144.38 50.95 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.36 -39.17 88.99 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.0 p -65.13 -38.68 91.43 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.836 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.51 -40.08 92.59 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.5 mtp -66.82 -40.49 88.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -64.39 -43.23 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.05 -43.43 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.85 98.35 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.98 -44.34 93.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 122.003 -0.436 . . . . 0.0 110.246 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.5 mt -68.93 -38.81 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.72 -40.39 97.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.81 96.86 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -106.63 65.37 0.67 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -81.63 57.62 3.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.34 148.12 43.76 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -63.59 -36.64 84.47 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.91 64.98 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.01 169.51 14.74 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 t -99.61 126.05 45.53 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -70.19 153.4 43.16 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -62.14 -41.39 98.22 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.6 -38.2 90.23 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.3 m -63.72 -38.28 90.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.6 mt -60.93 -49.78 83.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.66 -32.84 66.14 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.944 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -62.9 -45.31 93.1 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.815 -0.553 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -61.11 -47.89 84.17 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.46 -46.08 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.197 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.98 -39.56 93.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.518 -0.738 . . . . 0.0 110.29 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.39 -39.87 74.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.999 -0.438 . . . . 0.0 112.18 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -99.61 -13.59 19.33 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.13 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.36 148.84 52.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.663 ' H ' ' N ' ' A' ' 1' ' ' GLY . 24.5 tptm -87.14 118.56 26.62 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.91 157.96 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.01 177.27 35.21 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -39.29 87.61 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -63.79 -38.31 90.64 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.11 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.77 -40.37 92.32 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -65.28 -39.96 93.27 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.79 -38.2 88.34 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.54 -45.32 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.57 -41.24 98.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.98 -39.59 87.2 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.8 m -64.72 -40.75 95.88 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.2 mt -62.13 -45.33 98.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -64.02 -39.95 95.25 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.2 -40.97 99.0 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.21 -38.45 89.21 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.46 -40.64 88.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -60.78 -44.18 97.13 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.082 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.9 p -72.89 -16.72 61.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.773 -0.58 . . . . 0.0 109.725 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.86 7.6 64.32 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.5 -43.23 94.42 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.7 mt -99.43 146.78 25.95 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -86.1 151.9 23.31 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.16 136.26 33.12 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -127.8 163.7 23.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -58.81 172.04 0.58 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.146 0.974 . . . . 0.0 110.845 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 32.18 57.33 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.73 119.47 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -37.94 3.29 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -63.3 1.42 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.1 p -108.75 -29.08 8.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.49 47.93 39.59 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.4 m -70.27 139.76 52.22 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -132.93 150.29 52.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -114.94 154.28 29.02 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.45 127.47 35.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.29 108.21 19.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.261 1.704 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 CA--C 1.498 -1.058 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -66.8 -38.48 86.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 11' ' ' VAL . 69.8 m -63.2 -39.54 94.92 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.34 -40.6 97.75 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.2 mtm -66.85 -40.12 87.8 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.23 -44.2 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 7' ' ' SER . 55.5 t -62.28 -43.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -41.57 97.39 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.27 -43.41 98.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 122.0 -0.438 . . . . 0.0 110.108 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.99 -39.65 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.16 -38.12 89.93 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.51 92.29 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -113.04 68.84 0.68 Allowed 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -84.0 57.13 4.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.88 158.52 34.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.44 -36.99 85.55 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 -7.72 53.84 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.57 -178.58 35.37 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.0 t -101.83 132.8 47.38 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -69.57 154.99 41.19 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -61.78 -42.57 99.17 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.16 -38.24 90.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.1 m -62.29 -38.2 88.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.141 -0.349 . . . . 0.0 110.279 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.451 HG21 HD11 ' A' ' 50' ' ' ILE . 84.9 mt -60.75 -49.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.88 -33.26 65.94 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.101 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.91 -46.55 87.25 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.921 -0.487 . . . . 0.0 109.764 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -61.41 -48.28 81.93 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.1 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.96 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.93 -42.68 97.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.703 -0.623 . . . . 0.0 110.389 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -67.42 -42.05 83.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.983 -0.448 . . . . 0.0 111.826 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -93.99 -21.17 19.35 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.006 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.05 145.66 51.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.38 130.27 37.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.92 160.41 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.08 -178.47 18.73 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.209 -2.356 . . . . 0.0 107.209 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -65.15 -40.13 93.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.68 -38.98 92.86 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.0 93.35 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.9 -40.02 91.48 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.1 t -64.43 -41.57 96.51 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -64.79 -39.1 93.05 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.09 -45.46 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.52 -40.64 97.4 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.83 -43.36 88.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.8 m -63.99 -41.2 97.57 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.979 -0.45 . . . . 0.0 110.094 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 28' ' ' ILE . 88.7 mt -62.51 -44.2 99.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.02 -43.18 99.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.61 98.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.923 -0.486 . . . . 0.0 109.962 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.602 ' HB3' HD13 ' A' ' 59' ' ' LEU . 79.5 mt -62.13 -39.12 91.5 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.1 t -66.79 -40.02 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 m -61.13 -43.94 98.1 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -72.29 -16.82 61.9 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.818 -0.551 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.45 2.21 70.66 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -44.08 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 53' ' ' LEU . 4.2 mp -91.82 136.62 33.01 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 51.3 mttm -85.13 150.97 24.47 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -91.25 138.94 31.2 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -127.11 164.26 21.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 62' ' ' THR . 19.4 ptpt -61.77 173.31 1.04 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.132 0.967 . . . . 0.0 110.614 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.55 33.82 57.86 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.38 120.21 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.25 -38.29 3.15 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.86 -62.34 1.7 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.3 m -108.38 -33.72 7.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.48 47.68 33.79 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.8 m -70.68 141.52 51.61 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 54' ' ' VAL . 87.7 m-85 -131.27 149.04 52.73 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 73.0 mtp85 -117.46 153.48 33.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp . . . . . 0 CA--C 1.496 -1.114 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.853 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 CA--C 1.502 -0.881 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 -37.88 89.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 11' ' ' VAL . 67.1 m -62.45 -39.39 93.19 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.82 -38.69 92.05 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.76 -41.62 95.74 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.43 -43.3 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 7' ' ' SER . 59.6 t -62.16 -43.02 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.06 98.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.32 92.05 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.913 -0.492 . . . . 0.0 110.291 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -63.48 -36.7 84.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.21 85.46 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.09 75.72 1.17 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -83.49 59.6 5.18 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -69.39 167.1 17.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 -38.0 89.11 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 6.46 33.25 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.9 -159.78 34.69 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.0 t -115.31 138.33 51.08 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 78.0 p -72.9 162.01 30.02 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -62.6 -41.82 99.2 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.49 -39.19 93.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.3 m -63.65 -39.25 93.86 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 122.05 -0.406 . . . . 0.0 110.009 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 50' ' ' ILE . 85.0 mt -61.55 -49.46 84.32 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.029 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.36 -32.64 66.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.925 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.59 -45.39 90.61 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.11 -48.36 82.0 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.62 -45.59 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.178 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.82 -41.15 97.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -69.73 -39.74 76.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.038 -0.414 . . . . 0.0 112.095 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -96.73 -17.99 19.94 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.487 -0.758 . . . . 0.0 112.085 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -129.21 147.6 51.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -82.03 121.57 26.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.89 158.39 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.29 179.29 26.98 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.15 -39.85 90.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -64.22 -38.66 91.83 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.52 91.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -39.94 91.21 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 m -65.14 -39.57 93.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -67.4 -37.72 83.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.81 -48.08 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 121.935 -0.478 . . . . 0.0 110.356 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -66.92 -31.15 71.55 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.188 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.92 -42.67 85.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.6 m -64.9 -40.64 95.41 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.511 HD11 HG21 ' A' ' 28' ' ' ILE . 89.7 mt -62.06 -44.61 99.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -43.05 99.63 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -63.21 -41.48 99.14 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.5 -39.71 95.17 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.705 -0.622 . . . . 0.0 109.375 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.631 HG21 ' CE2' ' A' ' 71' ' ' PHE . 74.1 t -65.0 -40.69 89.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -61.98 -40.86 97.07 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.9 m -69.98 -27.77 64.98 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 7.26 56.33 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.52 -43.12 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.0 mt -98.26 145.92 26.16 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.7 mttt -84.48 150.91 24.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.93 137.72 32.13 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.4 m -127.3 164.0 22.73 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -60.7 174.2 0.63 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.175 0.988 . . . . 0.0 110.813 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.77 33.02 58.45 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 120.16 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.45 -38.34 3.13 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -62.39 1.69 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 m -108.46 -33.13 7.15 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.09 47.84 28.95 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 72.7 m -70.73 141.01 51.53 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 54' ' ' VAL . 72.7 m-85 -132.39 147.32 52.38 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 90.8 mtt180 -114.01 154.49 27.56 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -179.265 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.5 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.6 -37.26 86.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 11' ' ' VAL . 68.6 m -61.99 -38.97 90.58 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.19 -40.33 97.2 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.3 mtm -65.7 -40.66 92.53 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 14' ' ' ILE . 60.1 mt -63.24 -43.75 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 7' ' ' SER . 55.8 t -60.59 -41.87 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.32 94.31 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.51 -38.7 91.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 73' ' ' LEU . 47.4 mm -66.0 -41.51 89.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -68.34 -24.68 64.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.96 90.97 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -122.36 81.22 1.81 Allowed 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -86.72 47.58 1.51 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.63 156.48 26.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -67.22 -19.17 65.5 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.68 -6.68 59.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.53 -175.63 39.21 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -106.01 132.97 51.46 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.8 150.8 46.48 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -62.45 -41.77 98.99 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -63.81 -39.43 94.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.31 -38.05 89.63 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 50' ' ' ILE . 84.3 mt -60.67 -48.42 88.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.021 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.85 -35.25 69.8 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.046 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -65.11 -40.69 94.9 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.613 -0.679 . . . . 0.0 109.664 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.52 -49.56 76.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -43.07 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.15 -40.43 97.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.916 -0.49 . . . . 0.0 111.11 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.8 p -83.47 -16.54 45.32 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.369 -0.832 . . . . 0.0 112.032 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.41 -24.94 12.09 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 119.327 0.967 . . . . 0.0 110.27 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.34 149.62 51.05 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.0 120.47 25.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.05 157.19 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.63 -177.75 25.95 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.7 -41.78 91.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.12 -39.58 94.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.18 93.59 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.5 -42.32 96.12 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.4 m -65.52 -39.48 91.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.84 -36.27 82.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.84 -43.9 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -62.51 -40.21 96.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.72 -40.26 95.03 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -65.23 -41.69 94.13 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 28' ' ' ILE . 91.5 mt -63.05 -45.16 99.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.74 -39.35 94.08 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.91 -41.13 97.75 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.85 -39.51 94.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.514 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.4 t -65.77 -40.48 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.1 m -61.45 -41.45 97.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.3 m -70.23 -27.66 64.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.45 1.37 59.15 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.16 -42.77 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.94 139.7 30.97 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.2 mttt -84.84 151.08 24.57 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -101.31 138.14 38.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.7 m -123.14 164.21 19.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 62' ' ' THR . 14.8 ptmm? -60.43 174.8 0.51 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 122.181 0.991 . . . . 0.0 110.868 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.02 58.66 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 108.334 -1.907 . . . . 0.0 108.334 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.95 121.09 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.14 -38.99 2.88 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -62.22 1.75 Allowed 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -108.08 -34.54 6.85 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.67 48.06 37.43 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.0 m -70.27 138.91 51.99 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.7 m-85 -131.7 151.79 51.37 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 87.7 mtm180 -122.41 153.74 38.67 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HB2' HG21 ' A' ' 14' ' ' ILE . 63.8 tp . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.49 -38.0 86.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 11' ' ' VAL . 48.3 t -62.34 -39.92 94.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.27 -41.27 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -67.27 -39.88 86.13 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 14' ' ' ILE . 54.4 mt -62.8 -43.39 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' SER . 59.3 t -60.49 -42.58 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.98 92.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.67 94.64 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.9 mm -65.33 -42.6 94.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.02 -37.7 88.49 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.52 93.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.96 67.56 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -89.44 59.33 4.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.51 161.57 18.51 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.78 -21.63 64.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.82 -7.46 57.89 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.4 177.76 38.64 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -97.63 132.37 43.35 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -71.35 148.59 46.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.63 -42.38 98.81 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.51 -38.55 91.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -66.63 -30.38 70.64 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.741 -0.599 . . . . 0.0 110.24 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.599 HG21 HD11 ' A' ' 50' ' ' ILE . 83.4 mt -63.29 -49.8 81.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.562 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -72.89 -33.44 66.03 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.624 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.0 -45.41 89.12 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -61.47 -48.48 80.94 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.33 -46.07 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.208 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.71 -41.4 96.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.75 -0.594 . . . . 0.0 110.294 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -70.06 -39.85 75.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.948 -0.47 . . . . 0.0 112.192 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -97.19 -15.24 20.97 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.981 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.44 146.76 52.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.43 119.6 25.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.5 161.52 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.83 167.01 52.47 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.57 -22.63 61.71 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -89.87 -1.96 58.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.24 59.31 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.44 -40.2 90.28 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 m -66.03 -40.3 90.9 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.73 -36.96 81.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.79 -43.63 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.49 -39.85 94.81 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.83 -40.86 95.87 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -64.41 -43.67 93.65 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.599 HD11 HG21 ' A' ' 28' ' ' ILE . 89.3 mt -62.71 -43.97 99.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.55 -42.31 98.65 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.95 -43.36 99.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.91 -39.75 95.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.419 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' CE2' ' A' ' 71' ' ' PHE . 75.2 t -64.78 -40.37 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -62.04 -41.82 98.52 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -69.86 -27.79 65.12 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.5 8.31 52.68 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.5 -44.65 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.83 143.16 26.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 33.5 tptt -91.78 151.0 20.81 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.04 137.35 35.08 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.6 m -128.41 164.0 23.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' H ' HG22 ' A' ' 62' ' ' THR . 19.3 ptpt -62.24 172.25 1.54 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.065 0.936 . . . . 0.0 110.578 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.15 34.97 57.71 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.51 119.22 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.24 -37.88 3.29 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.52 -62.08 1.78 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.06 -33.16 7.26 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.22 47.75 28.46 Favored Glycine 0 C--N 1.355 1.611 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -70.47 143.12 51.85 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.396 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 54' ' ' VAL . 95.5 m-85 -129.49 146.87 51.28 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 80.9 mtm180 -124.44 178.26 5.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 14' ' ' ILE . 93.4 mt . . . . . 0 CA--C 1.496 -1.132 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 CA--C 1.501 -0.92 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -66.68 -36.49 82.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.3 p -62.24 -36.11 80.98 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.85 -40.23 94.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.02 -40.01 87.15 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.12 -44.09 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 7' ' ' SER . 60.7 t -62.46 -43.16 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.42 98.77 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.94 91.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 122.187 -0.321 . . . . 0.0 110.513 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -69.12 -42.81 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.588 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.86 -19.9 61.89 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.526 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.5 97.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -113.52 77.41 1.05 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -83.64 59.93 5.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.61 163.04 25.82 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.75 -29.57 70.1 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.77 2.11 49.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.53 -165.36 35.29 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -107.86 137.13 46.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -72.57 157.16 38.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.66 -43.74 98.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.883 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.13 -26.9 65.12 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.718 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -65.88 -38.18 88.09 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.592 HG21 HD11 ' A' ' 50' ' ' ILE . 88.3 mt -61.04 -48.6 88.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -72.82 -36.92 67.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.793 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.53 -41.42 96.38 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.547 -0.721 . . . . 0.0 110.167 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -62.02 -48.72 79.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.61 -45.53 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.04 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -64.07 -41.91 97.17 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.549 -0.72 . . . . 0.0 110.318 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 t -69.0 -41.91 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.929 -0.482 . . . . 0.0 111.833 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -93.17 -20.38 20.53 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.091 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -128.75 147.87 50.81 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.99 119.51 26.37 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.62 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.15 171.39 48.26 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.25 -37.77 84.06 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -73.29 -12.15 60.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.2 62.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.07 -40.8 95.05 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -70.53 -35.6 73.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -66.6 -39.42 88.38 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.86 -44.08 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -41.63 98.46 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.49 -40.08 92.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -64.16 -43.17 95.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.592 HD11 HG21 ' A' ' 28' ' ' ILE . 88.0 mt -62.15 -44.94 99.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.98 -39.79 95.77 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -64.32 -41.92 96.56 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -39.44 93.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.9 t -64.59 -40.01 87.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.6 m -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -72.28 -17.21 61.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.882 -0.512 . . . . 0.0 109.689 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.63 5.72 66.51 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.37 -43.89 94.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.6 143.24 30.07 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.04 149.9 23.02 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -87.08 139.7 30.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.1 m -128.21 164.19 23.07 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 62' ' ' THR . 22.8 ptmt -61.22 174.39 0.7 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.056 0.931 . . . . 0.0 110.632 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.4 58.52 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.98 119.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.81 -38.12 3.22 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.01 -62.98 1.5 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.9 p -109.01 -29.35 8.61 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.25 47.72 56.8 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -70.53 143.75 51.54 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 54' ' ' VAL . 94.8 m-85 -129.82 145.92 51.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -109.87 150.67 28.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.497 -1.089 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.76 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -66.92 -36.25 81.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.519 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.1 p -62.89 -37.29 86.35 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.18 -39.46 92.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.4 mtp -65.89 -41.23 91.77 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.19 -43.89 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 7' ' ' SER . 56.5 t -62.09 -43.38 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.24 98.2 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -63.92 -43.17 96.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 122.035 -0.416 . . . . 0.0 110.331 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.2 mt -68.58 -39.62 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.9 -38.42 91.0 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.76 94.87 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.01 65.38 0.8 Allowed 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.22 45.34 0.74 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -68.01 149.65 49.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.99 -37.09 85.78 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -21.5 64.89 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.54 175.76 19.2 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -101.8 126.73 48.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -69.94 154.32 42.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.9 -41.42 97.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.23 -38.61 91.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -61.93 -37.51 84.95 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.512 HG21 HD11 ' A' ' 50' ' ' ILE . 82.2 mt -60.43 -48.74 87.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.93 -34.41 66.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.492 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.89 -41.48 97.71 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.444 -0.785 . . . . 0.0 110.038 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 76.8 t80 -61.87 -48.02 82.4 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.72 -45.04 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.002 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.07 -40.07 95.46 Favored 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 121.67 -0.644 . . . . 0.0 110.367 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 t -70.41 -42.05 72.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 122.028 -0.42 . . . . 0.0 111.795 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -96.73 -14.35 22.07 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.568 -0.708 . . . . 0.0 112.135 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.67 151.03 50.73 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.6 121.6 31.95 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.36 158.41 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.02 175.73 36.87 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.43 -39.86 85.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -66.75 -28.39 68.37 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.14 68.8 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.3 -40.56 94.62 Favored 'General case' 0 C--N 1.353 0.717 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.0 m -66.37 -40.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -65.15 -39.89 93.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.29 -45.84 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.01 -41.47 99.58 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -66.43 -39.49 88.95 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.95 -41.84 95.15 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 28' ' ' ILE . 89.4 mt -63.04 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.69 -42.32 99.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -42.46 99.57 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.1 -40.24 95.8 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 121.775 -0.578 . . . . 0.0 109.547 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.3 t -65.62 -40.8 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.4 m -62.08 -40.91 97.42 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 -27.64 65.1 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.09 7.77 54.58 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.16 -43.92 91.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.66 147.38 23.36 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -90.43 148.8 22.56 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.65 151.03 26.47 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -141.85 164.14 30.99 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -63.27 172.53 1.88 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 122.036 0.922 . . . . 0.0 110.762 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.27 34.32 58.02 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.41 119.44 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.13 3.2 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.2 1.74 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.3 m -107.74 -32.18 7.74 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.68 47.64 32.61 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -70.53 140.92 51.92 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 54' ' ' VAL . 81.9 m-85 -131.55 149.07 52.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 81.5 mtm180 -124.87 177.39 6.05 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.565 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.498 -1.042 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -66.64 -35.93 81.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.7 p -62.53 -36.62 83.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.22 -39.24 92.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.2 mtp -66.07 -40.86 91.23 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.32 -42.94 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 7' ' ' SER . 56.2 t -61.86 -42.54 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.103 -0.373 . . . . 0.0 110.123 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.05 94.08 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.061 -0.399 . . . . 0.0 110.172 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.42 -38.08 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -61.57 -36.9 81.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.84 89.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -114.56 69.32 0.71 Allowed 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -82.96 57.95 4.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -80.8 165.73 21.62 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.32 -36.6 84.64 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -8.82 57.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.9 -163.82 33.66 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.1 m -115.97 141.06 48.61 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.6 m -72.87 155.52 39.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.59 -42.38 98.78 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -62.9 -38.64 91.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -62.35 -39.65 93.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 50' ' ' ILE . 84.2 mt -60.56 -49.52 84.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.954 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.65 -33.18 66.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.938 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -64.09 -45.41 88.82 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.959 -0.463 . . . . 0.0 109.768 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -61.17 -48.34 82.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.14 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.094 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.72 -41.95 95.61 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 121.68 -0.637 . . . . 0.0 110.407 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -69.05 -42.07 76.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.916 -0.49 . . . . 0.0 111.942 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -94.69 -16.64 22.94 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.526 -0.734 . . . . 0.0 112.138 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.46 147.65 52.18 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.61 120.82 25.56 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.88 157.79 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.58 -179.1 24.78 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.64 -41.3 92.77 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.61 -38.92 92.96 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.86 92.65 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.03 -39.94 91.7 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.1 m -64.72 -39.97 94.54 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.19 -36.6 82.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.36 -45.88 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.34 -40.65 97.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.5 tp -63.63 -44.3 94.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -63.4 -43.07 98.62 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 28' ' ' ILE . 89.4 mt -61.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.84 -40.14 95.88 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -63.71 -42.29 97.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.27 -40.51 96.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.594 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.1 t -65.48 -40.92 89.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.0 m -61.97 -41.12 97.64 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.7 m -70.08 -27.61 64.75 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.93 8.53 55.43 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.12 -43.5 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.92 143.84 28.77 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -85.4 151.17 24.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -94.87 135.11 36.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.2 m -119.56 164.46 15.79 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' H ' HG22 ' A' ' 62' ' ' THR . 22.2 ptmt -59.24 175.17 0.33 Allowed 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.095 0.95 . . . . 0.0 110.982 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.26 35.08 53.66 Favored Glycine 0 C--N 1.357 1.741 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.79 119.89 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.1 -38.12 3.2 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -62.37 1.69 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.1 m -108.48 -35.1 6.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.5 47.86 32.67 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 64.4 m -70.58 143.46 51.54 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.594 ' CE2' HG21 ' A' ' 54' ' ' VAL . 85.2 m-85 -130.81 151.42 51.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -122.0 164.92 16.83 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.439 -0.998 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -67.83 -34.74 77.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.4 m -61.43 -38.13 86.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.08 -43.64 98.4 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -39.9 89.96 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.7 -44.79 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 7' ' ' SER . 64.3 t -63.17 -42.26 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.23 -42.77 99.19 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.25 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.51 -39.86 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -64.73 -37.62 88.22 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.493 -0.755 . . . . 0.0 109.017 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.63 91.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -106.96 68.84 0.74 Allowed 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -79.98 51.79 1.4 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -70.02 147.95 49.44 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -61.97 -37.65 85.59 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.44 -9.41 58.5 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.87 169.89 28.61 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 t -95.34 128.91 42.57 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -71.29 157.16 38.6 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -60.8 -42.57 97.87 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -63.15 -39.27 94.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.2 m -63.46 -39.03 93.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 50' ' ' ILE . 82.8 mt -61.04 -49.4 84.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.71 -32.89 66.06 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.131 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.66 -45.65 93.13 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.833 -0.542 . . . . 0.0 109.687 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.29 -48.2 82.48 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.99 -45.02 99.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.17 -39.59 94.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.486 -0.759 . . . . 0.0 110.211 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.36 -39.93 74.33 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.001 -0.437 . . . . 0.0 112.075 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -98.25 -16.94 19.21 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.841 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.09 147.4 52.61 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -84.52 121.52 27.71 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.0 159.49 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.54 179.44 26.7 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.09 -40.85 91.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.36 -38.57 91.66 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.76 91.42 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.89 -39.68 90.17 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.11 -40.38 94.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.69 -37.01 81.71 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -45.36 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.98 -40.18 96.95 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.29 -44.19 92.44 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.1 t -63.27 -42.81 99.16 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 28' ' ' ILE . 89.3 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.21 -42.65 99.49 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.56 -42.12 99.34 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.7 -40.71 97.46 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.808 -0.557 . . . . 0.0 109.574 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.661 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.0 t -66.0 -40.71 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.4 m -62.04 -40.97 97.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.1 m -69.86 -27.64 65.0 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.76 8.33 54.46 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.17 -43.49 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -98.29 144.82 27.3 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -84.73 151.1 24.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -87.87 137.58 32.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -127.59 164.49 21.89 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.51 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -60.51 173.5 0.7 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.09 0.948 . . . . 0.0 110.509 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.15 32.97 57.75 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.7 119.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -37.81 3.32 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.92 -63.07 1.47 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.9 p -109.32 -30.49 7.96 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 48.0 37.95 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -70.46 143.05 51.89 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.661 ' CE2' HG21 ' A' ' 54' ' ' VAL . 73.3 m-85 -132.18 149.57 52.36 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -118.9 165.4 14.11 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 CA--C 1.499 -1.007 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -67.0 -36.4 82.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.2 p -63.08 -36.33 83.22 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.08 -40.35 94.52 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -66.66 -40.4 88.62 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 14' ' ' ILE . 53.7 mt -63.66 -43.5 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 7' ' ' SER . 54.6 t -60.5 -42.4 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.24 93.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.09 -39.36 93.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.559 HG21 ' HG ' ' A' ' 73' ' ' LEU . 50.0 mm -65.8 -44.0 93.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.21 -35.75 81.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.45 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -116.11 71.56 0.79 Allowed 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -86.82 58.99 5.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -80.51 162.12 24.5 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.9 -27.68 66.86 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -1.73 47.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -177.59 37.62 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 t -98.93 129.44 45.26 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -70.44 150.72 45.93 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -61.75 -43.53 98.68 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.318 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.09 -38.97 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.26 -38.12 89.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.473 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 87.6 mt -61.37 -49.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 121.975 -0.453 . . . . 0.0 110.331 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.9 -33.86 68.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.076 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.28 -40.85 86.17 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.92 -49.07 77.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.63 -44.99 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.849 -0.532 . . . . 0.0 110.408 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -69.08 -39.66 78.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.808 -0.558 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -96.08 -20.19 18.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.966 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.8 146.27 51.54 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -75.27 135.1 40.96 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.48 160.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 42' ' ' ALA . . . -117.48 -178.63 17.54 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.03 -40.27 94.59 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -65.1 -39.43 93.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 39' ' ' GLY . . . -62.82 -38.76 91.98 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.01 -40.65 94.36 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 95.1 p -69.55 -34.84 74.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -68.39 -36.12 78.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.87 -39.89 95.81 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.92 -42.34 85.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -62.7 -44.92 94.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.202 -0.311 . . . . 0.0 110.59 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 pt -67.48 -34.24 67.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.925 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.95 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.5 -39.43 93.49 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 50' ' ' ILE . 73.9 t -65.76 -40.69 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.2 m -61.42 -44.34 97.3 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.099 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.2 p -73.0 -15.92 61.52 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.898 -0.501 . . . . 0.0 109.835 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.67 6.18 66.01 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.09 -43.83 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.67 138.08 35.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 55.1 mtpt -87.82 151.97 22.46 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -83.98 135.46 34.44 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.6 m -127.14 164.15 22.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' H ' HG22 ' A' ' 62' ' ' THR . 64.8 pttt -60.15 172.5 0.8 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.109 0.957 . . . . 0.0 110.671 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.22 33.09 57.42 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.56 119.11 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.93 -37.87 3.31 Favored Glycine 0 C--N 1.351 1.395 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.9 -62.97 1.5 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.7 p -108.96 -30.3 8.16 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.36 47.75 49.5 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.8 m -70.19 144.58 51.89 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.583 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.41 ' CE2' HG21 ' A' ' 54' ' ' VAL . 85.4 m-85 -130.07 148.92 51.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 80.7 mtm180 -120.07 169.75 9.92 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.559 ' HG ' HG21 ' A' ' 14' ' ' ILE . 95.4 mt . . . . . 0 CA--C 1.495 -1.145 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -66.63 -38.3 86.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 11' ' ' VAL . 70.0 m -63.29 -40.57 97.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.91 -39.92 95.3 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mtp -66.37 -40.49 89.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.03 -43.73 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 7' ' ' SER . 63.6 t -62.49 -41.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.33 98.33 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.14 97.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.72 -40.49 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.95 -36.54 84.72 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.97 90.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -121.67 73.67 1.08 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -84.68 57.69 4.5 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -66.11 148.41 51.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -62.16 -38.52 89.34 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.87 65.61 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.14 170.58 14.36 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.5 m -97.77 130.48 44.71 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -69.24 146.45 52.31 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -61.46 -40.57 94.99 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.74 -38.47 91.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -61.78 -39.88 93.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.09 -48.89 86.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.082 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.42 -34.87 68.14 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.409 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -66.56 -40.65 89.11 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.551 -0.718 . . . . 0.0 110.171 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.71 -48.68 79.66 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.28 -45.75 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.42 -41.77 96.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.744 -0.597 . . . . 0.0 110.448 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.0 m -70.22 -39.88 74.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.962 -0.461 . . . . 0.0 112.128 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -96.33 -16.75 21.13 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.873 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.35 147.64 52.59 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -84.23 121.43 27.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.83 156.41 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.89 179.62 34.14 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.1 -41.67 90.29 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.79 -39.02 93.25 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.63 91.88 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -60.91 -42.63 98.43 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -65.14 -39.19 92.68 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.38 -38.39 90.87 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.45 -45.02 99.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.27 -41.85 98.82 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.9 tp -66.57 -41.96 87.76 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -62.5 -42.76 99.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.58 -45.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -63.89 -40.51 96.7 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -62.94 -41.74 99.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.87 -39.27 93.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG21 ' CE2' ' A' ' 71' ' ' PHE . 76.5 t -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 m -61.5 -41.09 96.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -70.05 -27.94 65.06 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 7.58 56.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.38 -43.24 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.17 146.19 26.41 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 87.0 mttt -84.66 150.75 24.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -91.43 138.41 31.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 63' ' ' LYS . 5.0 m -128.02 163.65 24.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 62' ' ' THR . 22.4 ptmt -61.27 171.53 1.34 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.063 0.935 . . . . 0.0 110.574 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.22 23.89 64.86 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.88 120.61 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.595 0.712 . . . . 0.0 109.146 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.24 -38.92 2.91 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.41 -62.4 1.7 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -108.6 -33.47 7.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.22 20.4 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.9 m -70.25 140.87 52.48 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 54' ' ' VAL . 71.3 m-85 -131.22 149.67 52.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 16.7 mmm180 -117.68 158.04 25.39 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 CA--C 1.497 -1.089 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.506 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -68.22 -37.31 80.71 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.514 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.7 p -63.59 -34.69 78.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.7 -42.79 95.05 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.46 -41.03 93.84 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 14' ' ' ILE . 64.4 mt -63.14 -44.41 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 7' ' ' SER . 57.7 t -60.37 -43.08 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.36 95.05 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.62 -39.05 93.03 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.8 mm -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.26 -27.37 64.38 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.111 -0.368 . . . . 0.0 110.079 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.16 95.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.84 75.08 0.97 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -85.68 59.45 5.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -79.6 152.89 29.8 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.36 -37.27 86.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.06 64.66 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 173.92 16.49 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.5 p -96.16 137.56 35.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.5 p -77.34 159.69 29.35 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -65.32 -39.96 93.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -63.3 -39.67 95.23 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -61.95 -39.87 93.58 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.642 HG21 HD11 ' A' ' 50' ' ' ILE . 85.8 mt -60.82 -49.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.201 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.52 -33.74 67.11 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.001 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.61 -46.11 89.77 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.85 -48.81 78.85 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.57 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.172 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.77 -18.15 62.77 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.0 m -89.17 -35.75 16.06 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.501 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -100.88 -12.2 19.18 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.74 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 152.06 51.61 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 124.66 31.62 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.01 160.41 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.72 -178.07 19.29 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.93 -41.65 95.34 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -63.85 -38.84 92.57 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -38.81 92.38 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.73 -39.95 90.53 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.2 t -64.72 -41.64 95.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -64.72 -38.49 91.18 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.67 -45.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -62.33 -41.8 98.85 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.54 -39.42 88.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.9 -40.96 95.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 28' ' ' ILE . 87.4 mt -62.57 -44.82 99.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.44 -39.34 94.23 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.1 -40.95 97.33 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.75 -39.65 94.78 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.0 t -65.21 -40.72 89.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 m -61.42 -41.63 97.47 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -70.33 -27.74 64.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.67 56.28 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.21 -43.33 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.71 146.14 31.16 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.9 mttt -84.72 150.61 24.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.09 137.29 34.35 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.0 m -122.96 164.01 19.31 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' H ' HG22 ' A' ' 62' ' ' THR . 19.4 ptpt -61.0 174.09 0.69 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.1 0.952 . . . . 0.0 110.627 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.8 33.1 58.29 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.38 120.12 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.78 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.96 -62.53 1.64 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -108.44 -34.14 6.86 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.41 48.42 24.18 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -70.86 141.84 51.23 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 54' ' ' VAL . 93.9 m-85 -130.98 148.74 52.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 66.7 mtp180 -118.09 158.14 25.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HB2' HG21 ' A' ' 14' ' ' ILE . 59.7 tp . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -68.19 -37.33 80.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.7 m -62.42 -38.92 91.59 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.14 -41.36 99.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.4 mmt -66.47 -40.38 89.31 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 14' ' ' ILE . 57.1 mt -63.29 -43.48 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' SER . 53.8 t -60.71 -42.22 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.78 94.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 73' ' ' LEU . 48.1 mm -67.51 -41.66 86.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -62.95 -36.94 85.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.979 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.57 84.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.76 82.06 1.98 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.024 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.03 58.28 4.33 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.33 148.47 51.61 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.23 -36.4 83.53 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -5.65 44.85 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.51 167.18 27.56 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -86.72 133.34 33.68 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.3 t -69.09 147.61 51.22 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -61.09 -41.45 96.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.56 -38.31 90.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.9 m -63.05 -38.39 90.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 122.057 -0.402 . . . . 0.0 110.199 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.629 HG21 HD11 ' A' ' 50' ' ' ILE . 86.5 mt -60.96 -49.73 83.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.937 -0.477 . . . . 0.0 110.017 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.73 -34.06 66.81 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.769 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.25 -45.37 91.87 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.09 -49.13 78.57 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.74 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.169 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -65.43 -41.43 93.54 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.689 -0.632 . . . . 0.0 110.593 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.5 m -69.36 -39.98 77.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 112.026 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -97.18 -15.79 20.72 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.447 -0.783 . . . . 0.0 111.657 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -133.47 147.19 51.66 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.96 126.61 32.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.97 157.32 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.27 176.5 34.24 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.49 -41.56 88.75 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.95 -38.97 93.03 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.36 94.52 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.403 ' HA ' HD12 ' A' ' 46' ' ' ILE . 36.6 t70 -60.82 -42.12 97.07 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -65.59 -39.54 91.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.85 -34.0 76.84 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 43' ' ' ASP . 80.6 mt -60.49 -43.53 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.29 -39.78 89.58 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.4 m -64.5 -41.73 96.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.629 HD11 HG21 ' A' ' 28' ' ' ILE . 90.1 mt -63.16 -44.2 99.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -62.35 -42.95 99.8 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -62.45 -42.52 99.52 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 59' ' ' LEU . 80.0 mt -63.57 -39.55 94.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.6 t -66.72 -40.55 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.8 m -61.76 -43.57 98.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.068 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -72.44 -15.93 61.82 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.782 -0.574 . . . . 0.0 109.72 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.55 2.94 69.49 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.28 -44.3 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 53' ' ' LEU . 3.5 mp -97.12 143.53 27.84 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.2 mttt -84.85 150.65 24.85 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -96.27 138.37 33.98 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.4 m -123.7 164.39 19.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -63.09 174.92 0.99 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.115 0.959 . . . . 0.0 110.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.22 33.55 59.0 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.2 t -70.55 120.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.02 -62.32 1.71 Allowed 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -108.46 -34.62 6.71 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.53 47.88 25.8 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 60.8 m -70.61 141.5 51.75 Favored 'General case' 0 C--N 1.358 0.963 0 CA-C-N 118.109 0.954 . . . . 0.0 108.464 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.3 m-85 -131.85 150.02 52.28 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.417 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 88.6 mtm180 -122.25 155.57 35.61 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.613 ' HB2' HG21 ' A' ' 14' ' ' ILE . 62.9 tp . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -67.36 -37.45 83.23 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.7 m -62.52 -39.11 92.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.62 -43.17 97.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.58 -39.96 92.19 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' O ' HG12 ' A' ' 14' ' ' ILE . 61.4 mt -62.36 -44.16 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 7' ' ' SER . 58.1 t -60.82 -42.5 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.56 91.83 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.95 95.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.613 HG21 ' HG ' ' A' ' 73' ' ' LEU . 39.7 mm -69.39 -41.56 80.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.01 -39.23 93.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -40.92 93.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.74 71.24 0.88 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.78 58.52 5.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.14 164.2 25.88 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.01 -38.76 92.47 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.25 -4.49 42.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.4 -171.75 35.44 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 t -105.47 132.06 52.11 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -69.5 155.15 40.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.02 -43.07 99.44 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.98 -39.14 93.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.6 m -62.98 -38.53 91.49 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 50' ' ' ILE . 85.3 mt -60.66 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 121.987 -0.445 . . . . 0.0 110.187 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.91 -33.01 65.73 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.084 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.28 -44.64 94.52 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.24 -48.73 80.14 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.08 -45.11 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.199 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.29 -40.39 95.86 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.861 -0.525 . . . . 0.0 111.398 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -83.73 -14.79 50.76 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.568 -0.707 . . . . 0.0 112.358 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -111.39 -20.71 12.15 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 119.538 1.063 . . . . 0.0 110.651 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -129.75 149.02 51.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.92 121.11 25.6 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.17 161.44 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.57 170.08 51.6 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.31 -37.75 83.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -80.58 0.31 34.51 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.22 63.27 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -40.07 89.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -66.61 -39.96 88.59 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -66.14 -39.74 90.08 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.38 -45.35 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.71 -40.46 97.21 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.39 -42.88 92.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.5 t -63.13 -43.71 97.65 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.657 HD11 HG21 ' A' ' 28' ' ' ILE . 87.7 mt -62.28 -43.78 98.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -61.1 -43.01 99.54 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.55 -41.16 98.45 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.38 -39.16 92.29 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.7 t -66.69 -39.73 84.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 m -60.98 -44.34 97.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.006 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 p -72.58 -16.94 61.74 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 109.55 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.99 70.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -65.5 -44.75 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.25 149.3 24.67 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 84.8 tttt -97.16 142.27 29.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.416 HE21 HG21 ' A' ' 65' ' ' VAL . 63.0 tt0 -81.61 139.53 34.97 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.3 m -131.15 163.87 26.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -63.9 175.47 1.17 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.982 0.896 . . . . 0.0 110.588 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.23 31.47 59.37 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.416 HG21 HE21 ' A' ' 61' ' ' GLN . 99.0 t -70.25 119.45 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.06 3.25 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.11 -63.45 1.39 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 p -109.28 -29.54 8.43 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.88 38.62 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -70.6 143.14 51.61 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 54' ' ' VAL . 96.3 m-85 -132.45 149.74 52.28 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 72.3 mtp180 -127.27 177.52 6.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.613 ' HG ' HG21 ' A' ' 14' ' ' ILE . 93.3 mt . . . . . 0 CA--C 1.496 -1.115 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 -35.34 79.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.1 p -62.5 -37.19 85.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.4 mtp -66.81 -40.21 87.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 7' ' ' SER . 59.1 t -61.63 -43.02 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.3 98.8 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -64.01 -44.68 91.89 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 122.085 -0.384 . . . . 0.0 110.401 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.23 -39.74 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -63.26 -38.62 91.88 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.62 93.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.12 67.48 0.65 Allowed 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -83.98 58.35 4.66 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.12 155.13 39.99 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -67.27 -19.99 65.58 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.01 -2.74 58.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 177.7 41.43 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -105.4 130.93 53.39 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 m -68.94 153.56 43.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -62.21 -41.4 98.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.98 -38.49 91.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.7 m -61.97 -37.81 86.18 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.609 HG21 HD11 ' A' ' 50' ' ' ILE . 86.0 mt -60.66 -48.6 87.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -73.13 -37.13 66.75 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.487 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.1 -40.43 96.2 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.273 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.402 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 78.7 t80 -61.65 -48.52 80.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.0 mt -62.86 -44.95 99.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.165 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.49 -38.56 91.46 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.747 -0.596 . . . . 0.0 111.55 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.0 p -86.38 -15.34 40.7 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.485 -0.76 . . . . 0.0 112.256 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -110.48 -20.03 12.72 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 119.373 0.988 . . . . 0.0 110.465 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.42 150.15 52.26 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -86.24 118.38 25.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.85 161.69 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.22 167.41 50.83 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.87 -19.14 61.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -90.94 -1.61 57.81 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.47 -25.6 62.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.42 -39.01 85.88 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.6 t -63.79 -43.57 95.93 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -68.34 -37.84 80.92 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.34 -46.36 96.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.27 -39.91 95.92 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.94 -44.87 94.88 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -64.94 -41.74 95.25 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.609 HD11 HG21 ' A' ' 28' ' ' ILE . 87.0 mt -62.61 -44.46 99.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.66 -43.44 98.85 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.58 -41.97 98.32 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.31 -39.43 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.4 t -65.09 -39.84 86.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.2 m -60.91 -42.83 98.82 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -70.22 -27.88 64.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.94 54.16 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.68 -43.35 93.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.01 142.96 29.08 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.18 151.55 22.61 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.85 138.39 32.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.5 m -128.68 164.09 23.69 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 62' ' ' THR . 22.9 ptmt -61.01 174.1 0.69 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.062 0.934 . . . . 0.0 110.572 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.98 32.9 58.19 Favored Glycine 0 C--N 1.357 1.712 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.69 119.15 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -37.92 3.29 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.73 -63.03 1.48 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 p -108.92 -29.88 8.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.06 47.85 43.44 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.1 m -70.33 142.51 52.19 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CE2' HG21 ' A' ' 54' ' ' VAL . 89.5 m-85 -130.98 149.44 52.6 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -119.27 164.95 14.89 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.737 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttp . . . . . 0 N--CA 1.437 -1.11 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -67.53 -35.54 79.29 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.3 m -61.82 -38.7 89.13 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.45 -40.99 98.39 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.4 mtt -67.02 -40.23 87.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.67 -43.35 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 7' ' ' SER . 59.1 t -62.43 -43.57 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.0 98.71 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.74 -44.58 93.08 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 122.043 -0.411 . . . . 0.0 110.161 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.14 -39.89 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -63.6 -39.4 94.27 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.82 96.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -105.88 63.8 0.68 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -86.28 59.78 5.84 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -80.99 168.36 18.79 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -64.63 -36.89 85.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.64 -5.29 49.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.47 -167.83 32.88 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.7 t -107.21 131.63 53.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -71.6 158.24 36.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -60.61 -44.84 95.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -64.82 -37.7 88.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.9 m -62.87 -38.43 90.82 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 122.275 -0.266 . . . . 0.0 110.646 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 50' ' ' ILE . 88.2 mt -61.17 -49.95 82.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.232 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -73.11 -33.13 65.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.004 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.28 -45.84 89.58 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -61.36 -48.41 81.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.16 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.894 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.49 -41.45 96.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.655 -0.653 . . . . 0.0 110.313 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.89 -39.87 76.0 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.934 -0.479 . . . . 0.0 112.066 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -97.09 -16.42 20.52 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.959 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.59 147.08 52.23 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -81.1 121.92 26.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.13 157.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.82 -179.93 25.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -65.97 -39.77 90.66 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -64.4 -39.31 93.6 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.64 91.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.77 -40.21 91.67 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.9 p -68.04 -35.88 78.98 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -68.83 -35.72 77.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.88 -44.24 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.79 -40.54 97.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.08 -40.85 91.15 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -64.4 -43.42 94.48 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 28' ' ' ILE . 90.5 mt -61.73 -44.77 99.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.87 -43.82 98.08 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.82 -41.95 97.76 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 121.895 -0.503 . . . . 0.0 110.089 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.99 -39.97 94.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.655 -0.653 . . . . 0.0 109.428 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG21 ' CE2' ' A' ' 71' ' ' PHE . 76.2 t -65.26 -40.02 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 m -61.16 -43.55 98.71 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.827 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.409 ' OG1' HG23 ' A' ' 58' ' ' VAL . 60.0 p -72.29 -17.19 61.89 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.845 -0.535 . . . . 0.0 109.742 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.02 7.41 65.93 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' OG1' ' A' ' 56' ' ' THR . 53.3 t -65.4 -42.96 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.1 mt -97.64 143.68 28.06 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 151.86 21.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -90.39 134.5 34.3 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.7 m -121.82 164.16 17.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' H ' HG22 ' A' ' 62' ' ' THR . 22.8 ptmt -58.83 174.79 0.32 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.109 0.956 . . . . 0.0 111.042 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.63 53.38 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.9 119.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.48 -38.14 3.2 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.02 1.8 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.34 -34.43 6.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.08 47.23 38.87 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.1 m -71.04 142.85 50.89 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 54' ' ' VAL . 86.5 m-85 -131.3 151.37 51.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -120.57 168.89 10.88 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 CA--C 1.497 -1.081 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.745 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.15 -39.22 89.64 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.0 p -64.71 -36.57 84.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.48 -42.74 91.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.4 ' HB3' HG12 ' A' ' 32' ' ' ILE . 78.1 mtm -65.93 -39.5 90.56 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.83 -43.53 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 7' ' ' SER . 58.9 t -61.91 -43.92 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.6 98.88 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.68 93.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.146 -0.346 . . . . 0.0 110.142 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.69 -40.09 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.96 -39.87 95.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.38 97.51 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -107.64 66.72 0.67 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.84 59.7 4.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -75.01 150.65 38.88 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -68.34 -27.01 65.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -6.57 56.58 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.51 166.73 31.01 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -94.96 129.38 42.03 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -66.56 147.32 53.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -61.53 -40.52 94.94 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.17 -38.91 92.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -63.03 -36.54 83.9 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 50' ' ' ILE . 84.7 mt -60.25 -50.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.922 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -73.33 -32.92 64.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.24 -45.49 93.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.33 -47.83 84.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 9' ' ' MET . 95.2 mt -61.64 -46.56 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.19 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.14 -41.15 95.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.22 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.8 -39.83 76.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.914 -0.491 . . . . 0.0 112.237 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.8 -15.36 20.3 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.504 -0.747 . . . . 0.0 112.019 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -130.28 147.48 52.01 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.88 119.64 24.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.43 161.23 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.08 171.96 52.46 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.33 -39.83 85.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -77.82 -5.35 50.56 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.23 80.51 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.5 -38.95 82.25 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 t -63.66 -42.93 98.01 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -36.64 81.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.45 -43.06 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.81 -41.08 97.32 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.17 -40.9 90.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.5 m -65.65 -42.05 91.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 28' ' ' ILE . 88.4 mt -63.11 -44.37 99.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -61.85 -43.72 98.27 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.51 -41.71 98.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 121.967 -0.458 . . . . 0.0 110.049 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.03 -39.7 95.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.601 -0.687 . . . . 0.0 109.215 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.4 t -65.52 -40.12 87.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -61.19 -41.34 96.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.1 m -70.31 -27.62 64.53 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.99 8.05 55.79 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.26 -44.02 91.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.95 147.68 22.87 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -92.72 149.45 21.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -81.95 151.66 27.1 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.8 m -142.98 163.67 32.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -60.39 172.0 0.95 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.192 0.996 . . . . 0.0 110.865 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.99 33.04 57.98 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.6 t -70.57 119.88 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -38.12 3.21 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.47 1.65 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.5 m -108.52 -33.41 7.05 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.91 48.39 16.46 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 107.379 -2.288 . . . . 0.0 107.379 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.3 m -70.26 142.34 52.33 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.587 ' CE2' HG21 ' A' ' 54' ' ' VAL . 84.0 m-85 -130.94 149.22 52.67 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 14.8 mmm180 -123.32 177.52 5.56 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.578 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 CA--C 1.498 -1.049 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -67.14 -36.24 81.44 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.6 m -61.83 -38.85 89.73 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.42 -41.44 98.7 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.7 -39.22 84.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.04 -43.29 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 7' ' ' SER . 61.6 t -62.22 -43.2 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.96 98.55 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.26 93.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.997 -0.439 . . . . 0.0 110.283 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.95 -39.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -63.55 -39.15 93.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.79 95.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -107.72 65.13 0.64 Allowed 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -86.15 59.25 5.53 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.85 168.86 18.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -37.13 86.54 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.05 -2.46 40.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.16 38.48 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 t -111.38 132.12 54.67 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.4 p -73.08 162.26 29.67 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -63.36 -40.71 98.03 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.47 -39.01 93.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.5 m -63.32 -38.78 92.47 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.04 -0.412 . . . . 0.0 109.904 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.474 HG21 HD11 ' A' ' 50' ' ' ILE . 87.8 mt -61.3 -49.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.109 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.57 -33.44 66.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.972 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.11 -45.35 88.98 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.857 -0.527 . . . . 0.0 109.657 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.33 -48.64 80.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.41 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.085 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.01 -41.83 95.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.791 -0.568 . . . . 0.0 110.411 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.9 m -69.33 -40.06 77.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.85 -0.531 . . . . 0.0 112.08 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -98.18 -14.23 20.48 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.957 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -133.66 148.19 51.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -81.27 127.23 32.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.54 157.16 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.49 177.63 30.93 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.9 -42.07 90.68 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.54 -39.61 94.08 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.6 95.11 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.67 -41.87 95.92 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.3 m -65.51 -39.84 92.31 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.7 -34.88 78.83 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.37 -44.64 96.45 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.02 -40.34 97.46 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.95 -40.73 91.59 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -64.11 -42.89 96.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.474 HD11 HG21 ' A' ' 28' ' ' ILE . 90.2 mt -61.83 -44.56 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -62.07 -43.28 99.18 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.45 98.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.995 -0.441 . . . . 0.0 109.996 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -39.43 92.54 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.621 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.0 t -66.13 -40.19 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 m -60.85 -44.55 96.83 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -73.04 -15.94 61.5 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.812 -0.555 . . . . 0.0 109.877 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.68 64.72 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.25 -43.22 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.29 145.67 26.42 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -88.73 151.9 22.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -81.77 151.94 27.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.498 ' O ' HG13 ' A' ' 65' ' ' VAL . 4.6 m -143.52 164.06 31.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 62' ' ' THR . 23.4 pttp -59.24 167.17 1.88 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.181 0.991 . . . . 0.0 110.794 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.59 61.75 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -66.79 118.42 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.28 -38.33 3.14 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.67 1.92 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.7 m -107.54 -32.09 7.84 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 47.59 28.67 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 m -70.87 141.42 51.23 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.621 ' CE2' HG21 ' A' ' 54' ' ' VAL . 67.7 m-85 -133.11 150.15 52.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -118.39 166.3 12.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.496 -1.11 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.668 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 CA--C 1.501 -0.915 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -65.03 -37.95 89.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 11' ' ' VAL . 68.5 m -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.5 -40.1 96.18 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.4 mtm -66.46 -40.22 89.26 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.05 -43.93 99.3 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 7' ' ' SER . 59.9 t -62.45 -43.02 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.62 99.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.33 -44.58 91.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.029 -0.419 . . . . 0.0 110.282 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.2 mt -69.35 -39.63 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.49 -39.22 93.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.88 96.12 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -107.5 65.79 0.65 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -82.92 59.34 4.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -77.34 151.65 34.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.64 -37.34 86.96 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.0 64.71 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.35 175.45 15.5 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -100.07 131.69 45.87 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 t -70.46 145.99 50.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.26 -40.65 96.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.85 -38.87 92.71 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.1 m -62.56 -37.33 85.75 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 88.8 mt -60.74 -48.65 87.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.792 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -72.17 -37.32 69.35 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.354 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.99 -41.2 97.58 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.49 -0.756 . . . . 0.0 109.944 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -61.7 -48.49 80.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.85 -45.4 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.083 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.27 -39.81 94.7 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.645 -0.659 . . . . 0.0 110.383 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 t -70.57 -41.98 71.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.887 -0.508 . . . . 0.0 111.72 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -92.87 -21.17 20.02 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.031 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -128.82 146.82 50.82 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -87.5 120.91 29.28 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.04 160.2 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.64 173.99 51.45 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.84 -40.12 83.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.91 -14.93 61.57 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.93 -35.62 81.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.62 -41.25 90.01 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -64.85 -39.9 94.29 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -67.07 -37.07 83.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.88 -41.71 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.63 -40.29 94.34 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.55 -39.84 88.76 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -64.81 -41.58 95.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.078 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.1 pt -70.11 -34.84 60.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.169 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.26 -39.79 89.7 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -64.57 -41.98 95.94 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.17 -39.36 94.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 50' ' ' ILE . 73.9 t -65.46 -40.36 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 m -61.09 -44.41 97.4 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.1 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.4 p -73.17 -16.35 61.43 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.749 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.71 65.51 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.13 -43.46 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.53 142.86 31.43 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 27.8 mtpp -84.68 150.83 24.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.504 HE21 HG11 ' A' ' 65' ' ' VAL . 64.4 tt0 -87.49 139.08 30.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.9 m -129.98 163.95 25.32 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 62' ' ' THR . 10.1 ptpp? -62.53 170.47 2.45 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.09 0.948 . . . . 0.0 110.602 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 29.51 62.97 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -66.67 119.16 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.16 -38.66 3.01 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.81 1.87 Allowed 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 m -107.46 -32.32 7.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.4 47.19 36.8 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.5 m -70.95 140.71 51.01 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.4 m-85 -130.31 147.32 52.01 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 69.9 mtp180 -115.15 149.05 38.22 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 CA--C 1.498 -1.044 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -68.53 -29.2 67.73 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 11' ' ' VAL . 84.4 p -63.23 -26.82 68.97 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.81 -42.2 97.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.18 -40.16 82.33 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.59 -43.22 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 7' ' ' SER . 53.0 t -62.18 -42.72 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.63 -42.02 98.3 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.4 93.17 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.97 -0.456 . . . . 0.0 110.244 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.51 -39.33 76.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.17 -37.76 86.49 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.1 85.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.04 79.19 1.82 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.265 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -83.25 58.73 4.62 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -66.05 151.54 46.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.66 -35.89 81.11 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.77 -5.57 46.46 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.84 170.1 35.41 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -95.46 130.67 42.19 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -67.99 151.02 47.74 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -61.69 -41.44 97.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.49 -38.73 92.25 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.7 t -62.37 -39.93 94.77 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.54 -48.83 86.86 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 O-C-N 122.005 -0.435 . . . . 0.0 110.09 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -72.67 -33.98 66.91 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.318 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -66.21 -40.68 90.52 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.42 -48.57 80.57 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.34 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.17 -41.94 96.91 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.77 -0.582 . . . . 0.0 110.457 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -69.46 -39.96 77.42 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.863 -0.523 . . . . 0.0 111.987 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -94.75 -21.21 18.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.569 -0.707 . . . . 0.0 111.826 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -128.62 143.38 50.94 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -77.44 128.1 33.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.81 158.23 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.64 -179.92 28.02 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.52 -31.87 69.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.14 -38.25 81.97 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.36 90.82 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.67 -40.44 92.11 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.31 -39.85 93.01 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -65.3 -39.06 92.02 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.17 -45.0 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.36 -42.1 99.14 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.34 -39.49 85.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -63.58 -43.69 96.25 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.21 -45.39 98.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.9 -39.98 95.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.917 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.76 -41.21 96.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.855 -0.528 . . . . 0.0 109.809 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.99 -39.72 95.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.8 t -65.4 -40.58 88.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -61.18 -41.7 97.26 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -70.22 -27.79 64.75 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.34 8.03 55.35 Favored Glycine 0 C--N 1.349 1.288 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.27 -43.36 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.87 143.8 28.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 87.0 mttt -84.68 150.95 24.79 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -86.76 151.65 23.2 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.4 m -142.35 164.36 30.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 62' ' ' THR . 64.9 pttt -60.59 167.9 2.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 122.01 0.91 . . . . 0.0 110.663 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.19 26.63 67.94 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.4 p -66.16 120.76 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.91 0.862 . . . . 0.0 108.832 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -38.82 2.95 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -61.9 1.84 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -107.79 -31.48 8.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.84 48.05 29.54 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -70.51 141.02 51.98 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 54' ' ' VAL . 72.1 m-85 -132.13 149.46 52.39 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 75.4 mtp180 -116.06 152.62 33.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.5 -0.958 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 CA--C 1.497 -1.067 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.36 -39.17 88.99 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.0 p -65.13 -38.68 91.43 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.836 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.51 -40.08 92.59 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.5 mtp -66.82 -40.49 88.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -64.39 -43.23 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 7' ' ' SER . 53.0 t -62.05 -43.43 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.85 98.35 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -63.98 -44.34 93.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 122.003 -0.436 . . . . 0.0 110.246 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.5 mt -68.93 -38.81 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.72 -40.39 97.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.81 96.86 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -106.63 65.37 0.67 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -81.63 57.62 3.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.34 148.12 43.76 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -63.59 -36.64 84.47 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.91 64.98 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.01 169.51 14.74 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 t -99.61 126.05 45.53 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -70.19 153.4 43.16 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -62.14 -41.39 98.22 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.6 -38.2 90.23 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.3 m -63.72 -38.28 90.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.6 mt -60.93 -49.78 83.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.66 -32.84 66.14 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.944 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -62.9 -45.31 93.1 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.815 -0.553 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 77.6 t80 -61.11 -47.89 84.17 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.46 -46.08 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.197 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.98 -39.56 93.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.518 -0.738 . . . . 0.0 110.29 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.39 -39.87 74.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.999 -0.438 . . . . 0.0 112.18 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -99.61 -13.59 19.33 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.13 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.36 148.84 52.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -87.14 118.56 26.62 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.91 157.96 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.01 177.27 35.21 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -39.29 87.61 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -63.79 -38.31 90.64 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.11 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.77 -40.37 92.32 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -65.28 -39.96 93.27 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.79 -38.2 88.34 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.54 -45.32 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.57 -41.24 98.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.98 -39.59 87.2 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.8 m -64.72 -40.75 95.88 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.2 mt -62.13 -45.33 98.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -64.02 -39.95 95.25 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.2 -40.97 99.0 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.21 -38.45 89.21 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.629 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.5 t -65.46 -40.64 88.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -60.78 -44.18 97.13 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.082 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.9 p -72.89 -16.72 61.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.773 -0.58 . . . . 0.0 109.725 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.86 7.6 64.32 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.5 -43.23 94.42 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.7 mt -99.43 146.78 25.95 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -86.1 151.9 23.31 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.16 136.26 33.12 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 63' ' ' LYS . 6.0 m -127.8 163.7 23.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 62' ' ' THR . 26.1 pttm -58.81 172.04 0.58 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.146 0.974 . . . . 0.0 110.845 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 32.18 57.33 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.73 119.47 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -37.94 3.29 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -63.3 1.42 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.1 p -108.75 -29.08 8.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.49 47.93 39.59 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.4 m -70.27 139.76 52.22 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 54' ' ' VAL . 65.6 m-85 -132.93 150.29 52.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -114.94 154.28 29.02 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -84.88 -10.77 56.79 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -136.94 83.28 28.9 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.41 -76.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.746 1.631 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -131.72 146.83 52.38 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -66.8 -38.48 86.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 11' ' ' VAL . 69.8 m -63.2 -39.54 94.92 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.34 -40.6 97.75 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.2 mtm -66.85 -40.12 87.8 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.23 -44.2 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 7' ' ' SER . 55.5 t -62.28 -43.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -41.57 97.39 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.27 -43.41 98.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 122.0 -0.438 . . . . 0.0 110.108 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.99 -39.65 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.16 -38.12 89.93 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.51 92.29 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -113.04 68.84 0.68 Allowed 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -84.0 57.13 4.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.88 158.52 34.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.44 -36.99 85.55 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 -7.72 53.84 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.57 -178.58 35.37 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.0 t -101.83 132.8 47.38 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -69.57 154.99 41.19 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -61.78 -42.57 99.17 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.16 -38.24 90.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.1 m -62.29 -38.2 88.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.141 -0.349 . . . . 0.0 110.279 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.451 HG21 HD11 ' A' ' 50' ' ' ILE . 84.9 mt -60.75 -49.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.88 -33.26 65.94 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.101 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.91 -46.55 87.25 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.921 -0.487 . . . . 0.0 109.764 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -61.41 -48.28 81.93 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.1 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.96 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.93 -42.68 97.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.703 -0.623 . . . . 0.0 110.389 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -67.42 -42.05 83.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.983 -0.448 . . . . 0.0 111.826 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -93.99 -21.17 19.35 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.006 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.05 145.66 51.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.38 130.27 37.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.92 160.41 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.08 -178.47 18.73 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.209 -2.356 . . . . 0.0 107.209 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -65.15 -40.13 93.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.68 -38.98 92.86 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.0 93.35 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.9 -40.02 91.48 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.1 t -64.43 -41.57 96.51 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -64.79 -39.1 93.05 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.09 -45.46 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.52 -40.64 97.4 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.83 -43.36 88.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.8 m -63.99 -41.2 97.57 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.979 -0.45 . . . . 0.0 110.094 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 28' ' ' ILE . 88.7 mt -62.51 -44.2 99.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.02 -43.18 99.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.61 98.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.923 -0.486 . . . . 0.0 109.962 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.602 ' HB3' HD13 ' A' ' 59' ' ' LEU . 79.5 mt -62.13 -39.12 91.5 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.1 t -66.79 -40.02 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 m -61.13 -43.94 98.1 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -72.29 -16.82 61.9 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.818 -0.551 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.45 2.21 70.66 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -44.08 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 53' ' ' LEU . 4.2 mp -91.82 136.62 33.01 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 51.3 mttm -85.13 150.97 24.47 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -91.25 138.94 31.2 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -127.11 164.26 21.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 62' ' ' THR . 19.4 ptpt -61.77 173.31 1.04 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.132 0.967 . . . . 0.0 110.614 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.55 33.82 57.86 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.38 120.21 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.25 -38.29 3.15 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.86 -62.34 1.7 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.3 m -108.38 -33.72 7.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.48 47.68 33.79 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.8 m -70.68 141.52 51.61 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 54' ' ' VAL . 87.7 m-85 -131.27 149.04 52.73 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 73.0 mtp85 -117.46 153.48 33.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp -100.54 126.91 47.03 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.27 107.4 17.29 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.263 1.781 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.657 ' H1 ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -99.81 125.88 45.81 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.3 156.34 30.1 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -86.05 -66.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.921 1.748 . . . . 0.0 113.103 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.57 152.03 51.12 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 -37.88 89.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 11' ' ' VAL . 67.1 m -62.45 -39.39 93.19 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.82 -38.69 92.05 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.76 -41.62 95.74 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.43 -43.3 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 7' ' ' SER . 59.6 t -62.16 -43.02 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.06 98.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.32 92.05 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.913 -0.492 . . . . 0.0 110.291 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -63.48 -36.7 84.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.21 85.46 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.09 75.72 1.17 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -83.49 59.6 5.18 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -69.39 167.1 17.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 -38.0 89.11 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 6.46 33.25 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.9 -159.78 34.69 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.0 t -115.31 138.33 51.08 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 78.0 p -72.9 162.01 30.02 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -62.6 -41.82 99.2 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.49 -39.19 93.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.3 m -63.65 -39.25 93.86 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 122.05 -0.406 . . . . 0.0 110.009 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 50' ' ' ILE . 85.0 mt -61.55 -49.46 84.32 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.029 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.36 -32.64 66.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.925 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.59 -45.39 90.61 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.11 -48.36 82.0 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.62 -45.59 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.178 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.82 -41.15 97.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -69.73 -39.74 76.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.038 -0.414 . . . . 0.0 112.095 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -96.73 -17.99 19.94 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.487 -0.758 . . . . 0.0 112.085 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -129.21 147.6 51.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.657 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 62.8 mtpt -82.03 121.57 26.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.89 158.39 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.29 179.29 26.98 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.15 -39.85 90.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -64.22 -38.66 91.83 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.52 91.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -39.94 91.21 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 m -65.14 -39.57 93.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -67.4 -37.72 83.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.81 -48.08 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 121.935 -0.478 . . . . 0.0 110.356 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -66.92 -31.15 71.55 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.188 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.92 -42.67 85.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.6 m -64.9 -40.64 95.41 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.511 HD11 HG21 ' A' ' 28' ' ' ILE . 89.7 mt -62.06 -44.61 99.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -43.05 99.63 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -63.21 -41.48 99.14 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.5 -39.71 95.17 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.705 -0.622 . . . . 0.0 109.375 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.631 HG21 ' CE2' ' A' ' 71' ' ' PHE . 74.1 t -65.0 -40.69 89.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -61.98 -40.86 97.07 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.9 m -69.98 -27.77 64.98 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 7.26 56.33 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.52 -43.12 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.0 mt -98.26 145.92 26.16 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.459 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 88.7 mttt -84.48 150.91 24.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.93 137.72 32.13 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.4 m -127.3 164.0 22.73 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -60.7 174.2 0.63 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.175 0.988 . . . . 0.0 110.813 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.77 33.02 58.45 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 120.16 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.45 -38.34 3.13 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -62.39 1.69 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 m -108.46 -33.13 7.15 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.09 47.84 28.95 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 72.7 m -70.73 141.01 51.53 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 54' ' ' VAL . 72.7 m-85 -132.39 147.32 52.38 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 90.8 mtt180 -114.01 154.49 27.56 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 tp -97.19 126.55 42.46 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -84.12 107.06 16.23 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.26 1.643 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 -179.946 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.676 ' H1 ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -99.14 122.56 42.52 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -154.92 156.13 31.0 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.28 -63.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.797 1.665 . . . . 0.0 113.192 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.02 151.99 51.42 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.6 -37.26 86.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 11' ' ' VAL . 68.6 m -61.99 -38.97 90.58 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.19 -40.33 97.2 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.3 mtm -65.7 -40.66 92.53 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 14' ' ' ILE . 60.1 mt -63.24 -43.75 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 7' ' ' SER . 55.8 t -60.59 -41.87 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.32 94.31 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.51 -38.7 91.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 73' ' ' LEU . 47.4 mm -66.0 -41.51 89.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -68.34 -24.68 64.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.96 90.97 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -122.36 81.22 1.81 Allowed 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -86.72 47.58 1.51 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.63 156.48 26.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -67.22 -19.17 65.5 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.68 -6.68 59.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.53 -175.63 39.21 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -106.01 132.97 51.46 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.8 150.8 46.48 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -62.45 -41.77 98.99 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -63.81 -39.43 94.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.31 -38.05 89.63 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 50' ' ' ILE . 84.3 mt -60.67 -48.42 88.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.021 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.85 -35.25 69.8 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.046 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -65.11 -40.69 94.9 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.613 -0.679 . . . . 0.0 109.664 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.52 -49.56 76.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -43.07 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.15 -40.43 97.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.916 -0.49 . . . . 0.0 111.11 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.8 p -83.47 -16.54 45.32 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.369 -0.832 . . . . 0.0 112.032 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.41 -24.94 12.09 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 119.327 0.967 . . . . 0.0 110.27 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.34 149.62 51.05 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.676 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 88.1 tttt -83.0 120.47 25.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.05 157.19 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.63 -177.75 25.95 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.7 -41.78 91.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.12 -39.58 94.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.18 93.59 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.5 -42.32 96.12 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.4 m -65.52 -39.48 91.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.84 -36.27 82.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.84 -43.9 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -62.51 -40.21 96.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.72 -40.26 95.03 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -65.23 -41.69 94.13 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 28' ' ' ILE . 91.5 mt -63.05 -45.16 99.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.74 -39.35 94.08 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.91 -41.13 97.75 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.85 -39.51 94.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.514 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.4 t -65.77 -40.48 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.1 m -61.45 -41.45 97.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.3 m -70.23 -27.66 64.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.45 1.37 59.15 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.16 -42.77 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.94 139.7 30.97 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.2 mttt -84.84 151.08 24.57 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -101.31 138.14 38.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.7 m -123.14 164.21 19.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 62' ' ' THR . 14.8 ptmm? -60.43 174.8 0.51 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 122.181 0.991 . . . . 0.0 110.868 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.02 58.66 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 108.334 -1.907 . . . . 0.0 108.334 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.95 121.09 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.14 -38.99 2.88 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -62.22 1.75 Allowed 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -108.08 -34.54 6.85 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.67 48.06 37.43 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.0 m -70.27 138.91 51.99 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.7 m-85 -131.7 151.79 51.37 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 87.7 mtm180 -122.41 153.74 38.67 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HB2' HG21 ' A' ' 14' ' ' ILE . 63.8 tp -101.85 126.68 48.79 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.89 107.54 17.09 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.261 1.69 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.034 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -84.69 -10.93 56.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -136.9 83.19 29.36 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.62 -75.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.816 1.677 . . . . 0.0 112.915 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.2 148.71 52.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.49 -38.0 86.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 11' ' ' VAL . 48.3 t -62.34 -39.92 94.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.27 -41.27 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -67.27 -39.88 86.13 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 14' ' ' ILE . 54.4 mt -62.8 -43.39 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' SER . 59.3 t -60.49 -42.58 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.98 92.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.67 94.64 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.9 mm -65.33 -42.6 94.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.02 -37.7 88.49 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.52 93.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.96 67.56 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -89.44 59.33 4.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.51 161.57 18.51 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.78 -21.63 64.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.82 -7.46 57.89 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.4 177.76 38.64 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -97.63 132.37 43.35 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -71.35 148.59 46.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.63 -42.38 98.81 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.51 -38.55 91.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -66.63 -30.38 70.64 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.741 -0.599 . . . . 0.0 110.24 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.599 HG21 HD11 ' A' ' 50' ' ' ILE . 83.4 mt -63.29 -49.8 81.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.562 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -72.89 -33.44 66.03 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.624 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.0 -45.41 89.12 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -61.47 -48.48 80.94 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.33 -46.07 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.208 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.71 -41.4 96.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.75 -0.594 . . . . 0.0 110.294 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -70.06 -39.85 75.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.948 -0.47 . . . . 0.0 112.192 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -97.19 -15.24 20.97 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.981 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.44 146.76 52.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.43 119.6 25.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.5 161.52 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.83 167.01 52.47 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.57 -22.63 61.71 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -89.87 -1.96 58.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.24 59.31 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.44 -40.2 90.28 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 m -66.03 -40.3 90.9 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.73 -36.96 81.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.79 -43.63 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.49 -39.85 94.81 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.83 -40.86 95.87 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -64.41 -43.67 93.65 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.599 HD11 HG21 ' A' ' 28' ' ' ILE . 89.3 mt -62.71 -43.97 99.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.55 -42.31 98.65 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.95 -43.36 99.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.91 -39.75 95.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.419 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' CE2' ' A' ' 71' ' ' PHE . 75.2 t -64.78 -40.37 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -62.04 -41.82 98.52 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -69.86 -27.79 65.12 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.5 8.31 52.68 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.5 -44.65 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.83 143.16 26.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 33.5 tptt -91.78 151.0 20.81 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.04 137.35 35.08 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.6 m -128.41 164.0 23.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' H ' HG22 ' A' ' 62' ' ' THR . 19.3 ptpt -62.24 172.25 1.54 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.065 0.936 . . . . 0.0 110.578 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.15 34.97 57.71 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.51 119.22 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.24 -37.88 3.29 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.52 -62.08 1.78 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.06 -33.16 7.26 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.22 47.75 28.46 Favored Glycine 0 C--N 1.355 1.611 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -70.47 143.12 51.85 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.396 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 54' ' ' VAL . 95.5 m-85 -129.49 146.87 51.28 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 80.9 mtm180 -124.44 178.26 5.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 14' ' ' ILE . 93.4 mt -104.71 134.09 48.44 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.56 109.68 18.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.262 1.72 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.62 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -138.0 107.02 6.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -145.89 152.68 48.65 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.4 -55.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 113.478 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -132.49 149.8 52.27 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -66.68 -36.49 82.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.3 p -62.24 -36.11 80.98 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.85 -40.23 94.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.02 -40.01 87.15 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.12 -44.09 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 7' ' ' SER . 60.7 t -62.46 -43.16 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.42 98.77 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.94 91.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 122.187 -0.321 . . . . 0.0 110.513 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -69.12 -42.81 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.588 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.86 -19.9 61.89 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.526 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.5 97.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -113.52 77.41 1.05 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -83.64 59.93 5.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.61 163.04 25.82 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.75 -29.57 70.1 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.77 2.11 49.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.53 -165.36 35.29 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -107.86 137.13 46.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -72.57 157.16 38.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.66 -43.74 98.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.883 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.13 -26.9 65.12 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.718 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -65.88 -38.18 88.09 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.592 HG21 HD11 ' A' ' 50' ' ' ILE . 88.3 mt -61.04 -48.6 88.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -72.82 -36.92 67.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.793 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.53 -41.42 96.38 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.547 -0.721 . . . . 0.0 110.167 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -62.02 -48.72 79.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.61 -45.53 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.04 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -64.07 -41.91 97.17 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.549 -0.72 . . . . 0.0 110.318 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 t -69.0 -41.91 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.929 -0.482 . . . . 0.0 111.833 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -93.17 -20.38 20.53 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.091 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -128.75 147.87 50.81 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.62 ' H ' ' N ' ' A' ' 1' ' ' GLY . 88.1 tttt -85.99 119.51 26.37 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.62 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.15 171.39 48.26 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.25 -37.77 84.06 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -73.29 -12.15 60.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.2 62.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.07 -40.8 95.05 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -70.53 -35.6 73.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -66.6 -39.42 88.38 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.86 -44.08 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -41.63 98.46 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.49 -40.08 92.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -64.16 -43.17 95.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.592 HD11 HG21 ' A' ' 28' ' ' ILE . 88.0 mt -62.15 -44.94 99.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.98 -39.79 95.77 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -64.32 -41.92 96.56 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -39.44 93.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.9 t -64.59 -40.01 87.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.6 m -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -72.28 -17.21 61.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.882 -0.512 . . . . 0.0 109.689 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.63 5.72 66.51 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.37 -43.89 94.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.6 143.24 30.07 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.04 149.9 23.02 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -87.08 139.7 30.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.1 m -128.21 164.19 23.07 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 62' ' ' THR . 22.8 ptmt -61.22 174.39 0.7 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.056 0.931 . . . . 0.0 110.632 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.4 58.52 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.98 119.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.81 -38.12 3.22 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.01 -62.98 1.5 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.9 p -109.01 -29.35 8.61 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.25 47.72 56.8 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -70.53 143.75 51.54 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 54' ' ' VAL . 94.8 m-85 -129.82 145.92 51.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -109.87 150.67 28.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.41 126.08 45.24 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.28 107.91 18.16 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.264 1.824 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.994 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.31 170.78 21.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -155.2 157.87 31.88 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -84.99 -70.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.794 1.663 . . . . 0.0 112.941 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.98 147.51 52.46 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -66.92 -36.25 81.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.519 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.1 p -62.89 -37.29 86.35 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.18 -39.46 92.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.4 mtp -65.89 -41.23 91.77 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.19 -43.89 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 7' ' ' SER . 56.5 t -62.09 -43.38 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.24 98.2 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -63.92 -43.17 96.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 122.035 -0.416 . . . . 0.0 110.331 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.2 mt -68.58 -39.62 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.9 -38.42 91.0 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.76 94.87 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.01 65.38 0.8 Allowed 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.22 45.34 0.74 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -68.01 149.65 49.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.99 -37.09 85.78 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -21.5 64.89 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.54 175.76 19.2 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -101.8 126.73 48.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -69.94 154.32 42.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.9 -41.42 97.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.23 -38.61 91.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -61.93 -37.51 84.95 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.512 HG21 HD11 ' A' ' 50' ' ' ILE . 82.2 mt -60.43 -48.74 87.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.93 -34.41 66.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.492 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.89 -41.48 97.71 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.444 -0.785 . . . . 0.0 110.038 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 76.8 t80 -61.87 -48.02 82.4 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.72 -45.04 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.002 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.07 -40.07 95.46 Favored 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 121.67 -0.644 . . . . 0.0 110.367 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 t -70.41 -42.05 72.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 122.028 -0.42 . . . . 0.0 111.795 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -96.73 -14.35 22.07 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.568 -0.708 . . . . 0.0 112.135 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.67 151.03 50.73 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.6 121.6 31.95 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.36 158.41 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.02 175.73 36.87 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.43 -39.86 85.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -66.75 -28.39 68.37 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.14 68.8 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.3 -40.56 94.62 Favored 'General case' 0 C--N 1.353 0.717 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.0 m -66.37 -40.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -65.15 -39.89 93.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.29 -45.84 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.01 -41.47 99.58 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -66.43 -39.49 88.95 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.95 -41.84 95.15 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 28' ' ' ILE . 89.4 mt -63.04 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.69 -42.32 99.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -42.46 99.57 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.1 -40.24 95.8 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 121.775 -0.578 . . . . 0.0 109.547 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.3 t -65.62 -40.8 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.4 m -62.08 -40.91 97.42 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 -27.64 65.1 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.09 7.77 54.58 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.16 -43.92 91.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.66 147.38 23.36 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -90.43 148.8 22.56 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.65 151.03 26.47 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -141.85 164.14 30.99 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -63.27 172.53 1.88 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 122.036 0.922 . . . . 0.0 110.762 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.27 34.32 58.02 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.41 119.44 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.13 3.2 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.2 1.74 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.3 m -107.74 -32.18 7.74 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.68 47.64 32.61 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -70.53 140.92 51.92 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 54' ' ' VAL . 81.9 m-85 -131.55 149.07 52.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 81.5 mtm180 -124.87 177.39 6.05 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.67 133.52 52.65 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.09 108.54 17.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp . . . . . 0 C--O 1.262 1.742 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.52 -41.34 93.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -149.16 155.92 40.02 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.02 -64.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.719 1.613 . . . . 0.0 113.319 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.96 149.84 52.32 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -66.64 -35.93 81.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.7 p -62.53 -36.62 83.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.22 -39.24 92.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.2 mtp -66.07 -40.86 91.23 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.32 -42.94 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 7' ' ' SER . 56.2 t -61.86 -42.54 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.103 -0.373 . . . . 0.0 110.123 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.05 94.08 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.061 -0.399 . . . . 0.0 110.172 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.42 -38.08 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -61.57 -36.9 81.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.84 89.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -114.56 69.32 0.71 Allowed 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -82.96 57.95 4.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -80.8 165.73 21.62 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.32 -36.6 84.64 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -8.82 57.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.9 -163.82 33.66 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.1 m -115.97 141.06 48.61 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.6 m -72.87 155.52 39.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.59 -42.38 98.78 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -62.9 -38.64 91.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -62.35 -39.65 93.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 50' ' ' ILE . 84.2 mt -60.56 -49.52 84.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.954 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.65 -33.18 66.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.938 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -64.09 -45.41 88.82 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.959 -0.463 . . . . 0.0 109.768 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -61.17 -48.34 82.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.14 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.094 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.72 -41.95 95.61 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 121.68 -0.637 . . . . 0.0 110.407 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -69.05 -42.07 76.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.916 -0.49 . . . . 0.0 111.942 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -94.69 -16.64 22.94 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.526 -0.734 . . . . 0.0 112.138 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.46 147.65 52.18 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.61 120.82 25.56 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.88 157.79 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.58 -179.1 24.78 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.64 -41.3 92.77 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.61 -38.92 92.96 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.86 92.65 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.03 -39.94 91.7 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.1 m -64.72 -39.97 94.54 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.19 -36.6 82.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.36 -45.88 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.34 -40.65 97.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.5 tp -63.63 -44.3 94.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -63.4 -43.07 98.62 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 28' ' ' ILE . 89.4 mt -61.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.84 -40.14 95.88 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -63.71 -42.29 97.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.27 -40.51 96.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.594 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.1 t -65.48 -40.92 89.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.0 m -61.97 -41.12 97.64 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.7 m -70.08 -27.61 64.75 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.93 8.53 55.43 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.12 -43.5 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.92 143.84 28.77 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 84.3 mttt -85.4 151.17 24.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -94.87 135.11 36.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.2 m -119.56 164.46 15.79 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' H ' HG22 ' A' ' 62' ' ' THR . 22.2 ptmt -59.24 175.17 0.33 Allowed 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.095 0.95 . . . . 0.0 110.982 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.26 35.08 53.66 Favored Glycine 0 C--N 1.357 1.741 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.79 119.89 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.1 -38.12 3.2 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -62.37 1.69 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.1 m -108.48 -35.1 6.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.5 47.86 32.67 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 64.4 m -70.58 143.46 51.54 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.594 ' CE2' HG21 ' A' ' 54' ' ' VAL . 85.2 m-85 -130.81 151.42 51.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -122.0 164.92 16.83 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.03 132.32 44.42 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -89.8 108.74 19.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.262 1.723 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.095 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.71 106.56 18.55 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.626 ' CE1' HG12 ' A' ' 38' ' ' VAL . 49.9 m170 -118.64 92.58 44.37 Favored Pre-proline 0 CA--C 1.503 -0.848 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.89 -33.31 20.5 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 121.187 1.258 . . . . 0.0 112.875 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.81 100.37 4.9 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -67.83 -34.74 77.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.4 m -61.43 -38.13 86.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.08 -43.64 98.4 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -39.9 89.96 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.7 -44.79 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 7' ' ' SER . 64.3 t -63.17 -42.26 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.23 -42.77 99.19 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.25 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.51 -39.86 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -64.73 -37.62 88.22 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.493 -0.755 . . . . 0.0 109.017 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.63 91.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -106.96 68.84 0.74 Allowed 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -79.98 51.79 1.4 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -70.02 147.95 49.44 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -61.97 -37.65 85.59 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.44 -9.41 58.5 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.87 169.89 28.61 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 t -95.34 128.91 42.57 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -71.29 157.16 38.6 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -60.8 -42.57 97.87 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -63.15 -39.27 94.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.2 m -63.46 -39.03 93.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 50' ' ' ILE . 82.8 mt -61.04 -49.4 84.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.71 -32.89 66.06 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.131 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.66 -45.65 93.13 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.833 -0.542 . . . . 0.0 109.687 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.29 -48.2 82.48 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.99 -45.02 99.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.17 -39.59 94.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.486 -0.759 . . . . 0.0 110.211 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.36 -39.93 74.33 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.001 -0.437 . . . . 0.0 112.075 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -98.25 -16.94 19.21 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.841 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.09 147.4 52.61 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -84.52 121.52 27.71 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.626 HG12 ' CE1' ' A' ' 3' ' ' HIS . 33.2 m -133.0 159.49 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.54 179.44 26.7 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.09 -40.85 91.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.36 -38.57 91.66 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.76 91.42 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.89 -39.68 90.17 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.11 -40.38 94.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.69 -37.01 81.71 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -45.36 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.98 -40.18 96.95 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.29 -44.19 92.44 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.1 t -63.27 -42.81 99.16 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 28' ' ' ILE . 89.3 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.21 -42.65 99.49 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.56 -42.12 99.34 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.7 -40.71 97.46 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.808 -0.557 . . . . 0.0 109.574 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.661 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.0 t -66.0 -40.71 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.4 m -62.04 -40.97 97.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.1 m -69.86 -27.64 65.0 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.76 8.33 54.46 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.17 -43.49 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -98.29 144.82 27.3 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.517 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 83.7 mttt -84.73 151.1 24.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -87.87 137.58 32.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -127.59 164.49 21.89 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.51 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -60.51 173.5 0.7 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.09 0.948 . . . . 0.0 110.509 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.15 32.97 57.75 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.7 119.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -37.81 3.32 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.92 -63.07 1.47 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.9 p -109.32 -30.49 7.96 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 48.0 37.95 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -70.46 143.05 51.89 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.661 ' CE2' HG21 ' A' ' 54' ' ' VAL . 73.3 m-85 -132.18 149.57 52.36 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -118.9 165.4 14.11 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -99.66 133.37 44.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -89.86 109.24 20.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.262 1.742 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -93.68 -2.04 54.44 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -134.0 84.38 43.26 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -85.55 -79.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.674 1.582 . . . . 0.0 112.86 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -132.24 147.85 52.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -67.0 -36.4 82.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.2 p -63.08 -36.33 83.22 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.08 -40.35 94.52 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -66.66 -40.4 88.62 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 14' ' ' ILE . 53.7 mt -63.66 -43.5 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 7' ' ' SER . 54.6 t -60.5 -42.4 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.24 93.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.09 -39.36 93.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.559 HG21 ' HG ' ' A' ' 73' ' ' LEU . 50.0 mm -65.8 -44.0 93.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.21 -35.75 81.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.45 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -116.11 71.56 0.79 Allowed 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -86.82 58.99 5.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -80.51 162.12 24.5 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.9 -27.68 66.86 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -1.73 47.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -177.59 37.62 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 t -98.93 129.44 45.26 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -70.44 150.72 45.93 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -61.75 -43.53 98.68 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.318 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.09 -38.97 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.26 -38.12 89.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.473 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 87.6 mt -61.37 -49.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 121.975 -0.453 . . . . 0.0 110.331 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.9 -33.86 68.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.076 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.28 -40.85 86.17 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.92 -49.07 77.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.63 -44.99 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.849 -0.532 . . . . 0.0 110.408 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -69.08 -39.66 78.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.808 -0.558 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -96.08 -20.19 18.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.966 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.8 146.27 51.54 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -75.27 135.1 40.96 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.48 160.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 42' ' ' ALA . . . -117.48 -178.63 17.54 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.03 -40.27 94.59 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -65.1 -39.43 93.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 39' ' ' GLY . . . -62.82 -38.76 91.98 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.01 -40.65 94.36 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 95.1 p -69.55 -34.84 74.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -68.39 -36.12 78.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.87 -39.89 95.81 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.92 -42.34 85.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -62.7 -44.92 94.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.202 -0.311 . . . . 0.0 110.59 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 pt -67.48 -34.24 67.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.925 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.95 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.5 -39.43 93.49 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 50' ' ' ILE . 73.9 t -65.76 -40.69 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.2 m -61.42 -44.34 97.3 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.099 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.2 p -73.0 -15.92 61.52 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.898 -0.501 . . . . 0.0 109.835 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.67 6.18 66.01 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.09 -43.83 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.67 138.08 35.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.638 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 55.1 mtpt -87.82 151.97 22.46 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -83.98 135.46 34.44 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.6 m -127.14 164.15 22.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' H ' HG22 ' A' ' 62' ' ' THR . 64.8 pttt -60.15 172.5 0.8 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.109 0.957 . . . . 0.0 110.671 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.22 33.09 57.42 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.56 119.11 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.93 -37.87 3.31 Favored Glycine 0 C--N 1.351 1.395 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.9 -62.97 1.5 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.7 p -108.96 -30.3 8.16 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.36 47.75 49.5 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.8 m -70.19 144.58 51.89 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.583 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.41 ' CE2' HG21 ' A' ' 54' ' ' VAL . 85.4 m-85 -130.07 148.92 51.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 80.7 mtm180 -120.07 169.75 9.92 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.559 ' HG ' HG21 ' A' ' 14' ' ' ILE . 95.4 mt -100.06 134.8 42.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.638 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -94.89 109.41 21.41 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 tptm . . . . . 0 C--O 1.26 1.648 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.88 -39.12 93.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -136.05 84.08 31.95 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.43 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 121.866 1.711 . . . . 0.0 112.915 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.05 146.03 52.23 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -66.63 -38.3 86.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 11' ' ' VAL . 70.0 m -63.29 -40.57 97.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.91 -39.92 95.3 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mtp -66.37 -40.49 89.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.03 -43.73 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 7' ' ' SER . 63.6 t -62.49 -41.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.33 98.33 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.14 97.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.72 -40.49 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.95 -36.54 84.72 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.97 90.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -121.67 73.67 1.08 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -84.68 57.69 4.5 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -66.11 148.41 51.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -62.16 -38.52 89.34 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.87 65.61 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.14 170.58 14.36 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.5 m -97.77 130.48 44.71 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -69.24 146.45 52.31 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -61.46 -40.57 94.99 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.74 -38.47 91.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -61.78 -39.88 93.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.09 -48.89 86.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.082 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.42 -34.87 68.14 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.409 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -66.56 -40.65 89.11 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.551 -0.718 . . . . 0.0 110.171 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.71 -48.68 79.66 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.28 -45.75 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.42 -41.77 96.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.744 -0.597 . . . . 0.0 110.448 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.0 m -70.22 -39.88 74.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.962 -0.461 . . . . 0.0 112.128 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -96.33 -16.75 21.13 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.873 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.35 147.64 52.59 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -84.23 121.43 27.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.83 156.41 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.89 179.62 34.14 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.1 -41.67 90.29 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.79 -39.02 93.25 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.63 91.88 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -60.91 -42.63 98.43 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -65.14 -39.19 92.68 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.38 -38.39 90.87 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.45 -45.02 99.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.27 -41.85 98.82 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.9 tp -66.57 -41.96 87.76 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -62.5 -42.76 99.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.58 -45.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -63.89 -40.51 96.7 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -62.94 -41.74 99.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.87 -39.27 93.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG21 ' CE2' ' A' ' 71' ' ' PHE . 76.5 t -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 m -61.5 -41.09 96.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -70.05 -27.94 65.06 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 7.58 56.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.38 -43.24 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.17 146.19 26.41 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.511 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 87.0 mttt -84.66 150.75 24.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -91.43 138.41 31.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 63' ' ' LYS . 5.0 m -128.02 163.65 24.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 62' ' ' THR . 22.4 ptmt -61.27 171.53 1.34 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.063 0.935 . . . . 0.0 110.574 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.22 23.89 64.86 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.88 120.61 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.595 0.712 . . . . 0.0 109.146 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.24 -38.92 2.91 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.41 -62.4 1.7 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -108.6 -33.47 7.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.22 20.4 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.9 m -70.25 140.87 52.48 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 54' ' ' VAL . 71.3 m-85 -131.22 149.67 52.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 16.7 mmm180 -117.68 158.04 25.39 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp -99.0 126.7 44.75 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.511 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -84.71 107.5 16.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.26 1.636 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.15 -39.21 82.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -131.8 82.44 60.3 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.69 -33.59 12.83 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.5 1.466 . . . . 0.0 113.397 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.41 123.66 27.14 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -68.22 -37.31 80.71 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.514 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.7 p -63.59 -34.69 78.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.7 -42.79 95.05 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.46 -41.03 93.84 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 14' ' ' ILE . 64.4 mt -63.14 -44.41 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 7' ' ' SER . 57.7 t -60.37 -43.08 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.36 95.05 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.62 -39.05 93.03 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.8 mm -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.26 -27.37 64.38 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.111 -0.368 . . . . 0.0 110.079 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.16 95.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.84 75.08 0.97 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -85.68 59.45 5.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -79.6 152.89 29.8 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.36 -37.27 86.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.06 64.66 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 173.92 16.49 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.5 p -96.16 137.56 35.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.5 p -77.34 159.69 29.35 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -65.32 -39.96 93.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -63.3 -39.67 95.23 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -61.95 -39.87 93.58 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.642 HG21 HD11 ' A' ' 50' ' ' ILE . 85.8 mt -60.82 -49.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.201 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.52 -33.74 67.11 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.001 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.61 -46.11 89.77 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.85 -48.81 78.85 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.57 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.172 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.77 -18.15 62.77 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.0 m -89.17 -35.75 16.06 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.501 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -100.88 -12.2 19.18 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.74 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 152.06 51.61 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 124.66 31.62 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.01 160.41 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.72 -178.07 19.29 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.93 -41.65 95.34 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -63.85 -38.84 92.57 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -38.81 92.38 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.73 -39.95 90.53 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.2 t -64.72 -41.64 95.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -64.72 -38.49 91.18 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.67 -45.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -62.33 -41.8 98.85 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.54 -39.42 88.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.9 -40.96 95.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 28' ' ' ILE . 87.4 mt -62.57 -44.82 99.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.44 -39.34 94.23 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.1 -40.95 97.33 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.75 -39.65 94.78 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.0 t -65.21 -40.72 89.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 m -61.42 -41.63 97.47 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -70.33 -27.74 64.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.67 56.28 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.21 -43.33 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.71 146.14 31.16 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.556 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 88.9 mttt -84.72 150.61 24.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.09 137.29 34.35 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.0 m -122.96 164.01 19.31 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' H ' HG22 ' A' ' 62' ' ' THR . 19.4 ptpt -61.0 174.09 0.69 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.1 0.952 . . . . 0.0 110.627 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.8 33.1 58.29 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.38 120.12 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.78 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.96 -62.53 1.64 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -108.44 -34.14 6.86 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.41 48.42 24.18 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -70.86 141.84 51.23 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 54' ' ' VAL . 93.9 m-85 -130.98 148.74 52.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 66.7 mtp180 -118.09 158.14 25.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HB2' HG21 ' A' ' 14' ' ' ILE . 59.7 tp -97.79 126.78 43.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -85.04 107.9 17.37 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.261 1.663 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.17 -40.16 95.52 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -160.25 152.51 17.2 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.5 -45.24 0.43 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.614 1.542 . . . . 0.0 114.462 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.01 136.17 45.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -68.19 -37.33 80.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.7 m -62.42 -38.92 91.59 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.14 -41.36 99.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.4 mmt -66.47 -40.38 89.31 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 14' ' ' ILE . 57.1 mt -63.29 -43.48 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' SER . 53.8 t -60.71 -42.22 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.78 94.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 73' ' ' LEU . 48.1 mm -67.51 -41.66 86.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -62.95 -36.94 85.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.979 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.57 84.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.76 82.06 1.98 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.024 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.03 58.28 4.33 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.33 148.47 51.61 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.23 -36.4 83.53 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -5.65 44.85 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.51 167.18 27.56 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -86.72 133.34 33.68 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.3 t -69.09 147.61 51.22 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -61.09 -41.45 96.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.56 -38.31 90.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.9 m -63.05 -38.39 90.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 122.057 -0.402 . . . . 0.0 110.199 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.629 HG21 HD11 ' A' ' 50' ' ' ILE . 86.5 mt -60.96 -49.73 83.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.937 -0.477 . . . . 0.0 110.017 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.73 -34.06 66.81 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.769 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.25 -45.37 91.87 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.09 -49.13 78.57 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.74 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.169 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -65.43 -41.43 93.54 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.689 -0.632 . . . . 0.0 110.593 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.5 m -69.36 -39.98 77.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 112.026 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -97.18 -15.79 20.72 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.447 -0.783 . . . . 0.0 111.657 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -133.47 147.19 51.66 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.96 126.61 32.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.97 157.32 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.27 176.5 34.24 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.49 -41.56 88.75 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.95 -38.97 93.03 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.36 94.52 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' HA ' HD12 ' A' ' 46' ' ' ILE . 36.6 t70 -60.82 -42.12 97.07 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -65.59 -39.54 91.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.85 -34.0 76.84 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 43' ' ' ASP . 80.6 mt -60.49 -43.53 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.29 -39.78 89.58 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.4 m -64.5 -41.73 96.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.629 HD11 HG21 ' A' ' 28' ' ' ILE . 90.1 mt -63.16 -44.2 99.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -62.35 -42.95 99.8 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -62.45 -42.52 99.52 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 59' ' ' LEU . 80.0 mt -63.57 -39.55 94.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.6 t -66.72 -40.55 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.8 m -61.76 -43.57 98.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.068 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -72.44 -15.93 61.82 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.782 -0.574 . . . . 0.0 109.72 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.55 2.94 69.49 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.28 -44.3 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 53' ' ' LEU . 3.5 mp -97.12 143.53 27.84 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 88.2 mttt -84.85 150.65 24.85 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -96.27 138.37 33.98 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.4 m -123.7 164.39 19.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -63.09 174.92 0.99 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.115 0.959 . . . . 0.0 110.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.22 33.55 59.0 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.2 t -70.55 120.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.02 -62.32 1.71 Allowed 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -108.46 -34.62 6.71 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.53 47.88 25.8 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 60.8 m -70.61 141.5 51.75 Favored 'General case' 0 C--N 1.358 0.963 0 CA-C-N 118.109 0.954 . . . . 0.0 108.464 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.3 m-85 -131.85 150.02 52.28 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.417 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 88.6 mtm180 -122.25 155.57 35.61 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.613 ' HB2' HG21 ' A' ' 14' ' ' ILE . 62.9 tp -103.25 127.07 50.68 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -82.69 107.69 15.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 pttt . . . . . 0 C--O 1.261 1.694 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.22 -39.47 94.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -156.61 156.75 30.4 Favored Pre-proline 0 N--CA 1.438 -1.052 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.13 -70.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 121.741 1.627 . . . . 0.0 113.103 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.82 144.79 51.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -67.36 -37.45 83.23 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.7 m -62.52 -39.11 92.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.62 -43.17 97.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.58 -39.96 92.19 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' O ' HG12 ' A' ' 14' ' ' ILE . 61.4 mt -62.36 -44.16 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 7' ' ' SER . 58.1 t -60.82 -42.5 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.56 91.83 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.95 95.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.613 HG21 ' HG ' ' A' ' 73' ' ' LEU . 39.7 mm -69.39 -41.56 80.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.01 -39.23 93.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -40.92 93.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.74 71.24 0.88 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.78 58.52 5.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.14 164.2 25.88 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.01 -38.76 92.47 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.25 -4.49 42.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.4 -171.75 35.44 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 t -105.47 132.06 52.11 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -69.5 155.15 40.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.02 -43.07 99.44 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.98 -39.14 93.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.6 m -62.98 -38.53 91.49 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 50' ' ' ILE . 85.3 mt -60.66 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 121.987 -0.445 . . . . 0.0 110.187 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.91 -33.01 65.73 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.084 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.28 -44.64 94.52 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.24 -48.73 80.14 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.08 -45.11 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.199 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.29 -40.39 95.86 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.861 -0.525 . . . . 0.0 111.398 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -83.73 -14.79 50.76 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.568 -0.707 . . . . 0.0 112.358 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -111.39 -20.71 12.15 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 119.538 1.063 . . . . 0.0 110.651 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -129.75 149.02 51.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.92 121.11 25.6 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.17 161.44 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.57 170.08 51.6 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.31 -37.75 83.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -80.58 0.31 34.51 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.22 63.27 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -40.07 89.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -66.61 -39.96 88.59 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -66.14 -39.74 90.08 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.38 -45.35 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.71 -40.46 97.21 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.39 -42.88 92.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.5 t -63.13 -43.71 97.65 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.657 HD11 HG21 ' A' ' 28' ' ' ILE . 87.7 mt -62.28 -43.78 98.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -61.1 -43.01 99.54 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.55 -41.16 98.45 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.38 -39.16 92.29 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.7 t -66.69 -39.73 84.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 m -60.98 -44.34 97.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.006 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 p -72.58 -16.94 61.74 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 109.55 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.99 70.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -65.5 -44.75 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.25 149.3 24.67 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 84.8 tttt -97.16 142.27 29.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.416 HE21 HG21 ' A' ' 65' ' ' VAL . 63.0 tt0 -81.61 139.53 34.97 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.3 m -131.15 163.87 26.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -63.9 175.47 1.17 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.982 0.896 . . . . 0.0 110.588 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.23 31.47 59.37 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG21 HE21 ' A' ' 61' ' ' GLN . 99.0 t -70.25 119.45 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.06 3.25 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.11 -63.45 1.39 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 p -109.28 -29.54 8.43 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.88 38.62 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -70.6 143.14 51.61 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 54' ' ' VAL . 96.3 m-85 -132.45 149.74 52.28 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 72.3 mtp180 -127.27 177.52 6.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.613 ' HG ' HG21 ' A' ' 14' ' ' ILE . 93.3 mt -110.87 127.45 55.44 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 109.27 19.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.262 1.712 0 CA-C-O 117.956 -1.021 . . . . 0.0 108.586 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -84.91 -10.37 57.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -153.06 156.85 32.97 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.0 -69.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.649 1.566 . . . . 0.0 113.279 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -132.14 148.65 52.49 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 -35.34 79.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.1 p -62.5 -37.19 85.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.4 mtp -66.81 -40.21 87.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 7' ' ' SER . 59.1 t -61.63 -43.02 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.3 98.8 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -64.01 -44.68 91.89 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 122.085 -0.384 . . . . 0.0 110.401 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.23 -39.74 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -63.26 -38.62 91.88 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.62 93.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.12 67.48 0.65 Allowed 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -83.98 58.35 4.66 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.12 155.13 39.99 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -67.27 -19.99 65.58 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.01 -2.74 58.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 177.7 41.43 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -105.4 130.93 53.39 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 m -68.94 153.56 43.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -62.21 -41.4 98.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.98 -38.49 91.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.7 m -61.97 -37.81 86.18 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.609 HG21 HD11 ' A' ' 50' ' ' ILE . 86.0 mt -60.66 -48.6 87.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -73.13 -37.13 66.75 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.487 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.1 -40.43 96.2 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.273 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.402 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 78.7 t80 -61.65 -48.52 80.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.0 mt -62.86 -44.95 99.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.165 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.49 -38.56 91.46 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.747 -0.596 . . . . 0.0 111.55 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.0 p -86.38 -15.34 40.7 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.485 -0.76 . . . . 0.0 112.256 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -110.48 -20.03 12.72 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 119.373 0.988 . . . . 0.0 110.465 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.42 150.15 52.26 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -86.24 118.38 25.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.85 161.69 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.22 167.41 50.83 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.87 -19.14 61.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -90.94 -1.61 57.81 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.47 -25.6 62.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.42 -39.01 85.88 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.6 t -63.79 -43.57 95.93 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -68.34 -37.84 80.92 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.34 -46.36 96.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.27 -39.91 95.92 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.94 -44.87 94.88 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -64.94 -41.74 95.25 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.609 HD11 HG21 ' A' ' 28' ' ' ILE . 87.0 mt -62.61 -44.46 99.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.66 -43.44 98.85 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.58 -41.97 98.32 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.31 -39.43 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.4 t -65.09 -39.84 86.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.2 m -60.91 -42.83 98.82 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -70.22 -27.88 64.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.94 54.16 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.68 -43.35 93.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.01 142.96 29.08 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.577 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 26.0 mtpp -88.18 151.55 22.61 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.85 138.39 32.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.5 m -128.68 164.09 23.69 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 62' ' ' THR . 22.9 ptmt -61.01 174.1 0.69 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.062 0.934 . . . . 0.0 110.572 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.98 32.9 58.19 Favored Glycine 0 C--N 1.357 1.712 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.69 119.15 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -37.92 3.29 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.73 -63.03 1.48 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 p -108.92 -29.88 8.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.06 47.85 43.44 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.1 m -70.33 142.51 52.19 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CE2' HG21 ' A' ' 54' ' ' VAL . 89.5 m-85 -130.98 149.44 52.6 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -119.27 164.95 14.89 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.64 132.54 44.91 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.577 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -89.31 110.27 21.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm . . . . . 0 C--O 1.261 1.686 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.847 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.2 t0 61.66 44.19 9.15 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -150.76 155.66 35.77 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -85.45 -79.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.688 1.592 . . . . 0.0 112.64 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -132.34 143.77 50.09 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -67.53 -35.54 79.29 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.3 m -61.82 -38.7 89.13 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.45 -40.99 98.39 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.4 mtt -67.02 -40.23 87.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.67 -43.35 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 7' ' ' SER . 59.1 t -62.43 -43.57 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.0 98.71 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.74 -44.58 93.08 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 122.043 -0.411 . . . . 0.0 110.161 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.14 -39.89 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -63.6 -39.4 94.27 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.82 96.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -105.88 63.8 0.68 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -86.28 59.78 5.84 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -80.99 168.36 18.79 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -64.63 -36.89 85.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.64 -5.29 49.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.47 -167.83 32.88 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.7 t -107.21 131.63 53.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -71.6 158.24 36.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -60.61 -44.84 95.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -64.82 -37.7 88.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.9 m -62.87 -38.43 90.82 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 122.275 -0.266 . . . . 0.0 110.646 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 50' ' ' ILE . 88.2 mt -61.17 -49.95 82.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.232 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -73.11 -33.13 65.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.004 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.28 -45.84 89.58 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -61.36 -48.41 81.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.16 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.894 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.49 -41.45 96.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.655 -0.653 . . . . 0.0 110.313 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.89 -39.87 76.0 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.934 -0.479 . . . . 0.0 112.066 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -97.09 -16.42 20.52 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.959 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.59 147.08 52.23 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -81.1 121.92 26.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.13 157.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.82 -179.93 25.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -65.97 -39.77 90.66 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -64.4 -39.31 93.6 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.64 91.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.77 -40.21 91.67 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.9 p -68.04 -35.88 78.98 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -68.83 -35.72 77.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.88 -44.24 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.79 -40.54 97.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.08 -40.85 91.15 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -64.4 -43.42 94.48 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 28' ' ' ILE . 90.5 mt -61.73 -44.77 99.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.87 -43.82 98.08 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.82 -41.95 97.76 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 121.895 -0.503 . . . . 0.0 110.089 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.99 -39.97 94.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.655 -0.653 . . . . 0.0 109.428 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG21 ' CE2' ' A' ' 71' ' ' PHE . 76.2 t -65.26 -40.02 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 m -61.16 -43.55 98.71 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.827 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.409 ' OG1' HG23 ' A' ' 58' ' ' VAL . 60.0 p -72.29 -17.19 61.89 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.845 -0.535 . . . . 0.0 109.742 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.02 7.41 65.93 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' OG1' ' A' ' 56' ' ' THR . 53.3 t -65.4 -42.96 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.1 mt -97.64 143.68 28.06 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 151.86 21.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -90.39 134.5 34.3 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.7 m -121.82 164.16 17.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' H ' HG22 ' A' ' 62' ' ' THR . 22.8 ptmt -58.83 174.79 0.32 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.109 0.956 . . . . 0.0 111.042 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.63 53.38 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.9 119.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.48 -38.14 3.2 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.02 1.8 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.34 -34.43 6.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.08 47.23 38.87 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.1 m -71.04 142.85 50.89 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 54' ' ' VAL . 86.5 m-85 -131.3 151.37 51.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -120.57 168.89 10.88 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.7 139.23 35.66 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.87 19.82 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.263 1.792 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.867 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 60.01 39.97 19.3 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -132.03 85.86 49.02 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.63 -79.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.746 1.63 . . . . 0.0 113.064 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.09 147.71 52.45 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.15 -39.22 89.64 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.0 p -64.71 -36.57 84.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.48 -42.74 91.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.4 ' HB3' HG12 ' A' ' 32' ' ' ILE . 78.1 mtm -65.93 -39.5 90.56 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.83 -43.53 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 7' ' ' SER . 58.9 t -61.91 -43.92 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.6 98.88 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.68 93.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.146 -0.346 . . . . 0.0 110.142 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.69 -40.09 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.96 -39.87 95.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.38 97.51 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -107.64 66.72 0.67 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.84 59.7 4.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -75.01 150.65 38.88 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -68.34 -27.01 65.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -6.57 56.58 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.51 166.73 31.01 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -94.96 129.38 42.03 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -66.56 147.32 53.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -61.53 -40.52 94.94 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.17 -38.91 92.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -63.03 -36.54 83.9 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 50' ' ' ILE . 84.7 mt -60.25 -50.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.922 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -73.33 -32.92 64.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.24 -45.49 93.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.33 -47.83 84.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 9' ' ' MET . 95.2 mt -61.64 -46.56 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.19 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.14 -41.15 95.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.22 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.8 -39.83 76.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.914 -0.491 . . . . 0.0 112.237 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.8 -15.36 20.3 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.504 -0.747 . . . . 0.0 112.019 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -130.28 147.48 52.01 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.88 119.64 24.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.43 161.23 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.08 171.96 52.46 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.33 -39.83 85.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -77.82 -5.35 50.56 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.23 80.51 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.5 -38.95 82.25 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 t -63.66 -42.93 98.01 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -36.64 81.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.45 -43.06 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.81 -41.08 97.32 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.17 -40.9 90.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.5 m -65.65 -42.05 91.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 28' ' ' ILE . 88.4 mt -63.11 -44.37 99.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -61.85 -43.72 98.27 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.51 -41.71 98.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 121.967 -0.458 . . . . 0.0 110.049 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.03 -39.7 95.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.601 -0.687 . . . . 0.0 109.215 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.4 t -65.52 -40.12 87.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -61.19 -41.34 96.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.1 m -70.31 -27.62 64.53 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.99 8.05 55.79 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.26 -44.02 91.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.95 147.68 22.87 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -92.72 149.45 21.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -81.95 151.66 27.1 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.8 m -142.98 163.67 32.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -60.39 172.0 0.95 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.192 0.996 . . . . 0.0 110.865 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.99 33.04 57.98 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.6 t -70.57 119.88 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -38.12 3.21 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.47 1.65 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.5 m -108.52 -33.41 7.05 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.91 48.39 16.46 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 107.379 -2.288 . . . . 0.0 107.379 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.3 m -70.26 142.34 52.33 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.587 ' CE2' HG21 ' A' ' 54' ' ' VAL . 84.0 m-85 -130.94 149.22 52.67 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 14.8 mmm180 -123.32 177.52 5.56 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -108.85 132.93 53.54 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.35 109.12 17.59 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.262 1.738 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -159.29 155.4 26.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -156.32 156.42 30.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -85.04 -64.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.726 1.617 . . . . 0.0 112.426 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.88 144.83 51.15 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -67.14 -36.24 81.44 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.6 m -61.83 -38.85 89.73 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.42 -41.44 98.7 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.7 -39.22 84.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.04 -43.29 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 7' ' ' SER . 61.6 t -62.22 -43.2 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.96 98.55 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.26 93.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.997 -0.439 . . . . 0.0 110.283 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.95 -39.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -63.55 -39.15 93.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.79 95.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -107.72 65.13 0.64 Allowed 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -86.15 59.25 5.53 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.85 168.86 18.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -37.13 86.54 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.05 -2.46 40.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.16 38.48 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 t -111.38 132.12 54.67 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.4 p -73.08 162.26 29.67 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -63.36 -40.71 98.03 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.47 -39.01 93.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.5 m -63.32 -38.78 92.47 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.04 -0.412 . . . . 0.0 109.904 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.474 HG21 HD11 ' A' ' 50' ' ' ILE . 87.8 mt -61.3 -49.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.109 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.57 -33.44 66.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.972 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.11 -45.35 88.98 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.857 -0.527 . . . . 0.0 109.657 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.33 -48.64 80.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.41 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.085 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.01 -41.83 95.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.791 -0.568 . . . . 0.0 110.411 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.9 m -69.33 -40.06 77.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.85 -0.531 . . . . 0.0 112.08 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -98.18 -14.23 20.48 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.957 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -133.66 148.19 51.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -81.27 127.23 32.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.54 157.16 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.49 177.63 30.93 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.9 -42.07 90.68 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.54 -39.61 94.08 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.6 95.11 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.67 -41.87 95.92 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.3 m -65.51 -39.84 92.31 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.7 -34.88 78.83 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.37 -44.64 96.45 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.02 -40.34 97.46 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.95 -40.73 91.59 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -64.11 -42.89 96.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.474 HD11 HG21 ' A' ' 28' ' ' ILE . 90.2 mt -61.83 -44.56 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -62.07 -43.28 99.18 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.45 98.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.995 -0.441 . . . . 0.0 109.996 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -39.43 92.54 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.621 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.0 t -66.13 -40.19 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 m -60.85 -44.55 96.83 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -73.04 -15.94 61.5 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.812 -0.555 . . . . 0.0 109.877 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.68 64.72 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.25 -43.22 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.29 145.67 26.42 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -88.73 151.9 22.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -81.77 151.94 27.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.498 ' O ' HG13 ' A' ' 65' ' ' VAL . 4.6 m -143.52 164.06 31.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 62' ' ' THR . 23.4 pttp -59.24 167.17 1.88 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.181 0.991 . . . . 0.0 110.794 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.59 61.75 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -66.79 118.42 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.28 -38.33 3.14 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.67 1.92 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.7 m -107.54 -32.09 7.84 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 47.59 28.67 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 m -70.87 141.42 51.23 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.621 ' CE2' HG21 ' A' ' 54' ' ' VAL . 67.7 m-85 -133.11 150.15 52.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -118.39 166.3 12.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.29 140.9 30.29 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 107.77 19.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.5 tptt . . . . . 0 C--O 1.261 1.665 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.772 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.621 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -103.67 124.09 48.2 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -154.44 155.93 31.19 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -85.72 -66.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.827 1.685 . . . . 0.0 113.315 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.55 153.29 50.0 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -65.03 -37.95 89.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 11' ' ' VAL . 68.5 m -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.5 -40.1 96.18 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.4 mtm -66.46 -40.22 89.26 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.05 -43.93 99.3 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 7' ' ' SER . 59.9 t -62.45 -43.02 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.62 99.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.33 -44.58 91.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.029 -0.419 . . . . 0.0 110.282 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.2 mt -69.35 -39.63 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.49 -39.22 93.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.88 96.12 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -107.5 65.79 0.65 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -82.92 59.34 4.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -77.34 151.65 34.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.64 -37.34 86.96 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.0 64.71 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.35 175.45 15.5 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -100.07 131.69 45.87 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 t -70.46 145.99 50.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.26 -40.65 96.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.85 -38.87 92.71 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.1 m -62.56 -37.33 85.75 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 88.8 mt -60.74 -48.65 87.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.792 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -72.17 -37.32 69.35 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.354 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.99 -41.2 97.58 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.49 -0.756 . . . . 0.0 109.944 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -61.7 -48.49 80.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.85 -45.4 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.083 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.27 -39.81 94.7 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.645 -0.659 . . . . 0.0 110.383 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 t -70.57 -41.98 71.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.887 -0.508 . . . . 0.0 111.72 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -92.87 -21.17 20.02 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.031 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -128.82 146.82 50.82 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.621 ' H ' ' N ' ' A' ' 1' ' ' GLY . 88.1 tttt -87.5 120.91 29.28 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.04 160.2 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.64 173.99 51.45 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.84 -40.12 83.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.91 -14.93 61.57 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.93 -35.62 81.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.62 -41.25 90.01 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -64.85 -39.9 94.29 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -67.07 -37.07 83.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.88 -41.71 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.63 -40.29 94.34 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.55 -39.84 88.76 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -64.81 -41.58 95.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.078 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.1 pt -70.11 -34.84 60.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.169 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.26 -39.79 89.7 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -64.57 -41.98 95.94 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.17 -39.36 94.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 50' ' ' ILE . 73.9 t -65.46 -40.36 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 m -61.09 -44.41 97.4 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.1 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.4 p -73.17 -16.35 61.43 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.749 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.71 65.51 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.13 -43.46 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.53 142.86 31.43 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.63 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 27.8 mtpp -84.68 150.83 24.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.504 HE21 HG11 ' A' ' 65' ' ' VAL . 64.4 tt0 -87.49 139.08 30.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.9 m -129.98 163.95 25.32 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 62' ' ' THR . 10.1 ptpp? -62.53 170.47 2.45 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.09 0.948 . . . . 0.0 110.602 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 29.51 62.97 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -66.67 119.16 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.16 -38.66 3.01 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.81 1.87 Allowed 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 m -107.46 -32.32 7.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.4 47.19 36.8 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.5 m -70.95 140.71 51.01 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.4 m-85 -130.31 147.32 52.01 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 69.9 mtp180 -115.15 149.05 38.22 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -87.89 127.05 35.35 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -87.89 110.45 20.54 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 C--O 1.26 1.644 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.45 -39.02 91.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.33 83.35 44.26 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.11 -26.11 36.95 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 121.553 1.502 . . . . 0.0 113.193 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -131.34 135.1 46.96 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -68.53 -29.2 67.73 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 11' ' ' VAL . 84.4 p -63.23 -26.82 68.97 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.81 -42.2 97.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.18 -40.16 82.33 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.59 -43.22 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 7' ' ' SER . 53.0 t -62.18 -42.72 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.63 -42.02 98.3 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.4 93.17 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.97 -0.456 . . . . 0.0 110.244 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.51 -39.33 76.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.17 -37.76 86.49 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.1 85.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.04 79.19 1.82 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.265 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -83.25 58.73 4.62 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -66.05 151.54 46.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.66 -35.89 81.11 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.77 -5.57 46.46 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.84 170.1 35.41 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -95.46 130.67 42.19 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -67.99 151.02 47.74 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -61.69 -41.44 97.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.49 -38.73 92.25 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.7 t -62.37 -39.93 94.77 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.54 -48.83 86.86 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 O-C-N 122.005 -0.435 . . . . 0.0 110.09 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -72.67 -33.98 66.91 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.318 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -66.21 -40.68 90.52 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.42 -48.57 80.57 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.34 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.17 -41.94 96.91 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.77 -0.582 . . . . 0.0 110.457 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -69.46 -39.96 77.42 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.863 -0.523 . . . . 0.0 111.987 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -94.75 -21.21 18.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.569 -0.707 . . . . 0.0 111.826 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -128.62 143.38 50.94 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -77.44 128.1 33.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.81 158.23 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.64 -179.92 28.02 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.52 -31.87 69.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.14 -38.25 81.97 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.36 90.82 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.67 -40.44 92.11 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.31 -39.85 93.01 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -65.3 -39.06 92.02 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.17 -45.0 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.36 -42.1 99.14 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.34 -39.49 85.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -63.58 -43.69 96.25 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.21 -45.39 98.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.9 -39.98 95.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.917 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.76 -41.21 96.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.855 -0.528 . . . . 0.0 109.809 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.99 -39.72 95.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.8 t -65.4 -40.58 88.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -61.18 -41.7 97.26 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -70.22 -27.79 64.75 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.34 8.03 55.35 Favored Glycine 0 C--N 1.349 1.288 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.27 -43.36 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.87 143.8 28.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 87.0 mttt -84.68 150.95 24.79 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -86.76 151.65 23.2 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.4 m -142.35 164.36 30.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 62' ' ' THR . 64.9 pttt -60.59 167.9 2.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 122.01 0.91 . . . . 0.0 110.663 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.19 26.63 67.94 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.4 p -66.16 120.76 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.91 0.862 . . . . 0.0 108.832 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -38.82 2.95 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -61.9 1.84 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -107.79 -31.48 8.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.84 48.05 29.54 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -70.51 141.02 51.98 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 54' ' ' VAL . 72.1 m-85 -132.13 149.46 52.39 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 75.4 mtp180 -116.06 152.62 33.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -88.76 126.87 35.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -84.99 109.98 18.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 tptt . . . . . 0 C--O 1.263 1.795 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.67 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -100.05 127.8 46.22 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -135.04 83.17 40.55 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.93 -76.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 121.769 1.646 . . . . 0.0 112.476 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -131.71 144.38 50.95 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.36 -39.17 88.99 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.0 p -65.13 -38.68 91.43 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.836 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.51 -40.08 92.59 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.5 mtp -66.82 -40.49 88.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -64.39 -43.23 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 7' ' ' SER . 53.0 t -62.05 -43.43 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.85 98.35 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -63.98 -44.34 93.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 122.003 -0.436 . . . . 0.0 110.246 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.5 mt -68.93 -38.81 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.72 -40.39 97.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.81 96.86 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -106.63 65.37 0.67 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -81.63 57.62 3.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.34 148.12 43.76 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -63.59 -36.64 84.47 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.91 64.98 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.01 169.51 14.74 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 t -99.61 126.05 45.53 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -70.19 153.4 43.16 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -62.14 -41.39 98.22 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.6 -38.2 90.23 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.3 m -63.72 -38.28 90.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.6 mt -60.93 -49.78 83.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.66 -32.84 66.14 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.944 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -62.9 -45.31 93.1 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.815 -0.553 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 77.6 t80 -61.11 -47.89 84.17 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.46 -46.08 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.197 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.98 -39.56 93.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.518 -0.738 . . . . 0.0 110.29 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.39 -39.87 74.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.999 -0.438 . . . . 0.0 112.18 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -99.61 -13.59 19.33 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.13 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.36 148.84 52.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.67 ' H ' ' N ' ' A' ' 1' ' ' GLY . 24.5 tptm -87.14 118.56 26.62 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.91 157.96 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.01 177.27 35.21 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -39.29 87.61 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -63.79 -38.31 90.64 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.11 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.77 -40.37 92.32 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -65.28 -39.96 93.27 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.79 -38.2 88.34 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.54 -45.32 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.57 -41.24 98.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.98 -39.59 87.2 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.8 m -64.72 -40.75 95.88 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.2 mt -62.13 -45.33 98.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -64.02 -39.95 95.25 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.2 -40.97 99.0 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.21 -38.45 89.21 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.629 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.5 t -65.46 -40.64 88.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -60.78 -44.18 97.13 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.082 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.9 p -72.89 -16.72 61.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.773 -0.58 . . . . 0.0 109.725 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.86 7.6 64.32 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.5 -43.23 94.42 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.7 mt -99.43 146.78 25.95 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -86.1 151.9 23.31 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.16 136.26 33.12 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 63' ' ' LYS . 6.0 m -127.8 163.7 23.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 62' ' ' THR . 26.1 pttm -58.81 172.04 0.58 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.146 0.974 . . . . 0.0 110.845 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 32.18 57.33 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.73 119.47 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -37.94 3.29 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -63.3 1.42 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.1 p -108.75 -29.08 8.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.49 47.93 39.59 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.4 m -70.27 139.76 52.22 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 54' ' ' VAL . 65.6 m-85 -132.93 150.29 52.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -114.94 154.28 29.02 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.45 127.47 35.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.29 108.21 19.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.261 1.704 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 CA--C 1.498 -1.058 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -66.8 -38.48 86.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 11' ' ' VAL . 69.8 m -63.2 -39.54 94.92 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.34 -40.6 97.75 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.2 mtm -66.85 -40.12 87.8 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.23 -44.2 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 7' ' ' SER . 55.5 t -62.28 -43.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -41.57 97.39 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.27 -43.41 98.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 122.0 -0.438 . . . . 0.0 110.108 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.99 -39.65 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.16 -38.12 89.93 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.51 92.29 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -113.04 68.84 0.68 Allowed 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -84.0 57.13 4.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.88 158.52 34.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.44 -36.99 85.55 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 -7.72 53.84 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.57 -178.58 35.37 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.0 t -101.83 132.8 47.38 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -69.57 154.99 41.19 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -61.78 -42.57 99.17 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.16 -38.24 90.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.1 m -62.29 -38.2 88.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.141 -0.349 . . . . 0.0 110.279 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.451 HG21 HD11 ' A' ' 50' ' ' ILE . 84.9 mt -60.75 -49.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.88 -33.26 65.94 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.101 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.91 -46.55 87.25 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.921 -0.487 . . . . 0.0 109.764 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -61.41 -48.28 81.93 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.1 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.96 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.93 -42.68 97.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.703 -0.623 . . . . 0.0 110.389 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -67.42 -42.05 83.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.983 -0.448 . . . . 0.0 111.826 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -93.99 -21.17 19.35 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.006 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.05 145.66 51.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.38 130.27 37.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.92 160.41 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.08 -178.47 18.73 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.209 -2.356 . . . . 0.0 107.209 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -65.15 -40.13 93.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.68 -38.98 92.86 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.0 93.35 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.9 -40.02 91.48 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.1 t -64.43 -41.57 96.51 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -64.79 -39.1 93.05 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.09 -45.46 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.52 -40.64 97.4 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.83 -43.36 88.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.8 m -63.99 -41.2 97.57 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.979 -0.45 . . . . 0.0 110.094 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 28' ' ' ILE . 88.7 mt -62.51 -44.2 99.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.02 -43.18 99.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.61 98.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.923 -0.486 . . . . 0.0 109.962 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.602 ' HB3' HD13 ' A' ' 59' ' ' LEU . 79.5 mt -62.13 -39.12 91.5 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.1 t -66.79 -40.02 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 m -61.13 -43.94 98.1 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -72.29 -16.82 61.9 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.818 -0.551 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.45 2.21 70.66 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -44.08 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 53' ' ' LEU . 4.2 mp -91.82 136.62 33.01 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 51.3 mttm -85.13 150.97 24.47 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -91.25 138.94 31.2 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -127.11 164.26 21.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 62' ' ' THR . 19.4 ptpt -61.77 173.31 1.04 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.132 0.967 . . . . 0.0 110.614 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.55 33.82 57.86 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.38 120.21 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.25 -38.29 3.15 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.86 -62.34 1.7 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.3 m -108.38 -33.72 7.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.48 47.68 33.79 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.8 m -70.68 141.52 51.61 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 54' ' ' VAL . 87.7 m-85 -131.27 149.04 52.73 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 73.0 mtp85 -117.46 153.48 33.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp . . . . . 0 CA--C 1.496 -1.114 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 CA--C 1.502 -0.881 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 -37.88 89.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 11' ' ' VAL . 67.1 m -62.45 -39.39 93.19 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.82 -38.69 92.05 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.76 -41.62 95.74 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.43 -43.3 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 7' ' ' SER . 59.6 t -62.16 -43.02 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.06 98.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.32 92.05 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.913 -0.492 . . . . 0.0 110.291 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -63.48 -36.7 84.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.21 85.46 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.09 75.72 1.17 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -83.49 59.6 5.18 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -69.39 167.1 17.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 -38.0 89.11 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 6.46 33.25 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.9 -159.78 34.69 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.0 t -115.31 138.33 51.08 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 78.0 p -72.9 162.01 30.02 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -62.6 -41.82 99.2 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.49 -39.19 93.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.3 m -63.65 -39.25 93.86 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 122.05 -0.406 . . . . 0.0 110.009 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 50' ' ' ILE . 85.0 mt -61.55 -49.46 84.32 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.029 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.36 -32.64 66.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.925 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.59 -45.39 90.61 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.11 -48.36 82.0 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.62 -45.59 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.178 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.82 -41.15 97.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -69.73 -39.74 76.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.038 -0.414 . . . . 0.0 112.095 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -96.73 -17.99 19.94 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.487 -0.758 . . . . 0.0 112.085 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -129.21 147.6 51.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -82.03 121.57 26.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.89 158.39 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.29 179.29 26.98 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.15 -39.85 90.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -64.22 -38.66 91.83 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.52 91.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -39.94 91.21 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 m -65.14 -39.57 93.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -67.4 -37.72 83.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.81 -48.08 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 121.935 -0.478 . . . . 0.0 110.356 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -66.92 -31.15 71.55 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.188 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.92 -42.67 85.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.6 m -64.9 -40.64 95.41 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.511 HD11 HG21 ' A' ' 28' ' ' ILE . 89.7 mt -62.06 -44.61 99.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -43.05 99.63 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -63.21 -41.48 99.14 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.5 -39.71 95.17 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.705 -0.622 . . . . 0.0 109.375 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.631 HG21 ' CE2' ' A' ' 71' ' ' PHE . 74.1 t -65.0 -40.69 89.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -61.98 -40.86 97.07 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.9 m -69.98 -27.77 64.98 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 7.26 56.33 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.52 -43.12 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.0 mt -98.26 145.92 26.16 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.7 mttt -84.48 150.91 24.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.93 137.72 32.13 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.4 m -127.3 164.0 22.73 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -60.7 174.2 0.63 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.175 0.988 . . . . 0.0 110.813 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.77 33.02 58.45 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 120.16 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.45 -38.34 3.13 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -62.39 1.69 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 m -108.46 -33.13 7.15 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.09 47.84 28.95 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 72.7 m -70.73 141.01 51.53 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 54' ' ' VAL . 72.7 m-85 -132.39 147.32 52.38 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 90.8 mtt180 -114.01 154.49 27.56 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -179.265 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.5 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.6 -37.26 86.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 11' ' ' VAL . 68.6 m -61.99 -38.97 90.58 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.19 -40.33 97.2 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.3 mtm -65.7 -40.66 92.53 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 14' ' ' ILE . 60.1 mt -63.24 -43.75 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 7' ' ' SER . 55.8 t -60.59 -41.87 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.32 94.31 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.51 -38.7 91.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 73' ' ' LEU . 47.4 mm -66.0 -41.51 89.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.445 HE21 HG12 ' A' ' 11' ' ' VAL . 57.8 mt-30 -68.34 -24.68 64.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.96 90.97 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -122.36 81.22 1.81 Allowed 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -86.72 47.58 1.51 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.63 156.48 26.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -67.22 -19.17 65.5 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.68 -6.68 59.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.53 -175.63 39.21 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -106.01 132.97 51.46 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.8 150.8 46.48 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -62.45 -41.77 98.99 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -63.81 -39.43 94.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.31 -38.05 89.63 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 50' ' ' ILE . 84.3 mt -60.67 -48.42 88.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.021 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.85 -35.25 69.8 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.046 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -65.11 -40.69 94.9 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.613 -0.679 . . . . 0.0 109.664 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.52 -49.56 76.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -43.07 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.15 -40.43 97.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.916 -0.49 . . . . 0.0 111.11 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.8 p -83.47 -16.54 45.32 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.369 -0.832 . . . . 0.0 112.032 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.41 -24.94 12.09 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 119.327 0.967 . . . . 0.0 110.27 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.34 149.62 51.05 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.0 120.47 25.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.05 157.19 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.63 -177.75 25.95 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.7 -41.78 91.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.12 -39.58 94.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.18 93.59 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.5 -42.32 96.12 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.4 m -65.52 -39.48 91.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.84 -36.27 82.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.84 -43.9 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -62.51 -40.21 96.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.72 -40.26 95.03 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -65.23 -41.69 94.13 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 28' ' ' ILE . 91.5 mt -63.05 -45.16 99.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.74 -39.35 94.08 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.91 -41.13 97.75 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.85 -39.51 94.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.514 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.4 t -65.77 -40.48 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.1 m -61.45 -41.45 97.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.3 m -70.23 -27.66 64.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.45 1.37 59.15 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.16 -42.77 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.94 139.7 30.97 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.2 mttt -84.84 151.08 24.57 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -101.31 138.14 38.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.7 m -123.14 164.21 19.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 62' ' ' THR . 14.8 ptmm? -60.43 174.8 0.51 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 122.181 0.991 . . . . 0.0 110.868 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.02 58.66 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 108.334 -1.907 . . . . 0.0 108.334 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.95 121.09 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.14 -38.99 2.88 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -62.22 1.75 Allowed 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -108.08 -34.54 6.85 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.67 48.06 37.43 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.0 m -70.27 138.91 51.99 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.7 m-85 -131.7 151.79 51.37 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 87.7 mtm180 -122.41 153.74 38.67 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HB2' HG21 ' A' ' 14' ' ' ILE . 63.8 tp . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.49 -38.0 86.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 11' ' ' VAL . 48.3 t -62.34 -39.92 94.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.27 -41.27 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -67.27 -39.88 86.13 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 14' ' ' ILE . 54.4 mt -62.8 -43.39 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' SER . 59.3 t -60.49 -42.58 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.98 92.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.67 94.64 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.9 mm -65.33 -42.6 94.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.02 -37.7 88.49 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.52 93.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.96 67.56 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -89.44 59.33 4.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.51 161.57 18.51 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.78 -21.63 64.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.82 -7.46 57.89 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.4 177.76 38.64 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -97.63 132.37 43.35 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -71.35 148.59 46.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.63 -42.38 98.81 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.51 -38.55 91.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -66.63 -30.38 70.64 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.741 -0.599 . . . . 0.0 110.24 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.599 HG21 HD11 ' A' ' 50' ' ' ILE . 83.4 mt -63.29 -49.8 81.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.562 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -72.89 -33.44 66.03 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.624 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.0 -45.41 89.12 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -61.47 -48.48 80.94 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.33 -46.07 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.208 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.71 -41.4 96.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.75 -0.594 . . . . 0.0 110.294 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -70.06 -39.85 75.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.948 -0.47 . . . . 0.0 112.192 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -97.19 -15.24 20.97 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.981 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.44 146.76 52.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.43 119.6 25.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.5 161.52 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.83 167.01 52.47 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.57 -22.63 61.71 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -89.87 -1.96 58.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.24 59.31 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.44 -40.2 90.28 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 m -66.03 -40.3 90.9 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.73 -36.96 81.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.79 -43.63 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.49 -39.85 94.81 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.83 -40.86 95.87 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -64.41 -43.67 93.65 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.599 HD11 HG21 ' A' ' 28' ' ' ILE . 89.3 mt -62.71 -43.97 99.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.55 -42.31 98.65 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.95 -43.36 99.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.91 -39.75 95.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.419 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' CE2' ' A' ' 71' ' ' PHE . 75.2 t -64.78 -40.37 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -62.04 -41.82 98.52 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -69.86 -27.79 65.12 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.5 8.31 52.68 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.5 -44.65 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.83 143.16 26.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 33.5 tptt -91.78 151.0 20.81 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.04 137.35 35.08 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.6 m -128.41 164.0 23.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' H ' HG22 ' A' ' 62' ' ' THR . 19.3 ptpt -62.24 172.25 1.54 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.065 0.936 . . . . 0.0 110.578 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.15 34.97 57.71 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.51 119.22 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.24 -37.88 3.29 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.52 -62.08 1.78 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.06 -33.16 7.26 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.22 47.75 28.46 Favored Glycine 0 C--N 1.355 1.611 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -70.47 143.12 51.85 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.396 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 54' ' ' VAL . 95.5 m-85 -129.49 146.87 51.28 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 80.9 mtm180 -124.44 178.26 5.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 14' ' ' ILE . 93.4 mt . . . . . 0 CA--C 1.496 -1.132 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 CA--C 1.501 -0.92 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -66.68 -36.49 82.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.3 p -62.24 -36.11 80.98 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.85 -40.23 94.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.02 -40.01 87.15 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.12 -44.09 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 7' ' ' SER . 60.7 t -62.46 -43.16 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.42 98.77 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.94 91.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 122.187 -0.321 . . . . 0.0 110.513 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -69.12 -42.81 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.588 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.86 -19.9 61.89 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.526 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.5 97.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -113.52 77.41 1.05 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -83.64 59.93 5.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.61 163.04 25.82 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.75 -29.57 70.1 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.77 2.11 49.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.53 -165.36 35.29 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -107.86 137.13 46.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -72.57 157.16 38.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.66 -43.74 98.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.883 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.13 -26.9 65.12 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.718 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -65.88 -38.18 88.09 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.592 HG21 HD11 ' A' ' 50' ' ' ILE . 88.3 mt -61.04 -48.6 88.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.82 -36.92 67.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.793 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.53 -41.42 96.38 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.547 -0.721 . . . . 0.0 110.167 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -62.02 -48.72 79.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.61 -45.53 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.04 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -64.07 -41.91 97.17 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.549 -0.72 . . . . 0.0 110.318 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 t -69.0 -41.91 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.929 -0.482 . . . . 0.0 111.833 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.17 -20.38 20.53 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.091 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -128.75 147.87 50.81 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.99 119.51 26.37 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.62 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.15 171.39 48.26 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.25 -37.77 84.06 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -73.29 -12.15 60.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.2 62.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.07 -40.8 95.05 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -70.53 -35.6 73.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -66.6 -39.42 88.38 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.86 -44.08 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -41.63 98.46 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.49 -40.08 92.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -64.16 -43.17 95.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.592 HD11 HG21 ' A' ' 28' ' ' ILE . 88.0 mt -62.15 -44.94 99.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.98 -39.79 95.77 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -64.32 -41.92 96.56 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -39.44 93.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.9 t -64.59 -40.01 87.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.6 m -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -72.28 -17.21 61.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.882 -0.512 . . . . 0.0 109.689 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.63 5.72 66.51 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.37 -43.89 94.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.6 143.24 30.07 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.04 149.9 23.02 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -87.08 139.7 30.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.1 m -128.21 164.19 23.07 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 62' ' ' THR . 22.8 ptmt -61.22 174.39 0.7 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.056 0.931 . . . . 0.0 110.632 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.4 58.52 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.98 119.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.81 -38.12 3.22 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.01 -62.98 1.5 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.9 p -109.01 -29.35 8.61 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.25 47.72 56.8 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -70.53 143.75 51.54 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 54' ' ' VAL . 94.8 m-85 -129.82 145.92 51.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -109.87 150.67 28.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.497 -1.089 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.76 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -66.92 -36.25 81.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.519 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.1 p -62.89 -37.29 86.35 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.18 -39.46 92.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.4 mtp -65.89 -41.23 91.77 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.19 -43.89 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 7' ' ' SER . 56.5 t -62.09 -43.38 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.24 98.2 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -63.92 -43.17 96.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 122.035 -0.416 . . . . 0.0 110.331 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.2 mt -68.58 -39.62 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.9 -38.42 91.0 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.76 94.87 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.01 65.38 0.8 Allowed 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.22 45.34 0.74 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -68.01 149.65 49.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.99 -37.09 85.78 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -21.5 64.89 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.54 175.76 19.2 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -101.8 126.73 48.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -69.94 154.32 42.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.9 -41.42 97.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.23 -38.61 91.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -61.93 -37.51 84.95 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.512 HG21 HD11 ' A' ' 50' ' ' ILE . 82.2 mt -60.43 -48.74 87.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.93 -34.41 66.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.492 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.89 -41.48 97.71 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.444 -0.785 . . . . 0.0 110.038 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 76.8 t80 -61.87 -48.02 82.4 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.72 -45.04 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.002 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.07 -40.07 95.46 Favored 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 121.67 -0.644 . . . . 0.0 110.367 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 t -70.41 -42.05 72.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 122.028 -0.42 . . . . 0.0 111.795 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -96.73 -14.35 22.07 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.568 -0.708 . . . . 0.0 112.135 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.67 151.03 50.73 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.6 121.6 31.95 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.36 158.41 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.02 175.73 36.87 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.43 -39.86 85.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -66.75 -28.39 68.37 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.14 68.8 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.3 -40.56 94.62 Favored 'General case' 0 C--N 1.353 0.717 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.0 m -66.37 -40.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -65.15 -39.89 93.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.29 -45.84 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.01 -41.47 99.58 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -66.43 -39.49 88.95 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.95 -41.84 95.15 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 28' ' ' ILE . 89.4 mt -63.04 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.69 -42.32 99.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -42.46 99.57 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.1 -40.24 95.8 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 121.775 -0.578 . . . . 0.0 109.547 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.3 t -65.62 -40.8 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.4 m -62.08 -40.91 97.42 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 -27.64 65.1 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.09 7.77 54.58 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.16 -43.92 91.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.66 147.38 23.36 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -90.43 148.8 22.56 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.65 151.03 26.47 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -141.85 164.14 30.99 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -63.27 172.53 1.88 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 122.036 0.922 . . . . 0.0 110.762 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.27 34.32 58.02 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.41 119.44 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.13 3.2 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.2 1.74 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.3 m -107.74 -32.18 7.74 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.68 47.64 32.61 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -70.53 140.92 51.92 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 54' ' ' VAL . 81.9 m-85 -131.55 149.07 52.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 81.5 mtm180 -124.87 177.39 6.05 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.496 -1.104 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.565 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.498 -1.042 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -66.64 -35.93 81.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.7 p -62.53 -36.62 83.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.22 -39.24 92.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.2 mtp -66.07 -40.86 91.23 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.32 -42.94 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 7' ' ' SER . 56.2 t -61.86 -42.54 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.103 -0.373 . . . . 0.0 110.123 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.05 94.08 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.061 -0.399 . . . . 0.0 110.172 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.42 -38.08 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -61.57 -36.9 81.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.84 89.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -114.56 69.32 0.71 Allowed 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -82.96 57.95 4.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -80.8 165.73 21.62 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.32 -36.6 84.64 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -8.82 57.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.9 -163.82 33.66 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.1 m -115.97 141.06 48.61 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.6 m -72.87 155.52 39.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.59 -42.38 98.78 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -62.9 -38.64 91.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -62.35 -39.65 93.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 50' ' ' ILE . 84.2 mt -60.56 -49.52 84.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.954 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.65 -33.18 66.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.938 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -64.09 -45.41 88.82 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.959 -0.463 . . . . 0.0 109.768 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -61.17 -48.34 82.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.14 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.094 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.72 -41.95 95.61 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 121.68 -0.637 . . . . 0.0 110.407 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -69.05 -42.07 76.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.916 -0.49 . . . . 0.0 111.942 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -94.69 -16.64 22.94 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.526 -0.734 . . . . 0.0 112.138 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.46 147.65 52.18 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.61 120.82 25.56 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.88 157.79 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.58 -179.1 24.78 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.64 -41.3 92.77 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.61 -38.92 92.96 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.86 92.65 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.03 -39.94 91.7 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.1 m -64.72 -39.97 94.54 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.19 -36.6 82.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.36 -45.88 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.34 -40.65 97.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.5 tp -63.63 -44.3 94.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -63.4 -43.07 98.62 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 28' ' ' ILE . 89.4 mt -61.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.84 -40.14 95.88 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -63.71 -42.29 97.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.27 -40.51 96.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.594 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.1 t -65.48 -40.92 89.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.0 m -61.97 -41.12 97.64 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.7 m -70.08 -27.61 64.75 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.93 8.53 55.43 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.12 -43.5 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.92 143.84 28.77 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -85.4 151.17 24.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -94.87 135.11 36.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.2 m -119.56 164.46 15.79 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' H ' HG22 ' A' ' 62' ' ' THR . 22.2 ptmt -59.24 175.17 0.33 Allowed 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.095 0.95 . . . . 0.0 110.982 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.26 35.08 53.66 Favored Glycine 0 C--N 1.357 1.741 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.79 119.89 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.1 -38.12 3.2 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -62.37 1.69 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.1 m -108.48 -35.1 6.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.5 47.86 32.67 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 64.4 m -70.58 143.46 51.54 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.594 ' CE2' HG21 ' A' ' 54' ' ' VAL . 85.2 m-85 -130.81 151.42 51.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -122.0 164.92 16.83 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.439 -0.998 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -67.83 -34.74 77.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.4 m -61.43 -38.13 86.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.08 -43.64 98.4 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -39.9 89.96 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.7 -44.79 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 7' ' ' SER . 64.3 t -63.17 -42.26 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.23 -42.77 99.19 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.25 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.51 -39.86 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -64.73 -37.62 88.22 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.493 -0.755 . . . . 0.0 109.017 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.63 91.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -106.96 68.84 0.74 Allowed 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -79.98 51.79 1.4 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -70.02 147.95 49.44 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -61.97 -37.65 85.59 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.44 -9.41 58.5 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.87 169.89 28.61 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 t -95.34 128.91 42.57 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -71.29 157.16 38.6 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -60.8 -42.57 97.87 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -63.15 -39.27 94.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.2 m -63.46 -39.03 93.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 50' ' ' ILE . 82.8 mt -61.04 -49.4 84.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.71 -32.89 66.06 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.131 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.66 -45.65 93.13 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.833 -0.542 . . . . 0.0 109.687 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.29 -48.2 82.48 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.99 -45.02 99.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.17 -39.59 94.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.486 -0.759 . . . . 0.0 110.211 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.36 -39.93 74.33 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.001 -0.437 . . . . 0.0 112.075 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -98.25 -16.94 19.21 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.841 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.09 147.4 52.61 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -84.52 121.52 27.71 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.0 159.49 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.54 179.44 26.7 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.09 -40.85 91.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.36 -38.57 91.66 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.76 91.42 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.89 -39.68 90.17 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.11 -40.38 94.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.69 -37.01 81.71 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -45.36 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.98 -40.18 96.95 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.29 -44.19 92.44 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.1 t -63.27 -42.81 99.16 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 28' ' ' ILE . 89.3 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.21 -42.65 99.49 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.56 -42.12 99.34 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.7 -40.71 97.46 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.808 -0.557 . . . . 0.0 109.574 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.661 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.0 t -66.0 -40.71 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.4 m -62.04 -40.97 97.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.1 m -69.86 -27.64 65.0 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.76 8.33 54.46 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.17 -43.49 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -98.29 144.82 27.3 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -84.73 151.1 24.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -87.87 137.58 32.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -127.59 164.49 21.89 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.51 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -60.51 173.5 0.7 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.09 0.948 . . . . 0.0 110.509 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.15 32.97 57.75 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.7 119.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -37.81 3.32 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.92 -63.07 1.47 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.9 p -109.32 -30.49 7.96 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 48.0 37.95 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -70.46 143.05 51.89 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.661 ' CE2' HG21 ' A' ' 54' ' ' VAL . 73.3 m-85 -132.18 149.57 52.36 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -118.9 165.4 14.11 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 CA--C 1.499 -1.007 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -67.0 -36.4 82.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.2 p -63.08 -36.33 83.22 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.08 -40.35 94.52 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -66.66 -40.4 88.62 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 14' ' ' ILE . 53.7 mt -63.66 -43.5 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 7' ' ' SER . 54.6 t -60.5 -42.4 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.24 93.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.09 -39.36 93.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.559 HG21 ' HG ' ' A' ' 73' ' ' LEU . 50.0 mm -65.8 -44.0 93.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.21 -35.75 81.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.45 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -116.11 71.56 0.79 Allowed 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -86.82 58.99 5.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -80.51 162.12 24.5 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.9 -27.68 66.86 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -1.73 47.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -177.59 37.62 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 t -98.93 129.44 45.26 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -70.44 150.72 45.93 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -61.75 -43.53 98.68 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.318 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.09 -38.97 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.26 -38.12 89.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.473 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 87.6 mt -61.37 -49.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 121.975 -0.453 . . . . 0.0 110.331 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.9 -33.86 68.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.076 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.28 -40.85 86.17 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.92 -49.07 77.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.63 -44.99 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.849 -0.532 . . . . 0.0 110.408 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -69.08 -39.66 78.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.808 -0.558 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.08 -20.19 18.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.966 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.8 146.27 51.54 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -75.27 135.1 40.96 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.48 160.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 42' ' ' ALA . . . -117.48 -178.63 17.54 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.03 -40.27 94.59 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -65.1 -39.43 93.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 39' ' ' GLY . . . -62.82 -38.76 91.98 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.01 -40.65 94.36 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 95.1 p -69.55 -34.84 74.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -68.39 -36.12 78.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.87 -39.89 95.81 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.92 -42.34 85.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -62.7 -44.92 94.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.202 -0.311 . . . . 0.0 110.59 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 pt -67.48 -34.24 67.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.925 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.95 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.5 -39.43 93.49 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 50' ' ' ILE . 73.9 t -65.76 -40.69 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.2 m -61.42 -44.34 97.3 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.099 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.2 p -73.0 -15.92 61.52 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.898 -0.501 . . . . 0.0 109.835 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.67 6.18 66.01 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.09 -43.83 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.67 138.08 35.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 55.1 mtpt -87.82 151.97 22.46 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -83.98 135.46 34.44 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.6 m -127.14 164.15 22.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' H ' HG22 ' A' ' 62' ' ' THR . 64.8 pttt -60.15 172.5 0.8 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.109 0.957 . . . . 0.0 110.671 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.22 33.09 57.42 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.56 119.11 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.93 -37.87 3.31 Favored Glycine 0 C--N 1.351 1.395 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.9 -62.97 1.5 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.7 p -108.96 -30.3 8.16 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.36 47.75 49.5 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.8 m -70.19 144.58 51.89 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.583 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.41 ' CE2' HG21 ' A' ' 54' ' ' VAL . 85.4 m-85 -130.07 148.92 51.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 80.7 mtm180 -120.07 169.75 9.92 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.559 ' HG ' HG21 ' A' ' 14' ' ' ILE . 95.4 mt . . . . . 0 CA--C 1.495 -1.145 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -66.63 -38.3 86.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 11' ' ' VAL . 70.0 m -63.29 -40.57 97.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.91 -39.92 95.3 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mtp -66.37 -40.49 89.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.03 -43.73 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 7' ' ' SER . 63.6 t -62.49 -41.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.33 98.33 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.14 97.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.72 -40.49 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.95 -36.54 84.72 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.97 90.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -121.67 73.67 1.08 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -84.68 57.69 4.5 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -66.11 148.41 51.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -62.16 -38.52 89.34 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.87 65.61 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.14 170.58 14.36 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.5 m -97.77 130.48 44.71 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -69.24 146.45 52.31 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -61.46 -40.57 94.99 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.74 -38.47 91.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -61.78 -39.88 93.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.09 -48.89 86.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.082 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.42 -34.87 68.14 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.409 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -66.56 -40.65 89.11 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.551 -0.718 . . . . 0.0 110.171 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.71 -48.68 79.66 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.28 -45.75 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.42 -41.77 96.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.744 -0.597 . . . . 0.0 110.448 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.0 m -70.22 -39.88 74.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.962 -0.461 . . . . 0.0 112.128 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -96.33 -16.75 21.13 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.873 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.35 147.64 52.59 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -84.23 121.43 27.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.83 156.41 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.89 179.62 34.14 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.1 -41.67 90.29 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.79 -39.02 93.25 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.63 91.88 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -60.91 -42.63 98.43 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -65.14 -39.19 92.68 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.38 -38.39 90.87 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.45 -45.02 99.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.27 -41.85 98.82 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.9 tp -66.57 -41.96 87.76 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -62.5 -42.76 99.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.58 -45.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -63.89 -40.51 96.7 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -62.94 -41.74 99.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.87 -39.27 93.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG21 ' CE2' ' A' ' 71' ' ' PHE . 76.5 t -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 m -61.5 -41.09 96.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -70.05 -27.94 65.06 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 7.58 56.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.38 -43.24 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.17 146.19 26.41 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 87.0 mttt -84.66 150.75 24.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -91.43 138.41 31.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 63' ' ' LYS . 5.0 m -128.02 163.65 24.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 62' ' ' THR . 22.4 ptmt -61.27 171.53 1.34 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.063 0.935 . . . . 0.0 110.574 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.22 23.89 64.86 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.88 120.61 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.595 0.712 . . . . 0.0 109.146 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.24 -38.92 2.91 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.41 -62.4 1.7 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -108.6 -33.47 7.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.22 20.4 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.9 m -70.25 140.87 52.48 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 54' ' ' VAL . 71.3 m-85 -131.22 149.67 52.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 16.7 mmm180 -117.68 158.04 25.39 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 CA--C 1.497 -1.089 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.506 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -68.22 -37.31 80.71 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.514 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.7 p -63.59 -34.69 78.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.7 -42.79 95.05 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.46 -41.03 93.84 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 14' ' ' ILE . 64.4 mt -63.14 -44.41 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 7' ' ' SER . 57.7 t -60.37 -43.08 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.36 95.05 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.62 -39.05 93.03 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.8 mm -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.26 -27.37 64.38 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.111 -0.368 . . . . 0.0 110.079 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.16 95.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.84 75.08 0.97 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -85.68 59.45 5.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -79.6 152.89 29.8 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.36 -37.27 86.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.06 64.66 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 173.92 16.49 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.5 p -96.16 137.56 35.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.5 p -77.34 159.69 29.35 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -65.32 -39.96 93.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -63.3 -39.67 95.23 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -61.95 -39.87 93.58 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.642 HG21 HD11 ' A' ' 50' ' ' ILE . 85.8 mt -60.82 -49.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.201 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.52 -33.74 67.11 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.001 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.61 -46.11 89.77 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.85 -48.81 78.85 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.57 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.172 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.77 -18.15 62.77 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.0 m -89.17 -35.75 16.06 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.501 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -100.88 -12.2 19.18 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.74 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 152.06 51.61 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 124.66 31.62 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.01 160.41 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.72 -178.07 19.29 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.93 -41.65 95.34 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -63.85 -38.84 92.57 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -38.81 92.38 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.73 -39.95 90.53 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.2 t -64.72 -41.64 95.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -64.72 -38.49 91.18 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.67 -45.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -62.33 -41.8 98.85 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.54 -39.42 88.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.9 -40.96 95.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 28' ' ' ILE . 87.4 mt -62.57 -44.82 99.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.44 -39.34 94.23 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.1 -40.95 97.33 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.75 -39.65 94.78 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.0 t -65.21 -40.72 89.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 m -61.42 -41.63 97.47 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -70.33 -27.74 64.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.67 56.28 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.21 -43.33 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.71 146.14 31.16 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.9 mttt -84.72 150.61 24.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.09 137.29 34.35 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.0 m -122.96 164.01 19.31 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' H ' HG22 ' A' ' 62' ' ' THR . 19.4 ptpt -61.0 174.09 0.69 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.1 0.952 . . . . 0.0 110.627 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.8 33.1 58.29 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.38 120.12 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.78 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.96 -62.53 1.64 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -108.44 -34.14 6.86 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.41 48.42 24.18 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -70.86 141.84 51.23 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 54' ' ' VAL . 93.9 m-85 -130.98 148.74 52.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 66.7 mtp180 -118.09 158.14 25.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HB2' HG21 ' A' ' 14' ' ' ILE . 59.7 tp . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -68.19 -37.33 80.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.7 m -62.42 -38.92 91.59 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.14 -41.36 99.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.4 mmt -66.47 -40.38 89.31 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 14' ' ' ILE . 57.1 mt -63.29 -43.48 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' SER . 53.8 t -60.71 -42.22 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.78 94.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 73' ' ' LEU . 48.1 mm -67.51 -41.66 86.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -62.95 -36.94 85.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.979 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.57 84.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.76 82.06 1.98 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.024 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.03 58.28 4.33 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.33 148.47 51.61 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.23 -36.4 83.53 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -5.65 44.85 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.51 167.18 27.56 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -86.72 133.34 33.68 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.3 t -69.09 147.61 51.22 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -61.09 -41.45 96.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.56 -38.31 90.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.9 m -63.05 -38.39 90.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 122.057 -0.402 . . . . 0.0 110.199 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.629 HG21 HD11 ' A' ' 50' ' ' ILE . 86.5 mt -60.96 -49.73 83.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.937 -0.477 . . . . 0.0 110.017 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.73 -34.06 66.81 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.769 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.25 -45.37 91.87 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.09 -49.13 78.57 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.74 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.169 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -65.43 -41.43 93.54 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.689 -0.632 . . . . 0.0 110.593 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.5 m -69.36 -39.98 77.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 112.026 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -97.18 -15.79 20.72 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.447 -0.783 . . . . 0.0 111.657 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -133.47 147.19 51.66 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.96 126.61 32.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.97 157.32 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.27 176.5 34.24 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.49 -41.56 88.75 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.95 -38.97 93.03 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.36 94.52 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.403 ' HA ' HD12 ' A' ' 46' ' ' ILE . 36.6 t70 -60.82 -42.12 97.07 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -65.59 -39.54 91.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.85 -34.0 76.84 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 43' ' ' ASP . 80.6 mt -60.49 -43.53 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.29 -39.78 89.58 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.4 m -64.5 -41.73 96.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.629 HD11 HG21 ' A' ' 28' ' ' ILE . 90.1 mt -63.16 -44.2 99.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -62.35 -42.95 99.8 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -62.45 -42.52 99.52 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 59' ' ' LEU . 80.0 mt -63.57 -39.55 94.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.6 t -66.72 -40.55 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.8 m -61.76 -43.57 98.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.068 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -72.44 -15.93 61.82 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.782 -0.574 . . . . 0.0 109.72 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.55 2.94 69.49 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.28 -44.3 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 53' ' ' LEU . 3.5 mp -97.12 143.53 27.84 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.2 mttt -84.85 150.65 24.85 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -96.27 138.37 33.98 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.4 m -123.7 164.39 19.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -63.09 174.92 0.99 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.115 0.959 . . . . 0.0 110.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.22 33.55 59.0 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.2 t -70.55 120.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.02 -62.32 1.71 Allowed 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -108.46 -34.62 6.71 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.53 47.88 25.8 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 60.8 m -70.61 141.5 51.75 Favored 'General case' 0 C--N 1.358 0.963 0 CA-C-N 118.109 0.954 . . . . 0.0 108.464 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.3 m-85 -131.85 150.02 52.28 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.417 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 88.6 mtm180 -122.25 155.57 35.61 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.613 ' HB2' HG21 ' A' ' 14' ' ' ILE . 62.9 tp . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -67.36 -37.45 83.23 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.7 m -62.52 -39.11 92.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.62 -43.17 97.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.58 -39.96 92.19 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' O ' HG12 ' A' ' 14' ' ' ILE . 61.4 mt -62.36 -44.16 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 7' ' ' SER . 58.1 t -60.82 -42.5 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.56 91.83 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.95 95.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.613 HG21 ' HG ' ' A' ' 73' ' ' LEU . 39.7 mm -69.39 -41.56 80.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.01 -39.23 93.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -40.92 93.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.74 71.24 0.88 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.78 58.52 5.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.14 164.2 25.88 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.01 -38.76 92.47 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.25 -4.49 42.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.4 -171.75 35.44 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 t -105.47 132.06 52.11 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -69.5 155.15 40.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.02 -43.07 99.44 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.98 -39.14 93.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.6 m -62.98 -38.53 91.49 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 50' ' ' ILE . 85.3 mt -60.66 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 121.987 -0.445 . . . . 0.0 110.187 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.91 -33.01 65.73 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.084 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.28 -44.64 94.52 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.24 -48.73 80.14 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.08 -45.11 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.199 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.29 -40.39 95.86 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.861 -0.525 . . . . 0.0 111.398 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -83.73 -14.79 50.76 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.568 -0.707 . . . . 0.0 112.358 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.39 -20.71 12.15 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 119.538 1.063 . . . . 0.0 110.651 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -129.75 149.02 51.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.92 121.11 25.6 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.17 161.44 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.57 170.08 51.6 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.31 -37.75 83.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -80.58 0.31 34.51 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.22 63.27 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -40.07 89.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -66.61 -39.96 88.59 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -66.14 -39.74 90.08 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.38 -45.35 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.71 -40.46 97.21 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.39 -42.88 92.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.5 t -63.13 -43.71 97.65 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.657 HD11 HG21 ' A' ' 28' ' ' ILE . 87.7 mt -62.28 -43.78 98.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -61.1 -43.01 99.54 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.55 -41.16 98.45 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.38 -39.16 92.29 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.7 t -66.69 -39.73 84.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 m -60.98 -44.34 97.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.006 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 p -72.58 -16.94 61.74 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 109.55 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.99 70.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -65.5 -44.75 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.25 149.3 24.67 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 84.8 tttt -97.16 142.27 29.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.416 HE21 HG21 ' A' ' 65' ' ' VAL . 63.0 tt0 -81.61 139.53 34.97 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.3 m -131.15 163.87 26.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -63.9 175.47 1.17 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.982 0.896 . . . . 0.0 110.588 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.23 31.47 59.37 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.416 HG21 HE21 ' A' ' 61' ' ' GLN . 99.0 t -70.25 119.45 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.06 3.25 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.11 -63.45 1.39 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 p -109.28 -29.54 8.43 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.88 38.62 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -70.6 143.14 51.61 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 54' ' ' VAL . 96.3 m-85 -132.45 149.74 52.28 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 72.3 mtp180 -127.27 177.52 6.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.613 ' HG ' HG21 ' A' ' 14' ' ' ILE . 93.3 mt . . . . . 0 CA--C 1.496 -1.115 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 -35.34 79.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.1 p -62.5 -37.19 85.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.4 mtp -66.81 -40.21 87.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 7' ' ' SER . 59.1 t -61.63 -43.02 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.3 98.8 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -64.01 -44.68 91.89 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 122.085 -0.384 . . . . 0.0 110.401 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.23 -39.74 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -63.26 -38.62 91.88 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.62 93.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.12 67.48 0.65 Allowed 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -83.98 58.35 4.66 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.12 155.13 39.99 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -67.27 -19.99 65.58 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.01 -2.74 58.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 177.7 41.43 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -105.4 130.93 53.39 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 m -68.94 153.56 43.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -62.21 -41.4 98.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.98 -38.49 91.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.7 m -61.97 -37.81 86.18 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.609 HG21 HD11 ' A' ' 50' ' ' ILE . 86.0 mt -60.66 -48.6 87.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -73.13 -37.13 66.75 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.487 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.1 -40.43 96.2 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.273 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.402 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 78.7 t80 -61.65 -48.52 80.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.0 mt -62.86 -44.95 99.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.165 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.49 -38.56 91.46 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.747 -0.596 . . . . 0.0 111.55 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.0 p -86.38 -15.34 40.7 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.485 -0.76 . . . . 0.0 112.256 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -110.48 -20.03 12.72 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 119.373 0.988 . . . . 0.0 110.465 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.42 150.15 52.26 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -86.24 118.38 25.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.85 161.69 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.22 167.41 50.83 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.87 -19.14 61.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -90.94 -1.61 57.81 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.47 -25.6 62.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.42 -39.01 85.88 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.6 t -63.79 -43.57 95.93 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -68.34 -37.84 80.92 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.34 -46.36 96.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.27 -39.91 95.92 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.94 -44.87 94.88 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -64.94 -41.74 95.25 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.609 HD11 HG21 ' A' ' 28' ' ' ILE . 87.0 mt -62.61 -44.46 99.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.66 -43.44 98.85 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.58 -41.97 98.32 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.31 -39.43 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.4 t -65.09 -39.84 86.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.2 m -60.91 -42.83 98.82 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -70.22 -27.88 64.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.94 54.16 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.68 -43.35 93.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.01 142.96 29.08 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.18 151.55 22.61 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.85 138.39 32.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.5 m -128.68 164.09 23.69 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 62' ' ' THR . 22.9 ptmt -61.01 174.1 0.69 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.062 0.934 . . . . 0.0 110.572 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.98 32.9 58.19 Favored Glycine 0 C--N 1.357 1.712 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.69 119.15 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -37.92 3.29 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.73 -63.03 1.48 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 p -108.92 -29.88 8.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.06 47.85 43.44 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.1 m -70.33 142.51 52.19 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CE2' HG21 ' A' ' 54' ' ' VAL . 89.5 m-85 -130.98 149.44 52.6 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -119.27 164.95 14.89 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.737 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttp . . . . . 0 N--CA 1.437 -1.11 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -67.53 -35.54 79.29 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.3 m -61.82 -38.7 89.13 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.45 -40.99 98.39 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.4 mtt -67.02 -40.23 87.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.67 -43.35 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 7' ' ' SER . 59.1 t -62.43 -43.57 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.0 98.71 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.74 -44.58 93.08 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 122.043 -0.411 . . . . 0.0 110.161 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.14 -39.89 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -63.6 -39.4 94.27 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.82 96.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -105.88 63.8 0.68 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -86.28 59.78 5.84 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -80.99 168.36 18.79 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -64.63 -36.89 85.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.64 -5.29 49.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.47 -167.83 32.88 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.7 t -107.21 131.63 53.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -71.6 158.24 36.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -60.61 -44.84 95.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -64.82 -37.7 88.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.9 m -62.87 -38.43 90.82 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 122.275 -0.266 . . . . 0.0 110.646 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 50' ' ' ILE . 88.2 mt -61.17 -49.95 82.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.232 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -73.11 -33.13 65.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.004 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.28 -45.84 89.58 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -61.36 -48.41 81.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.16 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.894 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.49 -41.45 96.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.655 -0.653 . . . . 0.0 110.313 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.89 -39.87 76.0 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.934 -0.479 . . . . 0.0 112.066 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -97.09 -16.42 20.52 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.959 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.59 147.08 52.23 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -81.1 121.92 26.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.13 157.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.82 -179.93 25.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -65.97 -39.77 90.66 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -64.4 -39.31 93.6 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.64 91.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.77 -40.21 91.67 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.9 p -68.04 -35.88 78.98 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -68.83 -35.72 77.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.88 -44.24 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.79 -40.54 97.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.08 -40.85 91.15 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -64.4 -43.42 94.48 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 28' ' ' ILE . 90.5 mt -61.73 -44.77 99.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.87 -43.82 98.08 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.82 -41.95 97.76 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 121.895 -0.503 . . . . 0.0 110.089 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.99 -39.97 94.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.655 -0.653 . . . . 0.0 109.428 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG21 ' CE2' ' A' ' 71' ' ' PHE . 76.2 t -65.26 -40.02 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 m -61.16 -43.55 98.71 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.827 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.409 ' OG1' HG23 ' A' ' 58' ' ' VAL . 60.0 p -72.29 -17.19 61.89 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.845 -0.535 . . . . 0.0 109.742 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.02 7.41 65.93 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' OG1' ' A' ' 56' ' ' THR . 53.3 t -65.4 -42.96 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.1 mt -97.64 143.68 28.06 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 151.86 21.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -90.39 134.5 34.3 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.7 m -121.82 164.16 17.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' H ' HG22 ' A' ' 62' ' ' THR . 22.8 ptmt -58.83 174.79 0.32 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.109 0.956 . . . . 0.0 111.042 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.63 53.38 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.9 119.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.48 -38.14 3.2 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.02 1.8 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.34 -34.43 6.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.08 47.23 38.87 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.1 m -71.04 142.85 50.89 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 54' ' ' VAL . 86.5 m-85 -131.3 151.37 51.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -120.57 168.89 10.88 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 CA--C 1.497 -1.081 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.745 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.15 -39.22 89.64 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.0 p -64.71 -36.57 84.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.48 -42.74 91.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.4 ' HB3' HG12 ' A' ' 32' ' ' ILE . 78.1 mtm -65.93 -39.5 90.56 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.83 -43.53 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 7' ' ' SER . 58.9 t -61.91 -43.92 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.6 98.88 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.68 93.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.146 -0.346 . . . . 0.0 110.142 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.69 -40.09 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.96 -39.87 95.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.38 97.51 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -107.64 66.72 0.67 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.84 59.7 4.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -75.01 150.65 38.88 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -68.34 -27.01 65.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -6.57 56.58 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.51 166.73 31.01 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -94.96 129.38 42.03 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -66.56 147.32 53.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -61.53 -40.52 94.94 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.17 -38.91 92.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -63.03 -36.54 83.9 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 50' ' ' ILE . 84.7 mt -60.25 -50.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.922 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.33 -32.92 64.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.24 -45.49 93.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.33 -47.83 84.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 9' ' ' MET . 95.2 mt -61.64 -46.56 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.19 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.14 -41.15 95.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.22 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.8 -39.83 76.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.914 -0.491 . . . . 0.0 112.237 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -97.8 -15.36 20.3 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.504 -0.747 . . . . 0.0 112.019 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -130.28 147.48 52.01 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.88 119.64 24.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.43 161.23 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.08 171.96 52.46 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.33 -39.83 85.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -77.82 -5.35 50.56 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.23 80.51 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.5 -38.95 82.25 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 t -63.66 -42.93 98.01 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -36.64 81.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.45 -43.06 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.81 -41.08 97.32 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.17 -40.9 90.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.5 m -65.65 -42.05 91.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 28' ' ' ILE . 88.4 mt -63.11 -44.37 99.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -61.85 -43.72 98.27 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.51 -41.71 98.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 121.967 -0.458 . . . . 0.0 110.049 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.03 -39.7 95.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.601 -0.687 . . . . 0.0 109.215 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.4 t -65.52 -40.12 87.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -61.19 -41.34 96.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.1 m -70.31 -27.62 64.53 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.99 8.05 55.79 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.26 -44.02 91.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.95 147.68 22.87 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -92.72 149.45 21.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -81.95 151.66 27.1 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.8 m -142.98 163.67 32.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -60.39 172.0 0.95 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.192 0.996 . . . . 0.0 110.865 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.99 33.04 57.98 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.6 t -70.57 119.88 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -38.12 3.21 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.47 1.65 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.5 m -108.52 -33.41 7.05 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.91 48.39 16.46 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 107.379 -2.288 . . . . 0.0 107.379 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.3 m -70.26 142.34 52.33 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.587 ' CE2' HG21 ' A' ' 54' ' ' VAL . 84.0 m-85 -130.94 149.22 52.67 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 14.8 mmm180 -123.32 177.52 5.56 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.578 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 CA--C 1.498 -1.049 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -67.14 -36.24 81.44 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.6 m -61.83 -38.85 89.73 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.42 -41.44 98.7 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.7 -39.22 84.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.04 -43.29 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 7' ' ' SER . 61.6 t -62.22 -43.2 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.96 98.55 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.26 93.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.997 -0.439 . . . . 0.0 110.283 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.95 -39.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -63.55 -39.15 93.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.79 95.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -107.72 65.13 0.64 Allowed 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -86.15 59.25 5.53 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.85 168.86 18.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -37.13 86.54 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.05 -2.46 40.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.16 38.48 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 t -111.38 132.12 54.67 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.4 p -73.08 162.26 29.67 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -63.36 -40.71 98.03 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.47 -39.01 93.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.5 m -63.32 -38.78 92.47 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.04 -0.412 . . . . 0.0 109.904 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.474 HG21 HD11 ' A' ' 50' ' ' ILE . 87.8 mt -61.3 -49.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.109 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.57 -33.44 66.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.972 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.11 -45.35 88.98 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.857 -0.527 . . . . 0.0 109.657 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.33 -48.64 80.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.41 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.085 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.01 -41.83 95.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.791 -0.568 . . . . 0.0 110.411 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.9 m -69.33 -40.06 77.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.85 -0.531 . . . . 0.0 112.08 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -98.18 -14.23 20.48 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.957 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -133.66 148.19 51.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -81.27 127.23 32.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.54 157.16 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.49 177.63 30.93 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.9 -42.07 90.68 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.54 -39.61 94.08 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.6 95.11 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.67 -41.87 95.92 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.3 m -65.51 -39.84 92.31 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.7 -34.88 78.83 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.37 -44.64 96.45 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.02 -40.34 97.46 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.95 -40.73 91.59 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -64.11 -42.89 96.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.474 HD11 HG21 ' A' ' 28' ' ' ILE . 90.2 mt -61.83 -44.56 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -62.07 -43.28 99.18 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.45 98.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.995 -0.441 . . . . 0.0 109.996 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -39.43 92.54 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.621 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.0 t -66.13 -40.19 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 m -60.85 -44.55 96.83 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -73.04 -15.94 61.5 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.812 -0.555 . . . . 0.0 109.877 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.68 64.72 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.25 -43.22 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.29 145.67 26.42 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -88.73 151.9 22.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -81.77 151.94 27.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.498 ' O ' HG13 ' A' ' 65' ' ' VAL . 4.6 m -143.52 164.06 31.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 62' ' ' THR . 23.4 pttp -59.24 167.17 1.88 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.181 0.991 . . . . 0.0 110.794 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.59 61.75 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -66.79 118.42 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.28 -38.33 3.14 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.67 1.92 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.7 m -107.54 -32.09 7.84 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 47.59 28.67 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 m -70.87 141.42 51.23 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.621 ' CE2' HG21 ' A' ' 54' ' ' VAL . 67.7 m-85 -133.11 150.15 52.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -118.39 166.3 12.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.496 -1.11 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.668 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 CA--C 1.501 -0.915 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -65.03 -37.95 89.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 11' ' ' VAL . 68.5 m -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.5 -40.1 96.18 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.4 mtm -66.46 -40.22 89.26 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.05 -43.93 99.3 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 7' ' ' SER . 59.9 t -62.45 -43.02 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.62 99.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.33 -44.58 91.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.029 -0.419 . . . . 0.0 110.282 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.2 mt -69.35 -39.63 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.49 -39.22 93.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.88 96.12 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -107.5 65.79 0.65 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -82.92 59.34 4.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -77.34 151.65 34.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.64 -37.34 86.96 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.0 64.71 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.35 175.45 15.5 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -100.07 131.69 45.87 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 t -70.46 145.99 50.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.26 -40.65 96.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.85 -38.87 92.71 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.1 m -62.56 -37.33 85.75 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 88.8 mt -60.74 -48.65 87.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.792 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -72.17 -37.32 69.35 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.354 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.99 -41.2 97.58 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.49 -0.756 . . . . 0.0 109.944 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -61.7 -48.49 80.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.85 -45.4 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.083 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.27 -39.81 94.7 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.645 -0.659 . . . . 0.0 110.383 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 t -70.57 -41.98 71.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.887 -0.508 . . . . 0.0 111.72 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -92.87 -21.17 20.02 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.031 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -128.82 146.82 50.82 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -87.5 120.91 29.28 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.04 160.2 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.64 173.99 51.45 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.84 -40.12 83.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.91 -14.93 61.57 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.93 -35.62 81.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.62 -41.25 90.01 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -64.85 -39.9 94.29 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -67.07 -37.07 83.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.88 -41.71 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.63 -40.29 94.34 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.55 -39.84 88.76 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -64.81 -41.58 95.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.078 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.1 pt -70.11 -34.84 60.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.169 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.26 -39.79 89.7 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -64.57 -41.98 95.94 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.17 -39.36 94.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 50' ' ' ILE . 73.9 t -65.46 -40.36 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 m -61.09 -44.41 97.4 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.1 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.4 p -73.17 -16.35 61.43 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.749 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.71 65.51 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.13 -43.46 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.53 142.86 31.43 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 27.8 mtpp -84.68 150.83 24.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.504 HE21 HG11 ' A' ' 65' ' ' VAL . 64.4 tt0 -87.49 139.08 30.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.9 m -129.98 163.95 25.32 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 62' ' ' THR . 10.1 ptpp? -62.53 170.47 2.45 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.09 0.948 . . . . 0.0 110.602 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 29.51 62.97 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -66.67 119.16 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.16 -38.66 3.01 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.81 1.87 Allowed 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 m -107.46 -32.32 7.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.4 47.19 36.8 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.5 m -70.95 140.71 51.01 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.4 m-85 -130.31 147.32 52.01 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 69.9 mtp180 -115.15 149.05 38.22 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 CA--C 1.498 -1.044 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -68.53 -29.2 67.73 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 11' ' ' VAL . 84.4 p -63.23 -26.82 68.97 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.81 -42.2 97.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.18 -40.16 82.33 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.59 -43.22 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 7' ' ' SER . 53.0 t -62.18 -42.72 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.63 -42.02 98.3 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.4 93.17 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.97 -0.456 . . . . 0.0 110.244 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.51 -39.33 76.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.17 -37.76 86.49 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.1 85.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.04 79.19 1.82 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.265 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -83.25 58.73 4.62 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -66.05 151.54 46.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.66 -35.89 81.11 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.77 -5.57 46.46 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.84 170.1 35.41 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -95.46 130.67 42.19 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -67.99 151.02 47.74 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -61.69 -41.44 97.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.49 -38.73 92.25 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.7 t -62.37 -39.93 94.77 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.54 -48.83 86.86 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 O-C-N 122.005 -0.435 . . . . 0.0 110.09 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -72.67 -33.98 66.91 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.318 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -66.21 -40.68 90.52 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.42 -48.57 80.57 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.34 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.17 -41.94 96.91 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.77 -0.582 . . . . 0.0 110.457 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -69.46 -39.96 77.42 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.863 -0.523 . . . . 0.0 111.987 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -94.75 -21.21 18.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.569 -0.707 . . . . 0.0 111.826 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -128.62 143.38 50.94 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -77.44 128.1 33.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.81 158.23 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.64 -179.92 28.02 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.52 -31.87 69.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.14 -38.25 81.97 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.36 90.82 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.67 -40.44 92.11 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.31 -39.85 93.01 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -65.3 -39.06 92.02 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.17 -45.0 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.36 -42.1 99.14 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.34 -39.49 85.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -63.58 -43.69 96.25 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.21 -45.39 98.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.9 -39.98 95.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.917 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.76 -41.21 96.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.855 -0.528 . . . . 0.0 109.809 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.99 -39.72 95.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.8 t -65.4 -40.58 88.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -61.18 -41.7 97.26 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -70.22 -27.79 64.75 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.34 8.03 55.35 Favored Glycine 0 C--N 1.349 1.288 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.27 -43.36 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.87 143.8 28.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 87.0 mttt -84.68 150.95 24.79 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -86.76 151.65 23.2 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.4 m -142.35 164.36 30.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 62' ' ' THR . 64.9 pttt -60.59 167.9 2.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 122.01 0.91 . . . . 0.0 110.663 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.19 26.63 67.94 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.4 p -66.16 120.76 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.91 0.862 . . . . 0.0 108.832 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -38.82 2.95 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -61.9 1.84 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -107.79 -31.48 8.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.84 48.05 29.54 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -70.51 141.02 51.98 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 54' ' ' VAL . 72.1 m-85 -132.13 149.46 52.39 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 75.4 mtp180 -116.06 152.62 33.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.5 -0.958 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 CA--C 1.497 -1.067 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.36 -39.17 88.99 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.0 p -65.13 -38.68 91.43 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.836 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.51 -40.08 92.59 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.5 mtp -66.82 -40.49 88.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -64.39 -43.23 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 7' ' ' SER . 53.0 t -62.05 -43.43 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.85 98.35 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -63.98 -44.34 93.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 122.003 -0.436 . . . . 0.0 110.246 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.5 mt -68.93 -38.81 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.72 -40.39 97.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.81 96.86 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -106.63 65.37 0.67 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -81.63 57.62 3.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.34 148.12 43.76 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -63.59 -36.64 84.47 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.91 64.98 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.01 169.51 14.74 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 t -99.61 126.05 45.53 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -70.19 153.4 43.16 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -62.14 -41.39 98.22 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.6 -38.2 90.23 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.3 m -63.72 -38.28 90.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.6 mt -60.93 -49.78 83.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.66 -32.84 66.14 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.944 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -62.9 -45.31 93.1 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.815 -0.553 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 77.6 t80 -61.11 -47.89 84.17 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.46 -46.08 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.197 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.98 -39.56 93.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.518 -0.738 . . . . 0.0 110.29 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.39 -39.87 74.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.999 -0.438 . . . . 0.0 112.18 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -99.61 -13.59 19.33 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.13 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.36 148.84 52.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -87.14 118.56 26.62 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.91 157.96 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.01 177.27 35.21 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -39.29 87.61 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -63.79 -38.31 90.64 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.11 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.77 -40.37 92.32 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -65.28 -39.96 93.27 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.79 -38.2 88.34 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.54 -45.32 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.57 -41.24 98.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.98 -39.59 87.2 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.8 m -64.72 -40.75 95.88 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.2 mt -62.13 -45.33 98.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -64.02 -39.95 95.25 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.2 -40.97 99.0 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.21 -38.45 89.21 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.629 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.5 t -65.46 -40.64 88.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -60.78 -44.18 97.13 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.082 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.9 p -72.89 -16.72 61.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.773 -0.58 . . . . 0.0 109.725 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.86 7.6 64.32 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.5 -43.23 94.42 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.7 mt -99.43 146.78 25.95 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -86.1 151.9 23.31 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.16 136.26 33.12 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 63' ' ' LYS . 6.0 m -127.8 163.7 23.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 62' ' ' THR . 26.1 pttm -58.81 172.04 0.58 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.146 0.974 . . . . 0.0 110.845 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 32.18 57.33 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.73 119.47 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -37.94 3.29 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -63.3 1.42 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.1 p -108.75 -29.08 8.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.49 47.93 39.59 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.4 m -70.27 139.76 52.22 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 54' ' ' VAL . 65.6 m-85 -132.93 150.29 52.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -114.94 154.28 29.02 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -84.88 -10.77 56.79 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -136.94 83.28 28.9 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.41 -76.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.746 1.631 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -131.72 146.83 52.38 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -66.8 -38.48 86.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 11' ' ' VAL . 69.8 m -63.2 -39.54 94.92 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.34 -40.6 97.75 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.2 mtm -66.85 -40.12 87.8 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.23 -44.2 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 7' ' ' SER . 55.5 t -62.28 -43.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -41.57 97.39 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.27 -43.41 98.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 122.0 -0.438 . . . . 0.0 110.108 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.99 -39.65 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.16 -38.12 89.93 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.51 92.29 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -113.04 68.84 0.68 Allowed 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -84.0 57.13 4.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.88 158.52 34.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.44 -36.99 85.55 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.39 -7.72 53.84 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.57 -178.58 35.37 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.0 t -101.83 132.8 47.38 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -69.57 154.99 41.19 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -61.78 -42.57 99.17 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.16 -38.24 90.33 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.1 m -62.29 -38.2 88.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.141 -0.349 . . . . 0.0 110.279 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.451 HG21 HD11 ' A' ' 50' ' ' ILE . 84.9 mt -60.75 -49.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.88 -33.26 65.94 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.101 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.91 -46.55 87.25 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.921 -0.487 . . . . 0.0 109.764 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -61.41 -48.28 81.93 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.1 -45.76 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.96 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.93 -42.68 97.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.703 -0.623 . . . . 0.0 110.389 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -67.42 -42.05 83.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.983 -0.448 . . . . 0.0 111.826 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -93.99 -21.17 19.35 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.006 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.05 145.66 51.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.38 130.27 37.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.92 160.41 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.08 -178.47 18.73 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.209 -2.356 . . . . 0.0 107.209 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -65.15 -40.13 93.94 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.68 -38.98 92.86 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.0 93.35 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.9 -40.02 91.48 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.1 t -64.43 -41.57 96.51 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -64.79 -39.1 93.05 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.09 -45.46 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.52 -40.64 97.4 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.83 -43.36 88.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.8 m -63.99 -41.2 97.57 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.979 -0.45 . . . . 0.0 110.094 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 28' ' ' ILE . 88.7 mt -62.51 -44.2 99.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.02 -43.18 99.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.61 98.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.923 -0.486 . . . . 0.0 109.962 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.602 ' HB3' HD13 ' A' ' 59' ' ' LEU . 79.5 mt -62.13 -39.12 91.5 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.1 t -66.79 -40.02 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 m -61.13 -43.94 98.1 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -72.29 -16.82 61.9 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 121.818 -0.551 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.45 2.21 70.66 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -44.08 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 53' ' ' LEU . 4.2 mp -91.82 136.62 33.01 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 51.3 mttm -85.13 150.97 24.47 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -91.25 138.94 31.2 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -127.11 164.26 21.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 62' ' ' THR . 19.4 ptpt -61.77 173.31 1.04 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.132 0.967 . . . . 0.0 110.614 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.55 33.82 57.86 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.38 120.21 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.25 -38.29 3.15 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.86 -62.34 1.7 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.3 m -108.38 -33.72 7.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.48 47.68 33.79 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.8 m -70.68 141.52 51.61 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 54' ' ' VAL . 87.7 m-85 -131.27 149.04 52.73 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 73.0 mtp85 -117.46 153.48 33.04 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.0 tp -100.54 126.91 47.03 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.27 107.4 17.29 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.263 1.781 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.657 ' H1 ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -99.81 125.88 45.81 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.3 156.34 30.1 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -86.05 -66.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.921 1.748 . . . . 0.0 113.103 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.57 152.03 51.12 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 -37.88 89.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 11' ' ' VAL . 67.1 m -62.45 -39.39 93.19 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.82 -38.69 92.05 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.76 -41.62 95.74 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.43 -43.3 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 7' ' ' SER . 59.6 t -62.16 -43.02 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.06 98.26 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.32 92.05 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 121.913 -0.492 . . . . 0.0 110.291 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -63.48 -36.7 84.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.21 85.46 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.09 75.72 1.17 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -83.49 59.6 5.18 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -69.39 167.1 17.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.86 -38.0 89.11 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 6.46 33.25 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.9 -159.78 34.69 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.0 t -115.31 138.33 51.08 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 78.0 p -72.9 162.01 30.02 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -62.6 -41.82 99.2 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.49 -39.19 93.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.3 m -63.65 -39.25 93.86 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 122.05 -0.406 . . . . 0.0 110.009 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 50' ' ' ILE . 85.0 mt -61.55 -49.46 84.32 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.029 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.36 -32.64 66.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.925 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.59 -45.39 90.61 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.11 -48.36 82.0 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.62 -45.59 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.178 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.82 -41.15 97.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -69.73 -39.74 76.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.038 -0.414 . . . . 0.0 112.095 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -96.73 -17.99 19.94 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 121.487 -0.758 . . . . 0.0 112.085 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -129.21 147.6 51.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.657 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 62.8 mtpt -82.03 121.57 26.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.89 158.39 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.29 179.29 26.98 Favored Glycine 0 C--N 1.353 1.488 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.15 -39.85 90.11 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -64.22 -38.66 91.83 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.52 91.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -60.9 -39.94 91.21 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 m -65.14 -39.57 93.18 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -67.4 -37.72 83.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.81 -48.08 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 121.935 -0.478 . . . . 0.0 110.356 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -66.92 -31.15 71.55 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.188 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.92 -42.67 85.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.6 m -64.9 -40.64 95.41 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.511 HD11 HG21 ' A' ' 28' ' ' ILE . 89.7 mt -62.06 -44.61 99.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -43.05 99.63 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -63.21 -41.48 99.14 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.5 -39.71 95.17 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 121.705 -0.622 . . . . 0.0 109.375 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.631 HG21 ' CE2' ' A' ' 71' ' ' PHE . 74.1 t -65.0 -40.69 89.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -61.98 -40.86 97.07 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.9 m -69.98 -27.77 64.98 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 7.26 56.33 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.52 -43.12 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.0 mt -98.26 145.92 26.16 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.459 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 88.7 mttt -84.48 150.91 24.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -91.93 137.72 32.13 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.4 m -127.3 164.0 22.73 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -60.7 174.2 0.63 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.175 0.988 . . . . 0.0 110.813 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.77 33.02 58.45 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 120.16 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.45 -38.34 3.13 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -62.39 1.69 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 m -108.46 -33.13 7.15 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.09 47.84 28.95 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 72.7 m -70.73 141.01 51.53 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 54' ' ' VAL . 72.7 m-85 -132.39 147.32 52.38 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 90.8 mtt180 -114.01 154.49 27.56 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 tp -97.19 126.55 42.46 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -84.12 107.06 16.23 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.26 1.643 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 -179.946 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.676 ' H1 ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -99.14 122.56 42.52 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -154.92 156.13 31.0 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.28 -63.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.797 1.665 . . . . 0.0 113.192 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.02 151.99 51.42 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.6 -37.26 86.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 11' ' ' VAL . 68.6 m -61.99 -38.97 90.58 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.19 -40.33 97.2 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.3 mtm -65.7 -40.66 92.53 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 14' ' ' ILE . 60.1 mt -63.24 -43.75 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 7' ' ' SER . 55.8 t -60.59 -41.87 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.32 94.31 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.51 -38.7 91.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 73' ' ' LEU . 47.4 mm -66.0 -41.51 89.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.445 HE21 HG12 ' A' ' 11' ' ' VAL . 57.8 mt-30 -68.34 -24.68 64.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.96 90.97 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -122.36 81.22 1.81 Allowed 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -86.72 47.58 1.51 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.63 156.48 26.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -67.22 -19.17 65.5 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.68 -6.68 59.51 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.53 -175.63 39.21 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -106.01 132.97 51.46 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.8 150.8 46.48 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -62.45 -41.77 98.99 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -63.81 -39.43 94.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.31 -38.05 89.63 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 50' ' ' ILE . 84.3 mt -60.67 -48.42 88.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.021 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.85 -35.25 69.8 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.046 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -65.11 -40.69 94.9 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.613 -0.679 . . . . 0.0 109.664 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.52 -49.56 76.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.53 -43.07 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.15 -40.43 97.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.916 -0.49 . . . . 0.0 111.11 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.8 p -83.47 -16.54 45.32 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.369 -0.832 . . . . 0.0 112.032 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -106.41 -24.94 12.09 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 119.327 0.967 . . . . 0.0 110.27 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.34 149.62 51.05 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.676 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 88.1 tttt -83.0 120.47 25.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.05 157.19 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.63 -177.75 25.95 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.7 -41.78 91.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.12 -39.58 94.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.18 93.59 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.5 -42.32 96.12 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.4 m -65.52 -39.48 91.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -65.84 -36.27 82.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.84 -43.9 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -62.51 -40.21 96.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.72 -40.26 95.03 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -65.23 -41.69 94.13 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 28' ' ' ILE . 91.5 mt -63.05 -45.16 99.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.74 -39.35 94.08 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.91 -41.13 97.75 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.85 -39.51 94.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.514 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.4 t -65.77 -40.48 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.1 m -61.45 -41.45 97.24 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.3 m -70.23 -27.66 64.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.45 1.37 59.15 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.16 -42.77 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.94 139.7 30.97 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 88.2 mttt -84.84 151.08 24.57 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -101.31 138.14 38.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.7 m -123.14 164.21 19.09 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 62' ' ' THR . 14.8 ptmm? -60.43 174.8 0.51 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 122.181 0.991 . . . . 0.0 110.868 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.02 58.66 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 108.334 -1.907 . . . . 0.0 108.334 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.95 121.09 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.14 -38.99 2.88 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -62.22 1.75 Allowed 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -108.08 -34.54 6.85 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.67 48.06 37.43 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.0 m -70.27 138.91 51.99 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.7 m-85 -131.7 151.79 51.37 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 87.7 mtm180 -122.41 153.74 38.67 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HB2' HG21 ' A' ' 14' ' ' ILE . 63.8 tp -101.85 126.68 48.79 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.89 107.54 17.09 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.261 1.69 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.034 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -84.69 -10.93 56.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -136.9 83.19 29.36 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.62 -75.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.816 1.677 . . . . 0.0 112.915 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.2 148.71 52.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.49 -38.0 86.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 11' ' ' VAL . 48.3 t -62.34 -39.92 94.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.27 -41.27 98.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -67.27 -39.88 86.13 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 14' ' ' ILE . 54.4 mt -62.8 -43.39 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' SER . 59.3 t -60.49 -42.58 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.98 92.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.67 94.64 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.9 mm -65.33 -42.6 94.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.02 -37.7 88.49 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.52 93.75 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.96 67.56 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -89.44 59.33 4.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.51 161.57 18.51 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.78 -21.63 64.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.82 -7.46 57.89 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.4 177.76 38.64 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -97.63 132.37 43.35 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -71.35 148.59 46.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -61.63 -42.38 98.81 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.51 -38.55 91.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -66.63 -30.38 70.64 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 121.741 -0.599 . . . . 0.0 110.24 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.599 HG21 HD11 ' A' ' 50' ' ' ILE . 83.4 mt -63.29 -49.8 81.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.562 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -72.89 -33.44 66.03 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.624 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.0 -45.41 89.12 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -61.47 -48.48 80.94 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.33 -46.07 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.208 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.71 -41.4 96.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.75 -0.594 . . . . 0.0 110.294 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -70.06 -39.85 75.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.948 -0.47 . . . . 0.0 112.192 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -97.19 -15.24 20.97 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.981 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.44 146.76 52.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.43 119.6 25.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.5 161.52 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.83 167.01 52.47 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.57 -22.63 61.71 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -89.87 -1.96 58.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.24 59.31 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.44 -40.2 90.28 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 m -66.03 -40.3 90.9 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.73 -36.96 81.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.79 -43.63 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.49 -39.85 94.81 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.83 -40.86 95.87 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -64.41 -43.67 93.65 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.599 HD11 HG21 ' A' ' 28' ' ' ILE . 89.3 mt -62.71 -43.97 99.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.55 -42.31 98.65 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.95 -43.36 99.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.91 -39.75 95.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.419 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG21 ' CE2' ' A' ' 71' ' ' PHE . 75.2 t -64.78 -40.37 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -62.04 -41.82 98.52 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -69.86 -27.79 65.12 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.5 8.31 52.68 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.5 -44.65 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.83 143.16 26.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 33.5 tptt -91.78 151.0 20.81 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.04 137.35 35.08 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.6 m -128.41 164.0 23.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' H ' HG22 ' A' ' 62' ' ' THR . 19.3 ptpt -62.24 172.25 1.54 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.065 0.936 . . . . 0.0 110.578 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.15 34.97 57.71 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.51 119.22 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.24 -37.88 3.29 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.52 -62.08 1.78 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.06 -33.16 7.26 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.22 47.75 28.46 Favored Glycine 0 C--N 1.355 1.611 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -70.47 143.12 51.85 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.396 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 54' ' ' VAL . 95.5 m-85 -129.49 146.87 51.28 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 80.9 mtm180 -124.44 178.26 5.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 14' ' ' ILE . 93.4 mt -104.71 134.09 48.44 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.56 109.68 18.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.262 1.72 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.62 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -138.0 107.02 6.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -145.89 152.68 48.65 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.4 -55.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.626 1.551 . . . . 0.0 113.478 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -132.49 149.8 52.27 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -66.68 -36.49 82.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.3 p -62.24 -36.11 80.98 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.85 -40.23 94.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.02 -40.01 87.15 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.12 -44.09 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 7' ' ' SER . 60.7 t -62.46 -43.16 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.42 98.77 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.94 91.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 O-C-N 122.187 -0.321 . . . . 0.0 110.513 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.6 mt -69.12 -42.81 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.588 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.86 -19.9 61.89 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.526 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.5 97.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -113.52 77.41 1.05 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -83.64 59.93 5.42 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.61 163.04 25.82 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.75 -29.57 70.1 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.77 2.11 49.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.53 -165.36 35.29 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.4 t -107.86 137.13 46.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -72.57 157.16 38.1 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.66 -43.74 98.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.883 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.13 -26.9 65.12 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.718 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -65.88 -38.18 88.09 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.592 HG21 HD11 ' A' ' 50' ' ' ILE . 88.3 mt -61.04 -48.6 88.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.82 -36.92 67.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.793 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.53 -41.42 96.38 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.547 -0.721 . . . . 0.0 110.167 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -62.02 -48.72 79.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.61 -45.53 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.04 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -64.07 -41.91 97.17 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.549 -0.72 . . . . 0.0 110.318 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 t -69.0 -41.91 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.929 -0.482 . . . . 0.0 111.833 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.17 -20.38 20.53 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.091 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -128.75 147.87 50.81 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.62 ' H ' ' N ' ' A' ' 1' ' ' GLY . 88.1 tttt -85.99 119.51 26.37 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.62 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.15 171.39 48.26 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.25 -37.77 84.06 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -73.29 -12.15 60.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.2 62.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.07 -40.8 95.05 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -70.53 -35.6 73.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -66.6 -39.42 88.38 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.86 -44.08 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.14 -41.63 98.46 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.49 -40.08 92.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -64.16 -43.17 95.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.592 HD11 HG21 ' A' ' 28' ' ' ILE . 88.0 mt -62.15 -44.94 99.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.98 -39.79 95.77 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -64.32 -41.92 96.56 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -39.44 93.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.9 t -64.59 -40.01 87.58 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.6 m -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -72.28 -17.21 61.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.882 -0.512 . . . . 0.0 109.689 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.63 5.72 66.51 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.37 -43.89 94.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.6 143.24 30.07 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.04 149.9 23.02 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -87.08 139.7 30.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.1 m -128.21 164.19 23.07 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 62' ' ' THR . 22.8 ptmt -61.22 174.39 0.7 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.056 0.931 . . . . 0.0 110.632 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.4 58.52 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.98 119.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.81 -38.12 3.22 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.01 -62.98 1.5 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.9 p -109.01 -29.35 8.61 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.25 47.72 56.8 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -70.53 143.75 51.54 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 54' ' ' VAL . 94.8 m-85 -129.82 145.92 51.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -109.87 150.67 28.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.41 126.08 45.24 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.28 107.91 18.16 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.264 1.824 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.994 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.31 170.78 21.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -155.2 157.87 31.88 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -84.99 -70.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.794 1.663 . . . . 0.0 112.941 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.98 147.51 52.46 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -66.92 -36.25 81.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.519 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.1 p -62.89 -37.29 86.35 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.18 -39.46 92.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.4 mtp -65.89 -41.23 91.77 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.19 -43.89 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 7' ' ' SER . 56.5 t -62.09 -43.38 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.24 98.2 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -63.92 -43.17 96.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 122.035 -0.416 . . . . 0.0 110.331 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.2 mt -68.58 -39.62 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.9 -38.42 91.0 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.76 94.87 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -104.01 65.38 0.8 Allowed 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.22 45.34 0.74 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -68.01 149.65 49.45 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.99 -37.09 85.78 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -21.5 64.89 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.54 175.76 19.2 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -101.8 126.73 48.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -69.94 154.32 42.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -61.9 -41.42 97.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.23 -38.61 91.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -61.93 -37.51 84.95 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.512 HG21 HD11 ' A' ' 50' ' ' ILE . 82.2 mt -60.43 -48.74 87.15 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.93 -34.41 66.56 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.492 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.89 -41.48 97.71 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.444 -0.785 . . . . 0.0 110.038 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 76.8 t80 -61.87 -48.02 82.4 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.72 -45.04 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.002 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.07 -40.07 95.46 Favored 'General case' 0 CA--C 1.511 -0.542 0 O-C-N 121.67 -0.644 . . . . 0.0 110.367 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 t -70.41 -42.05 72.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 122.028 -0.42 . . . . 0.0 111.795 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -96.73 -14.35 22.07 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.568 -0.708 . . . . 0.0 112.135 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.67 151.03 50.73 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.6 121.6 31.95 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.36 158.41 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.02 175.73 36.87 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.43 -39.86 85.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -66.75 -28.39 68.37 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.14 68.8 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.3 -40.56 94.62 Favored 'General case' 0 C--N 1.353 0.717 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.0 m -66.37 -40.03 89.49 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -65.15 -39.89 93.63 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.29 -45.84 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.01 -41.47 99.58 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -66.43 -39.49 88.95 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.95 -41.84 95.15 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 28' ' ' ILE . 89.4 mt -63.04 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.69 -42.32 99.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -42.46 99.57 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.1 -40.24 95.8 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 121.775 -0.578 . . . . 0.0 109.547 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.3 t -65.62 -40.8 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.4 m -62.08 -40.91 97.42 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -69.77 -27.64 65.1 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.09 7.77 54.58 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.16 -43.92 91.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.66 147.38 23.36 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -90.43 148.8 22.56 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.65 151.03 26.47 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -141.85 164.14 30.99 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -63.27 172.53 1.88 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 122.036 0.922 . . . . 0.0 110.762 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.27 34.32 58.02 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.41 119.44 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.13 3.2 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.2 1.74 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.3 m -107.74 -32.18 7.74 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.68 47.64 32.61 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -70.53 140.92 51.92 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 54' ' ' VAL . 81.9 m-85 -131.55 149.07 52.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 81.5 mtm180 -124.87 177.39 6.05 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.67 133.52 52.65 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.09 108.54 17.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp . . . . . 0 C--O 1.262 1.742 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.52 -41.34 93.26 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -149.16 155.92 40.02 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.02 -64.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.719 1.613 . . . . 0.0 113.319 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.96 149.84 52.32 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -66.64 -35.93 81.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.7 p -62.53 -36.62 83.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.22 -39.24 92.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.2 mtp -66.07 -40.86 91.23 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.32 -42.94 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 7' ' ' SER . 56.2 t -61.86 -42.54 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.02 98.05 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.103 -0.373 . . . . 0.0 110.123 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.05 94.08 Favored 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 122.061 -0.399 . . . . 0.0 110.172 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.42 -38.08 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -61.57 -36.9 81.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.84 89.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -114.56 69.32 0.71 Allowed 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -82.96 57.95 4.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -80.8 165.73 21.62 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.32 -36.6 84.64 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -8.82 57.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.9 -163.82 33.66 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.1 m -115.97 141.06 48.61 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.6 m -72.87 155.52 39.81 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.59 -42.38 98.78 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -62.9 -38.64 91.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -62.35 -39.65 93.8 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 50' ' ' ILE . 84.2 mt -60.56 -49.52 84.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.954 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.65 -33.18 66.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.938 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -64.09 -45.41 88.82 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.959 -0.463 . . . . 0.0 109.768 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -61.17 -48.34 82.04 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.14 -45.86 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.094 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.72 -41.95 95.61 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 121.68 -0.637 . . . . 0.0 110.407 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -69.05 -42.07 76.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.916 -0.49 . . . . 0.0 111.942 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -94.69 -16.64 22.94 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.526 -0.734 . . . . 0.0 112.138 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.46 147.65 52.18 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.61 120.82 25.56 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.88 157.79 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.58 -179.1 24.78 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.64 -41.3 92.77 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.61 -38.92 92.96 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.86 92.65 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.03 -39.94 91.7 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.1 m -64.72 -39.97 94.54 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.19 -36.6 82.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.36 -45.88 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.34 -40.65 97.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.5 tp -63.63 -44.3 94.28 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -63.4 -43.07 98.62 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 28' ' ' ILE . 89.4 mt -61.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.84 -40.14 95.88 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -63.71 -42.29 97.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.27 -40.51 96.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.594 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.1 t -65.48 -40.92 89.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.0 m -61.97 -41.12 97.64 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.7 m -70.08 -27.61 64.75 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.93 8.53 55.43 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.12 -43.5 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.92 143.84 28.77 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 84.3 mttt -85.4 151.17 24.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -94.87 135.11 36.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.2 m -119.56 164.46 15.79 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' H ' HG22 ' A' ' 62' ' ' THR . 22.2 ptmt -59.24 175.17 0.33 Allowed 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.095 0.95 . . . . 0.0 110.982 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.26 35.08 53.66 Favored Glycine 0 C--N 1.357 1.741 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.79 119.89 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.1 -38.12 3.2 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -62.37 1.69 Allowed 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.1 m -108.48 -35.1 6.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.5 47.86 32.67 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 64.4 m -70.58 143.46 51.54 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.594 ' CE2' HG21 ' A' ' 54' ' ' VAL . 85.2 m-85 -130.81 151.42 51.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -122.0 164.92 16.83 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.03 132.32 44.42 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -89.8 108.74 19.87 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.262 1.723 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.095 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.71 106.56 18.55 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.626 ' CE1' HG12 ' A' ' 38' ' ' VAL . 49.9 m170 -118.64 92.58 44.37 Favored Pre-proline 0 CA--C 1.503 -0.848 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.89 -33.31 20.5 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 121.187 1.258 . . . . 0.0 112.875 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.81 100.37 4.9 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -67.83 -34.74 77.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.4 m -61.43 -38.13 86.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.08 -43.64 98.4 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -39.9 89.96 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.7 -44.79 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 7' ' ' SER . 64.3 t -63.17 -42.26 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.23 -42.77 99.19 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.25 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.51 -39.86 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -64.73 -37.62 88.22 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.493 -0.755 . . . . 0.0 109.017 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.63 91.67 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -106.96 68.84 0.74 Allowed 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -79.98 51.79 1.4 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -70.02 147.95 49.44 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -61.97 -37.65 85.59 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.44 -9.41 58.5 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.87 169.89 28.61 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 t -95.34 128.91 42.57 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -71.29 157.16 38.6 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -60.8 -42.57 97.87 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -63.15 -39.27 94.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.2 m -63.46 -39.03 93.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 50' ' ' ILE . 82.8 mt -61.04 -49.4 84.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -72.71 -32.89 66.06 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.131 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.66 -45.65 93.13 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.833 -0.542 . . . . 0.0 109.687 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.29 -48.2 82.48 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.99 -45.02 99.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.17 -39.59 94.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.486 -0.759 . . . . 0.0 110.211 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.36 -39.93 74.33 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 122.001 -0.437 . . . . 0.0 112.075 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -98.25 -16.94 19.21 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.841 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.09 147.4 52.61 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -84.52 121.52 27.71 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.626 HG12 ' CE1' ' A' ' 3' ' ' HIS . 33.2 m -133.0 159.49 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.54 179.44 26.7 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.09 -40.85 91.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.36 -38.57 91.66 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.76 91.42 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.89 -39.68 90.17 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.11 -40.38 94.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.69 -37.01 81.71 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -45.36 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -62.98 -40.18 96.95 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.29 -44.19 92.44 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.1 t -63.27 -42.81 99.16 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 28' ' ' ILE . 89.3 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.21 -42.65 99.49 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.56 -42.12 99.34 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.7 -40.71 97.46 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.808 -0.557 . . . . 0.0 109.574 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.661 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.0 t -66.0 -40.71 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.4 m -62.04 -40.97 97.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.1 m -69.86 -27.64 65.0 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.76 8.33 54.46 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.17 -43.49 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -98.29 144.82 27.3 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.517 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 83.7 mttt -84.73 151.1 24.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -87.87 137.58 32.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.0 m -127.59 164.49 21.89 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.51 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -60.51 173.5 0.7 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 122.09 0.948 . . . . 0.0 110.509 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.15 32.97 57.75 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.7 119.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -37.81 3.32 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.92 -63.07 1.47 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.9 p -109.32 -30.49 7.96 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 48.0 37.95 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.1 m -70.46 143.05 51.89 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.661 ' CE2' HG21 ' A' ' 54' ' ' VAL . 73.3 m-85 -132.18 149.57 52.36 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -118.9 165.4 14.11 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -99.66 133.37 44.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -89.86 109.24 20.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.262 1.742 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -93.68 -2.04 54.44 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -134.0 84.38 43.26 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -85.55 -79.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.674 1.582 . . . . 0.0 112.86 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -132.24 147.85 52.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -67.0 -36.4 82.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.2 p -63.08 -36.33 83.22 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.08 -40.35 94.52 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -66.66 -40.4 88.62 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 14' ' ' ILE . 53.7 mt -63.66 -43.5 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 7' ' ' SER . 54.6 t -60.5 -42.4 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.24 93.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.09 -39.36 93.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.559 HG21 ' HG ' ' A' ' 73' ' ' LEU . 50.0 mm -65.8 -44.0 93.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.21 -35.75 81.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.65 88.45 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -116.11 71.56 0.79 Allowed 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -86.82 58.99 5.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -80.51 162.12 24.5 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.9 -27.68 66.86 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -1.73 47.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -177.59 37.62 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 t -98.93 129.44 45.26 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -70.44 150.72 45.93 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -61.75 -43.53 98.68 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.318 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.09 -38.97 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 m -63.26 -38.12 89.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.473 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 87.6 mt -61.37 -49.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 121.975 -0.453 . . . . 0.0 110.331 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.9 -33.86 68.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.076 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.28 -40.85 86.17 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.92 -49.07 77.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.63 -44.99 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.849 -0.532 . . . . 0.0 110.408 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -69.08 -39.66 78.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.808 -0.558 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.08 -20.19 18.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.966 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.8 146.27 51.54 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -75.27 135.1 40.96 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.48 160.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 42' ' ' ALA . . . -117.48 -178.63 17.54 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.03 -40.27 94.59 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -65.1 -39.43 93.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 39' ' ' GLY . . . -62.82 -38.76 91.98 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.01 -40.65 94.36 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 95.1 p -69.55 -34.84 74.79 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -68.39 -36.12 78.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.77 -44.73 99.22 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.87 -39.89 95.81 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.92 -42.34 85.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -62.7 -44.92 94.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 122.202 -0.311 . . . . 0.0 110.59 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 pt -67.48 -34.24 67.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.925 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.95 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.5 -39.43 93.49 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 50' ' ' ILE . 73.9 t -65.76 -40.69 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.2 m -61.42 -44.34 97.3 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.099 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.2 p -73.0 -15.92 61.52 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 121.898 -0.501 . . . . 0.0 109.835 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.67 6.18 66.01 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.09 -43.83 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.67 138.08 35.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.638 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 55.1 mtpt -87.82 151.97 22.46 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -83.98 135.46 34.44 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.6 m -127.14 164.15 22.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' H ' HG22 ' A' ' 62' ' ' THR . 64.8 pttt -60.15 172.5 0.8 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.109 0.957 . . . . 0.0 110.671 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.22 33.09 57.42 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.56 119.11 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.93 -37.87 3.31 Favored Glycine 0 C--N 1.351 1.395 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.9 -62.97 1.5 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.7 p -108.96 -30.3 8.16 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.36 47.75 49.5 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.8 m -70.19 144.58 51.89 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.583 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.41 ' CE2' HG21 ' A' ' 54' ' ' VAL . 85.4 m-85 -130.07 148.92 51.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 80.7 mtm180 -120.07 169.75 9.92 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.559 ' HG ' HG21 ' A' ' 14' ' ' ILE . 95.4 mt -100.06 134.8 42.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.638 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -94.89 109.41 21.41 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 tptm . . . . . 0 C--O 1.26 1.648 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.88 -39.12 93.05 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -136.05 84.08 31.95 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.43 -73.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 121.866 1.711 . . . . 0.0 112.915 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -131.05 146.03 52.23 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -66.63 -38.3 86.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 11' ' ' VAL . 70.0 m -63.29 -40.57 97.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.91 -39.92 95.3 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mtp -66.37 -40.49 89.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.03 -43.73 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 7' ' ' SER . 63.6 t -62.49 -41.48 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.33 98.33 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.14 97.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.72 -40.49 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.95 -36.54 84.72 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.521 -0.737 . . . . 0.0 109.431 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.97 90.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -121.67 73.67 1.08 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -84.68 57.69 4.5 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -66.11 148.41 51.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -62.16 -38.52 89.34 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.87 65.61 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.14 170.58 14.36 Favored Glycine 0 CA--C 1.493 -1.314 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.5 m -97.77 130.48 44.71 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -69.24 146.45 52.31 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -61.46 -40.57 94.99 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.74 -38.47 91.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -61.78 -39.88 93.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.09 -48.89 86.99 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.082 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.42 -34.87 68.14 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.409 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -66.56 -40.65 89.11 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.551 -0.718 . . . . 0.0 110.171 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.71 -48.68 79.66 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.28 -45.75 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.42 -41.77 96.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.744 -0.597 . . . . 0.0 110.448 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.0 m -70.22 -39.88 74.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.962 -0.461 . . . . 0.0 112.128 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -96.33 -16.75 21.13 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.873 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -131.35 147.64 52.59 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -84.23 121.43 27.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.83 156.41 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.89 179.62 34.14 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.1 -41.67 90.29 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.79 -39.02 93.25 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.63 91.88 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -60.91 -42.63 98.43 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -65.14 -39.19 92.68 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.38 -38.39 90.87 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.45 -45.02 99.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.27 -41.85 98.82 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.9 tp -66.57 -41.96 87.76 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -62.5 -42.76 99.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.58 -45.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -63.89 -40.51 96.7 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -62.94 -41.74 99.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.87 -39.27 93.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG21 ' CE2' ' A' ' 71' ' ' PHE . 76.5 t -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.8 m -61.5 -41.09 96.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.4 m -70.05 -27.94 65.06 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 7.58 56.58 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.38 -43.24 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.17 146.19 26.41 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.511 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 87.0 mttt -84.66 150.75 24.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -91.43 138.41 31.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 63' ' ' LYS . 5.0 m -128.02 163.65 24.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 62' ' ' THR . 22.4 ptmt -61.27 171.53 1.34 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.063 0.935 . . . . 0.0 110.574 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.22 23.89 64.86 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.88 120.61 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.595 0.712 . . . . 0.0 109.146 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.24 -38.92 2.91 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.41 -62.4 1.7 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -108.6 -33.47 7.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.22 20.4 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.9 m -70.25 140.87 52.48 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 54' ' ' VAL . 71.3 m-85 -131.22 149.67 52.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 16.7 mmm180 -117.68 158.04 25.39 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp -99.0 126.7 44.75 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.511 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -84.71 107.5 16.93 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.26 1.636 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -68.15 -39.21 82.7 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -131.8 82.44 60.3 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.69 -33.59 12.83 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.5 1.466 . . . . 0.0 113.397 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.41 123.66 27.14 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -68.22 -37.31 80.71 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.514 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.7 p -63.59 -34.69 78.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.7 -42.79 95.05 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.46 -41.03 93.84 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 14' ' ' ILE . 64.4 mt -63.14 -44.41 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 7' ' ' SER . 57.7 t -60.37 -43.08 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.36 95.05 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.62 -39.05 93.03 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' ILE . 50.8 mm -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.26 -27.37 64.38 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.111 -0.368 . . . . 0.0 110.079 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.16 95.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.84 75.08 0.97 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -85.68 59.45 5.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -79.6 152.89 29.8 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.36 -37.27 86.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.06 64.66 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 173.92 16.49 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.5 p -96.16 137.56 35.05 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.5 p -77.34 159.69 29.35 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -65.32 -39.96 93.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -63.3 -39.67 95.23 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -61.95 -39.87 93.58 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.642 HG21 HD11 ' A' ' 50' ' ' ILE . 85.8 mt -60.82 -49.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.201 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.52 -33.74 67.11 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.001 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.61 -46.11 89.77 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.85 -48.81 78.85 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.57 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.172 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.77 -18.15 62.77 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.0 m -89.17 -35.75 16.06 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 110.501 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -100.88 -12.2 19.18 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.74 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 152.06 51.61 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 124.66 31.62 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.9 m -137.01 160.41 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.72 -178.07 19.29 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.93 -41.65 95.34 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -63.85 -38.84 92.57 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -38.81 92.38 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.73 -39.95 90.53 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.2 t -64.72 -41.64 95.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -64.72 -38.49 91.18 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.67 -45.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -62.33 -41.8 98.85 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.54 -39.42 88.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -64.9 -40.96 95.91 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 28' ' ' ILE . 87.4 mt -62.57 -44.82 99.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.44 -39.34 94.23 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.1 -40.95 97.33 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.75 -39.65 94.78 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.0 t -65.21 -40.72 89.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.6 m -61.42 -41.63 97.47 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -70.33 -27.74 64.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.67 56.28 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.21 -43.33 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.71 146.14 31.16 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.556 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 88.9 mttt -84.72 150.61 24.98 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.09 137.29 34.35 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.0 m -122.96 164.01 19.31 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' H ' HG22 ' A' ' 62' ' ' THR . 19.4 ptpt -61.0 174.09 0.69 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.1 0.952 . . . . 0.0 110.627 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.8 33.1 58.29 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.38 120.12 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.78 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.96 -62.53 1.64 Allowed 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -108.44 -34.14 6.86 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.41 48.42 24.18 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.6 m -70.86 141.84 51.23 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 54' ' ' VAL . 93.9 m-85 -130.98 148.74 52.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 66.7 mtp180 -118.09 158.14 25.57 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HB2' HG21 ' A' ' 14' ' ' ILE . 59.7 tp -97.79 126.78 43.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -85.04 107.9 17.37 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.261 1.663 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.17 -40.16 95.52 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -160.25 152.51 17.2 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.5 -45.24 0.43 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.614 1.542 . . . . 0.0 114.462 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.01 136.17 45.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -68.19 -37.33 80.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.7 m -62.42 -38.92 91.59 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.14 -41.36 99.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.4 mmt -66.47 -40.38 89.31 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 14' ' ' ILE . 57.1 mt -63.29 -43.48 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' SER . 53.8 t -60.71 -42.22 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.78 94.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 73' ' ' LEU . 48.1 mm -67.51 -41.66 86.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -62.95 -36.94 85.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.979 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.57 84.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -132.76 82.06 1.98 Allowed 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.024 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.03 58.28 4.33 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.33 148.47 51.61 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.23 -36.4 83.53 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -5.65 44.85 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.51 167.18 27.56 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -86.72 133.34 33.68 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.3 t -69.09 147.61 51.22 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -61.09 -41.45 96.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.56 -38.31 90.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.9 m -63.05 -38.39 90.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 122.057 -0.402 . . . . 0.0 110.199 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.629 HG21 HD11 ' A' ' 50' ' ' ILE . 86.5 mt -60.96 -49.73 83.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.717 0 O-C-N 121.937 -0.477 . . . . 0.0 110.017 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -72.73 -34.06 66.81 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.769 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.25 -45.37 91.87 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.09 -49.13 78.57 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.74 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.169 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -65.43 -41.43 93.54 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.689 -0.632 . . . . 0.0 110.593 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.5 m -69.36 -39.98 77.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 112.026 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -97.18 -15.79 20.72 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.447 -0.783 . . . . 0.0 111.657 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -133.47 147.19 51.66 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -81.96 126.61 32.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.97 157.32 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.27 176.5 34.24 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.49 -41.56 88.75 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -63.95 -38.97 93.03 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.36 94.52 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' HA ' HD12 ' A' ' 46' ' ' ILE . 36.6 t70 -60.82 -42.12 97.07 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.2 m -65.59 -39.54 91.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -66.85 -34.0 76.84 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 43' ' ' ASP . 80.6 mt -60.49 -43.53 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -62.1 -40.57 96.32 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.29 -39.78 89.58 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.4 m -64.5 -41.73 96.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.629 HD11 HG21 ' A' ' 28' ' ' ILE . 90.1 mt -63.16 -44.2 99.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -62.35 -42.95 99.8 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -62.45 -42.52 99.52 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 59' ' ' LEU . 80.0 mt -63.57 -39.55 94.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.6 t -66.72 -40.55 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.8 m -61.76 -43.57 98.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.068 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -72.44 -15.93 61.82 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 121.782 -0.574 . . . . 0.0 109.72 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.55 2.94 69.49 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.28 -44.3 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 53' ' ' LEU . 3.5 mp -97.12 143.53 27.84 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 88.2 mttt -84.85 150.65 24.85 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -96.27 138.37 33.98 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.4 m -123.7 164.39 19.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 62' ' ' THR . 65.0 pttt -63.09 174.92 0.99 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.115 0.959 . . . . 0.0 110.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.22 33.55 59.0 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.2 t -70.55 120.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -38.28 3.16 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.02 -62.32 1.71 Allowed 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -108.46 -34.62 6.71 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.53 47.88 25.8 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 62' ' ' THR . 60.8 m -70.61 141.5 51.75 Favored 'General case' 0 C--N 1.358 0.963 0 CA-C-N 118.109 0.954 . . . . 0.0 108.464 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.3 m-85 -131.85 150.02 52.28 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.417 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 88.6 mtm180 -122.25 155.57 35.61 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.613 ' HB2' HG21 ' A' ' 14' ' ' ILE . 62.9 tp -103.25 127.07 50.68 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -82.69 107.69 15.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.9 pttt . . . . . 0 C--O 1.261 1.694 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.22 -39.47 94.04 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -156.61 156.75 30.4 Favored Pre-proline 0 N--CA 1.438 -1.052 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.13 -70.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 121.741 1.627 . . . . 0.0 113.103 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.82 144.79 51.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -67.36 -37.45 83.23 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.7 m -62.52 -39.11 92.5 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.62 -43.17 97.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.8 mtm -65.58 -39.96 92.19 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' O ' HG12 ' A' ' 14' ' ' ILE . 61.4 mt -62.36 -44.16 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 7' ' ' SER . 58.1 t -60.82 -42.5 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.56 91.83 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.95 95.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.613 HG21 ' HG ' ' A' ' 73' ' ' LEU . 39.7 mm -69.39 -41.56 80.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.01 -39.23 93.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -40.92 93.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.74 71.24 0.88 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.78 58.52 5.11 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.14 164.2 25.88 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.01 -38.76 92.47 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.25 -4.49 42.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.4 -171.75 35.44 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 t -105.47 132.06 52.11 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -69.5 155.15 40.92 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -61.02 -43.07 99.44 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.98 -39.14 93.46 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.6 m -62.98 -38.53 91.49 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 50' ' ' ILE . 85.3 mt -60.66 -49.83 82.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 O-C-N 121.987 -0.445 . . . . 0.0 110.187 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.91 -33.01 65.73 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.084 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.28 -44.64 94.52 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.24 -48.73 80.14 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.08 -45.11 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.199 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -64.29 -40.39 95.86 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.861 -0.525 . . . . 0.0 111.398 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -83.73 -14.79 50.76 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.568 -0.707 . . . . 0.0 112.358 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -111.39 -20.71 12.15 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 119.538 1.063 . . . . 0.0 110.651 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -129.75 149.02 51.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.92 121.11 25.6 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.17 161.44 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.57 170.08 51.6 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.31 -37.75 83.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -80.58 0.31 34.51 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.22 63.27 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -40.07 89.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -66.61 -39.96 88.59 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -66.14 -39.74 90.08 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.38 -45.35 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -62.71 -40.46 97.21 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.39 -42.88 92.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.5 t -63.13 -43.71 97.65 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.657 HD11 HG21 ' A' ' 28' ' ' ILE . 87.7 mt -62.28 -43.78 98.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -61.1 -43.01 99.54 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.55 -41.16 98.45 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.38 -39.16 92.29 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.7 t -66.69 -39.73 84.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 m -60.98 -44.34 97.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.006 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 p -72.58 -16.94 61.74 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 109.55 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.99 70.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -65.5 -44.75 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.25 149.3 24.67 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 84.8 tttt -97.16 142.27 29.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.416 HE21 HG21 ' A' ' 65' ' ' VAL . 63.0 tt0 -81.61 139.53 34.97 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.3 m -131.15 163.87 26.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -63.9 175.47 1.17 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.982 0.896 . . . . 0.0 110.588 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.23 31.47 59.37 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG21 HE21 ' A' ' 61' ' ' GLN . 99.0 t -70.25 119.45 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.01 -38.06 3.25 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.11 -63.45 1.39 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 p -109.28 -29.54 8.43 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.88 38.62 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -70.6 143.14 51.61 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 54' ' ' VAL . 96.3 m-85 -132.45 149.74 52.28 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 72.3 mtp180 -127.27 177.52 6.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.613 ' HG ' HG21 ' A' ' 14' ' ' ILE . 93.3 mt -110.87 127.45 55.44 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 109.27 19.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.262 1.712 0 CA-C-O 117.956 -1.021 . . . . 0.0 108.586 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -84.91 -10.37 57.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -153.06 156.85 32.97 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.0 -69.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.649 1.566 . . . . 0.0 113.279 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -132.14 148.65 52.49 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 -35.34 79.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.1 p -62.5 -37.19 85.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 97.4 mtp -66.81 -40.21 87.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 7' ' ' SER . 59.1 t -61.63 -43.02 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.3 98.8 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -64.01 -44.68 91.89 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 122.085 -0.384 . . . . 0.0 110.401 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.23 -39.74 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -63.26 -38.62 91.88 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.62 93.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.12 67.48 0.65 Allowed 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -83.98 58.35 4.66 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -73.12 155.13 39.99 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -67.27 -19.99 65.58 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.01 -2.74 58.59 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 177.7 41.43 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -105.4 130.93 53.39 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 m -68.94 153.56 43.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -62.21 -41.4 98.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.98 -38.49 91.27 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.7 m -61.97 -37.81 86.18 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.609 HG21 HD11 ' A' ' 50' ' ' ILE . 86.0 mt -60.66 -48.6 87.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -73.13 -37.13 66.75 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.487 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.1 -40.43 96.2 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.575 -0.703 . . . . 0.0 110.273 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.402 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 78.7 t80 -61.65 -48.52 80.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.0 mt -62.86 -44.95 99.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.165 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.49 -38.56 91.46 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 121.747 -0.596 . . . . 0.0 111.55 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.0 p -86.38 -15.34 40.7 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.485 -0.76 . . . . 0.0 112.256 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -110.48 -20.03 12.72 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 119.373 0.988 . . . . 0.0 110.465 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.42 150.15 52.26 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -86.24 118.38 25.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.85 161.69 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.22 167.41 50.83 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.87 -19.14 61.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -90.94 -1.61 57.81 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.47 -25.6 62.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.42 -39.01 85.88 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.6 t -63.79 -43.57 95.93 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -68.34 -37.84 80.92 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.34 -46.36 96.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.27 -39.91 95.92 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.94 -44.87 94.88 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -64.94 -41.74 95.25 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.609 HD11 HG21 ' A' ' 28' ' ' ILE . 87.0 mt -62.61 -44.46 99.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.66 -43.44 98.85 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -63.58 -41.97 98.32 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.31 -39.43 92.99 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' CE2' ' A' ' 71' ' ' PHE . 73.4 t -65.09 -39.84 86.92 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.2 m -60.91 -42.83 98.82 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -70.22 -27.88 64.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.51 8.94 54.16 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.68 -43.35 93.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.01 142.96 29.08 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.577 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 26.0 mtpp -88.18 151.55 22.61 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -85.85 138.39 32.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.5 m -128.68 164.09 23.69 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 62' ' ' THR . 22.9 ptmt -61.01 174.1 0.69 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.062 0.934 . . . . 0.0 110.572 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.98 32.9 58.19 Favored Glycine 0 C--N 1.357 1.712 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.69 119.15 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -37.92 3.29 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.73 -63.03 1.48 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 p -108.92 -29.88 8.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.06 47.85 43.44 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.1 m -70.33 142.51 52.19 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CE2' HG21 ' A' ' 54' ' ' VAL . 89.5 m-85 -130.98 149.44 52.6 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -119.27 164.95 14.89 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.64 132.54 44.91 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.577 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -89.31 110.27 21.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm . . . . . 0 C--O 1.261 1.686 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.847 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.2 t0 61.66 44.19 9.15 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -150.76 155.66 35.77 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -85.45 -79.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.688 1.592 . . . . 0.0 112.64 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -132.34 143.77 50.09 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -67.53 -35.54 79.29 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.3 m -61.82 -38.7 89.13 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.45 -40.99 98.39 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.4 mtt -67.02 -40.23 87.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.67 -43.35 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 7' ' ' SER . 59.1 t -62.43 -43.57 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.0 98.71 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.74 -44.58 93.08 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 122.043 -0.411 . . . . 0.0 110.161 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.14 -39.89 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -63.6 -39.4 94.27 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.82 96.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -105.88 63.8 0.68 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -86.28 59.78 5.84 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -80.99 168.36 18.79 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -64.63 -36.89 85.71 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.64 -5.29 49.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.47 -167.83 32.88 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.7 t -107.21 131.63 53.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -71.6 158.24 36.54 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -60.61 -44.84 95.84 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -64.82 -37.7 88.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.9 m -62.87 -38.43 90.82 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 122.275 -0.266 . . . . 0.0 110.646 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 50' ' ' ILE . 88.2 mt -61.17 -49.95 82.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.232 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -73.11 -33.13 65.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.004 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.28 -45.84 89.58 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -61.36 -48.41 81.41 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.16 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.894 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.49 -41.45 96.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.655 -0.653 . . . . 0.0 110.313 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.89 -39.87 76.0 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.934 -0.479 . . . . 0.0 112.066 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -97.09 -16.42 20.52 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.959 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.59 147.08 52.23 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -81.1 121.92 26.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.13 157.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -103.82 -179.93 25.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -65.97 -39.77 90.66 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -64.4 -39.31 93.6 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.64 91.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.77 -40.21 91.67 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.9 p -68.04 -35.88 78.98 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -68.83 -35.72 77.31 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.88 -44.24 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.79 -40.54 97.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.08 -40.85 91.15 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -64.4 -43.42 94.48 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 28' ' ' ILE . 90.5 mt -61.73 -44.77 99.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.87 -43.82 98.08 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.82 -41.95 97.76 Favored 'General case' 0 CA--C 1.505 -0.774 0 O-C-N 121.895 -0.503 . . . . 0.0 110.089 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.99 -39.97 94.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.655 -0.653 . . . . 0.0 109.428 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG21 ' CE2' ' A' ' 71' ' ' PHE . 76.2 t -65.26 -40.02 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 m -61.16 -43.55 98.71 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.827 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.409 ' OG1' HG23 ' A' ' 58' ' ' VAL . 60.0 p -72.29 -17.19 61.89 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.845 -0.535 . . . . 0.0 109.742 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.02 7.41 65.93 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' OG1' ' A' ' 56' ' ' THR . 53.3 t -65.4 -42.96 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.1 mt -97.64 143.68 28.06 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 151.86 21.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -90.39 134.5 34.3 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.7 m -121.82 164.16 17.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' H ' HG22 ' A' ' 62' ' ' THR . 22.8 ptmt -58.83 174.79 0.32 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.109 0.956 . . . . 0.0 111.042 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.63 53.38 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.9 119.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.48 -38.14 3.2 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.02 1.8 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -108.34 -34.43 6.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.08 47.23 38.87 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.1 m -71.04 142.85 50.89 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 54' ' ' VAL . 86.5 m-85 -131.3 151.37 51.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -120.57 168.89 10.88 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.7 139.23 35.66 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.87 19.82 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.263 1.792 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 60.01 39.97 19.3 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -132.03 85.86 49.02 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -85.63 -79.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.746 1.63 . . . . 0.0 113.064 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.09 147.71 52.45 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -66.15 -39.22 89.64 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.0 p -64.71 -36.57 84.7 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.48 -42.74 91.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.4 ' HB3' HG12 ' A' ' 32' ' ' ILE . 78.1 mtm -65.93 -39.5 90.56 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.83 -43.53 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 7' ' ' SER . 58.9 t -61.91 -43.92 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.6 98.88 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.68 93.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.146 -0.346 . . . . 0.0 110.142 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.69 -40.09 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.96 -39.87 95.12 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.38 97.51 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -107.64 66.72 0.67 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.84 59.7 4.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -75.01 150.65 38.88 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -68.34 -27.01 65.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -6.57 56.58 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.51 166.73 31.01 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.2 t -94.96 129.38 42.03 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -66.56 147.32 53.45 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -61.53 -40.52 94.94 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.17 -38.91 92.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.5 m -63.03 -36.54 83.9 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 50' ' ' ILE . 84.7 mt -60.25 -50.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.922 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.33 -32.92 64.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.24 -45.49 93.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.33 -47.83 84.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 9' ' ' MET . 95.2 mt -61.64 -46.56 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.19 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.14 -41.15 95.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.22 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -69.8 -39.83 76.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.914 -0.491 . . . . 0.0 112.237 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -97.8 -15.36 20.3 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.504 -0.747 . . . . 0.0 112.019 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -130.28 147.48 52.01 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.88 119.64 24.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.43 161.23 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.08 171.96 52.46 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.33 -39.83 85.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -77.82 -5.35 50.56 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.23 80.51 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.5 -38.95 82.25 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 t -63.66 -42.93 98.01 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -67.44 -36.64 81.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.45 -43.06 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.81 -41.08 97.32 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.17 -40.9 90.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.5 m -65.65 -42.05 91.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 28' ' ' ILE . 88.4 mt -63.11 -44.37 99.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -61.85 -43.72 98.27 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.51 -41.71 98.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 121.967 -0.458 . . . . 0.0 110.049 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.03 -39.7 95.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 121.601 -0.687 . . . . 0.0 109.215 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG21 ' CE2' ' A' ' 71' ' ' PHE . 77.4 t -65.52 -40.12 87.2 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.3 m -61.19 -41.34 96.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.1 m -70.31 -27.62 64.53 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.99 8.05 55.79 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.26 -44.02 91.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.95 147.68 22.87 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 36.6 tptt -92.72 149.45 21.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -81.95 151.66 27.1 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 63' ' ' LYS . 4.8 m -142.98 163.67 32.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 62' ' ' THR . 65.1 pttt -60.39 172.0 0.95 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.192 0.996 . . . . 0.0 110.865 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.99 33.04 57.98 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.6 t -70.57 119.88 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.61 -38.12 3.21 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.47 1.65 Allowed 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.5 m -108.52 -33.41 7.05 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.91 48.39 16.46 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 107.379 -2.288 . . . . 0.0 107.379 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.3 m -70.26 142.34 52.33 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.587 ' CE2' HG21 ' A' ' 54' ' ' VAL . 84.0 m-85 -130.94 149.22 52.67 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 14.8 mmm180 -123.32 177.52 5.56 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -108.85 132.93 53.54 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.35 109.12 17.59 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.262 1.738 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -159.29 155.4 26.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -156.32 156.42 30.18 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -85.04 -64.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.726 1.617 . . . . 0.0 112.426 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.88 144.83 51.15 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -67.14 -36.24 81.44 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 11' ' ' VAL . 66.6 m -61.83 -38.85 89.73 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.42 -41.44 98.7 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.7 -39.22 84.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.04 -43.29 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 7' ' ' SER . 61.6 t -62.22 -43.2 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.96 98.55 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.26 93.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.997 -0.439 . . . . 0.0 110.283 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.95 -39.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -63.55 -39.15 93.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.79 95.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -107.72 65.13 0.64 Allowed 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -86.15 59.25 5.53 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.85 168.86 18.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -37.13 86.54 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.05 -2.46 40.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.16 38.48 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 t -111.38 132.12 54.67 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.4 p -73.08 162.26 29.67 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -63.36 -40.71 98.03 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -64.47 -39.01 93.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.5 m -63.32 -38.78 92.47 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.04 -0.412 . . . . 0.0 109.904 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.474 HG21 HD11 ' A' ' 50' ' ' ILE . 87.8 mt -61.3 -49.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.109 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.57 -33.44 66.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.972 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.11 -45.35 88.98 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.857 -0.527 . . . . 0.0 109.657 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.33 -48.64 80.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.41 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.085 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.01 -41.83 95.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.791 -0.568 . . . . 0.0 110.411 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.9 m -69.33 -40.06 77.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.85 -0.531 . . . . 0.0 112.08 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -98.18 -14.23 20.48 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.957 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -133.66 148.19 51.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -81.27 127.23 32.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.54 157.16 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.49 177.63 30.93 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.9 -42.07 90.68 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.54 -39.61 94.08 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.6 95.11 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.67 -41.87 95.92 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.3 m -65.51 -39.84 92.31 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.7 -34.88 78.83 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.37 -44.64 96.45 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.02 -40.34 97.46 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.95 -40.73 91.59 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -64.11 -42.89 96.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.474 HD11 HG21 ' A' ' 28' ' ' ILE . 90.2 mt -61.83 -44.56 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -62.07 -43.28 99.18 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.32 -41.45 98.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.995 -0.441 . . . . 0.0 109.996 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -39.43 92.54 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.621 HG21 ' CE2' ' A' ' 71' ' ' PHE . 78.0 t -66.13 -40.19 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 m -60.85 -44.55 96.83 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.095 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -73.04 -15.94 61.5 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.812 -0.555 . . . . 0.0 109.877 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.68 64.72 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.25 -43.22 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.29 145.67 26.42 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -88.73 151.9 22.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -81.77 151.94 27.21 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.498 ' O ' HG13 ' A' ' 65' ' ' VAL . 4.6 m -143.52 164.06 31.42 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 62' ' ' THR . 23.4 pttp -59.24 167.17 1.88 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.181 0.991 . . . . 0.0 110.794 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.39 29.59 61.75 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -66.79 118.42 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.28 -38.33 3.14 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.67 1.92 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.7 m -107.54 -32.09 7.84 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 47.59 28.67 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.8 m -70.87 141.42 51.23 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.621 ' CE2' HG21 ' A' ' 54' ' ' VAL . 67.7 m-85 -133.11 150.15 52.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -118.39 166.3 12.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.29 140.9 30.29 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 107.77 19.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.5 tptt . . . . . 0 C--O 1.261 1.665 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.772 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.621 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -103.67 124.09 48.2 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -154.44 155.93 31.19 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -85.72 -66.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.827 1.685 . . . . 0.0 113.315 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.55 153.29 50.0 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -65.03 -37.95 89.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 11' ' ' VAL . 68.5 m -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.5 -40.1 96.18 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 77.4 mtm -66.46 -40.22 89.26 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.05 -43.93 99.3 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 7' ' ' SER . 59.9 t -62.45 -43.02 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.62 99.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 28' ' ' ILE . . . -64.33 -44.58 91.09 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.029 -0.419 . . . . 0.0 110.282 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.2 mt -69.35 -39.63 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -63.49 -39.22 93.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.88 96.12 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -107.5 65.79 0.65 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -82.92 59.34 4.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -77.34 151.65 34.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.64 -37.34 86.96 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.0 64.71 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.35 175.45 15.5 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.3 t -100.07 131.69 45.87 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 t -70.46 145.99 50.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.26 -40.65 96.91 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.85 -38.87 92.71 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.1 m -62.56 -37.33 85.75 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 88.8 mt -60.74 -48.65 87.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.792 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -72.17 -37.32 69.35 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.354 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.99 -41.2 97.58 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.49 -0.756 . . . . 0.0 109.944 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -61.7 -48.49 80.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.85 -45.4 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.083 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.27 -39.81 94.7 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.645 -0.659 . . . . 0.0 110.383 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 t -70.57 -41.98 71.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.887 -0.508 . . . . 0.0 111.72 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -92.87 -21.17 20.02 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.031 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -128.82 146.82 50.82 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.621 ' H ' ' N ' ' A' ' 1' ' ' GLY . 88.1 tttt -87.5 120.91 29.28 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.04 160.2 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.64 173.99 51.45 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.84 -40.12 83.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.91 -14.93 61.57 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.93 -35.62 81.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.62 -41.25 90.01 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -64.85 -39.9 94.29 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -67.07 -37.07 83.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.88 -41.71 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.63 -40.29 94.34 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.55 -39.84 88.76 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -64.81 -41.58 95.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.078 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.1 pt -70.11 -34.84 60.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.169 -178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.26 -39.79 89.7 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -64.57 -41.98 95.94 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.17 -39.36 94.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 50' ' ' ILE . 73.9 t -65.46 -40.36 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 m -61.09 -44.41 97.4 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.1 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.4 p -73.17 -16.35 61.43 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.749 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.71 65.51 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.13 -43.46 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.53 142.86 31.43 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.63 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 27.8 mtpp -84.68 150.83 24.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.504 HE21 HG11 ' A' ' 65' ' ' VAL . 64.4 tt0 -87.49 139.08 30.9 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 63' ' ' LYS . 2.9 m -129.98 163.95 25.32 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 62' ' ' THR . 10.1 ptpp? -62.53 170.47 2.45 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.09 0.948 . . . . 0.0 110.602 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 29.51 62.97 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -66.67 119.16 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.16 -38.66 3.01 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.81 1.87 Allowed 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 m -107.46 -32.32 7.77 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.4 47.19 36.8 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.5 m -70.95 140.71 51.01 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 54' ' ' VAL . 88.4 m-85 -130.31 147.32 52.01 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 69.9 mtp180 -115.15 149.05 38.22 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -87.89 127.05 35.35 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -87.89 110.45 20.54 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 C--O 1.26 1.644 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.45 -39.02 91.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.33 83.35 44.26 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.11 -26.11 36.95 Favored 'Trans proline' 0 CA--C 1.5 -1.206 0 C-N-CA 121.553 1.502 . . . . 0.0 113.193 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -131.34 135.1 46.96 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -68.53 -29.2 67.73 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 11' ' ' VAL . 84.4 p -63.23 -26.82 68.97 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.81 -42.2 97.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.18 -40.16 82.33 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.59 -43.22 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 7' ' ' SER . 53.0 t -62.18 -42.72 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.63 -42.02 98.3 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.4 93.17 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.97 -0.456 . . . . 0.0 110.244 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.51 -39.33 76.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.17 -37.76 86.49 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.1 85.05 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -126.04 79.19 1.82 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.265 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -83.25 58.73 4.62 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -66.05 151.54 46.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.66 -35.89 81.11 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.77 -5.57 46.46 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.84 170.1 35.41 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -95.46 130.67 42.19 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -67.99 151.02 47.74 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -61.69 -41.44 97.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.49 -38.73 92.25 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.7 t -62.37 -39.93 94.77 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.54 -48.83 86.86 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 O-C-N 122.005 -0.435 . . . . 0.0 110.09 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -72.67 -33.98 66.91 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.318 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -66.21 -40.68 90.52 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.42 -48.57 80.57 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.34 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.17 -41.94 96.91 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.77 -0.582 . . . . 0.0 110.457 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -69.46 -39.96 77.42 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.863 -0.523 . . . . 0.0 111.987 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -94.75 -21.21 18.89 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.569 -0.707 . . . . 0.0 111.826 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -128.62 143.38 50.94 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -77.44 128.1 33.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.81 158.23 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.64 -179.92 28.02 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -70.52 -31.87 69.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.14 -38.25 81.97 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.36 90.82 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.67 -40.44 92.11 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -65.31 -39.85 93.01 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -65.3 -39.06 92.02 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.17 -45.0 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.36 -42.1 99.14 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.34 -39.49 85.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -63.58 -43.69 96.25 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.21 -45.39 98.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.9 -39.98 95.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.917 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -64.76 -41.21 96.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.855 -0.528 . . . . 0.0 109.809 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.99 -39.72 95.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.8 t -65.4 -40.58 88.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 m -61.18 -41.7 97.26 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -70.22 -27.79 64.75 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.34 8.03 55.35 Favored Glycine 0 C--N 1.349 1.288 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.27 -43.36 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.87 143.8 28.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 87.0 mttt -84.68 150.95 24.79 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -86.76 151.65 23.2 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 63' ' ' LYS . 3.4 m -142.35 164.36 30.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 62' ' ' THR . 64.9 pttt -60.59 167.9 2.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 122.01 0.91 . . . . 0.0 110.663 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.19 26.63 67.94 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.4 p -66.16 120.76 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.91 0.862 . . . . 0.0 108.832 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -38.82 2.95 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -61.9 1.84 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 m -107.79 -31.48 8.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.84 48.05 29.54 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -70.51 141.02 51.98 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 54' ' ' VAL . 72.1 m-85 -132.13 149.46 52.39 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 75.4 mtp180 -116.06 152.62 33.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -88.76 126.87 35.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . . . -84.99 109.98 18.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 tptt . . . . . 0 C--O 1.263 1.795 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.67 ' N ' ' H ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -100.05 127.8 46.22 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -135.04 83.17 40.55 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.93 -76.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 121.769 1.646 . . . . 0.0 112.476 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -131.71 144.38 50.95 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.36 -39.17 88.99 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 11' ' ' VAL . 80.0 p -65.13 -38.68 91.43 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.836 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.51 -40.08 92.59 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.5 mtp -66.82 -40.49 88.06 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -64.39 -43.23 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 7' ' ' SER . 53.0 t -62.05 -43.43 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.85 98.35 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . . . -63.98 -44.34 93.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 122.003 -0.436 . . . . 0.0 110.246 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.5 mt -68.93 -38.81 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.72 -40.39 97.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.81 96.86 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -106.63 65.37 0.67 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -81.63 57.62 3.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.34 148.12 43.76 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -63.59 -36.64 84.47 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.91 64.98 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.01 169.51 14.74 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 t -99.61 126.05 45.53 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -70.19 153.4 43.16 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -62.14 -41.39 98.22 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.6 -38.2 90.23 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.3 m -63.72 -38.28 90.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.6 mt -60.93 -49.78 83.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.66 -32.84 66.14 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.944 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -62.9 -45.31 93.1 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 121.815 -0.553 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD2' ' HA ' ' A' ' 13' ' ' ALA . 77.6 t80 -61.11 -47.89 84.17 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.46 -46.08 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.197 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.98 -39.56 93.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.518 -0.738 . . . . 0.0 110.29 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -70.39 -39.87 74.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.999 -0.438 . . . . 0.0 112.18 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -99.61 -13.59 19.33 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.13 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.36 148.84 52.44 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.67 ' H ' ' N ' ' A' ' 1' ' ' GLY . 24.5 tptm -87.14 118.56 26.62 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.91 157.96 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.01 177.27 35.21 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -39.29 87.61 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -63.79 -38.31 90.64 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.11 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.77 -40.37 92.32 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -65.28 -39.96 93.27 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -65.79 -38.2 88.34 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.54 -45.32 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.57 -41.24 98.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.98 -39.59 87.2 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.8 m -64.72 -40.75 95.88 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.2 mt -62.13 -45.33 98.99 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -64.02 -39.95 95.25 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.2 -40.97 99.0 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.21 -38.45 89.21 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.629 HG21 ' CE2' ' A' ' 71' ' ' PHE . 79.5 t -65.46 -40.64 88.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.57 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 m -60.78 -44.18 97.13 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.082 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.9 p -72.89 -16.72 61.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.773 -0.58 . . . . 0.0 109.725 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.86 7.6 64.32 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.5 -43.23 94.42 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.7 mt -99.43 146.78 25.95 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -86.1 151.9 23.31 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.16 136.26 33.12 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 63' ' ' LYS . 6.0 m -127.8 163.7 23.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 62' ' ' THR . 26.1 pttm -58.81 172.04 0.58 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.146 0.974 . . . . 0.0 110.845 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.82 32.18 57.33 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.73 119.47 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.98 -37.94 3.29 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.84 -63.3 1.42 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.1 p -108.75 -29.08 8.86 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.49 47.93 39.59 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.4 m -70.27 139.76 52.22 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 54' ' ' VAL . 65.6 m-85 -132.93 150.29 52.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -114.94 154.28 29.02 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.45 127.47 35.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.29 108.21 19.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.261 1.704 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.832 . . . . . . . . 0 0 . 1 stop_ save_